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1 INTRODUCTION 
1.1 Rac1 – a small Rho GTPase 
1.1.1 The Rho family of small GTPases 
Rho GTPases belong to the Ras superfamily of small GTPases. They are 20-25 kDa 
signalling molecules, which regulate many cellular processes (1.1.3) acting as molecular 
switches (1.1.2). They are characterized by the presence of the ~20 kDa structurally conserved 
G-domain (six-stranded β-sheet surrounded by five α-helices), which conveys the ability to bind 
and to hydrolyze GTP (Vetter and Wittinghofer, 2001). Members of the Rho family are 
distinguished from other small GTPases by the Rho insert (conserved α-helical domain) located 
between the fifth β-strand and the fourth α-helix of the GTPase domain (Hirshberg et al., 1997).  
In mammals, the Rho family comprises 22 genes. They encode at least 25 proteins, which 
can be classified into sub-families on the basis of their amino acid sequence identity, structural 
motifs and biological functions (Fig. 1.1). 
Fig. 1.1 Phylogenetic tree of the Rho family GTPase. On the basis of primary amino acid sequence 
identity, closely related proteins can be further grouped within the family (colour patches). Sequences 
were aligned using the ClustalW algorithm and sequence distances displayed as unrooted 
dendrograms in TreeView. The alignment considered only the Rho GTPase domain in BTB-
containing Rho GTPases. Miro proteins were not included (modified form Wherlock and Mellor, 
2002). 
Classical Rho GTPases comprise four sub-families – Rho (RhoA, RhoB, RhoC), Rac (Rac1, 
Rac2, Rac3, RhoG), Cdc42 (Cdc42, TC10, TCL, Wrch-1, Chp/Wrch-2) and Rnd (Rnd1, Rnd2, 
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Rnd3/RhoE) – and three proteins that do not fall into any of the above groups – RhoD, Rif and 
RhoH/TTF. They consist only of a GTPase domain with short N- and C-terminal sequences and 
share 40-95% amino acid sequence identity. Most differences between members of subfamilies 
are found in the C-terminal sequence (Wennerberg and Der, 2004).  
With exception of Chp/Wrch-2, all classical members of the Rho family undergo 
post-translational modifications at the C-terminal end, which are determined by the presence of 
the CAAX motif (C: cystein, A: aliphatic and X: any amino acid). The cysteine residue becomes 
isoprenylated with either geranylgeranyl (C20) or farnesyl (C15). Subsequently, the AAX 
tripeptide is proteolytically removed and the cystein becomes carboxylmethylated (Clarke, 1992; 
Zhang and Casey, 1996). Some Rho GTPases are additionally modified with palmitoyl at another 
cystein residue, which directly precedes the CAAX motif (Fig. 1.2).  
Fig. 1.2 Differences in the domain structure and the variety of post-translational modifications 
of Rho GTPases. Classical Rho GTPases terminate with the CAAX motif, which determines the 
isoprenylation and the subsequent carboxylmethylation of the cysteine residue (after the removal of 
AAX residues). When a cysteine residue is present before the CAAX motif, it is modified with 
palmitoyl. The polybasic sequence is an additional membrane targeting signal. The atypical Rho 
GTPases are significantly bigger than other members of the family and contain additional domains 
after the Rho GTPase domain. Chp/Wrch-2 and the atypical Rho GTPases do not terminate with the 
CAAX sequence and do not undergo any known post-translational modifications. The proteins, which 
modifications are predicted but have not been experimentally verified, are marked with a question 
mark (?). EFH: EF-hand domain (based on a figure from Wennerberg and Der, 2004). 
Lipid moieties and a highly variable polybasic sequence present within the majority of 
C-terminal sequences (Fig. 1.2) mediate the association of Rho GTPases with cellular 
membranes, which is essential for their function. The diversity of post-translational 
modifications is likely to influence the translocation to a specific site within the cell and 
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contribute to the diversity of functions seen in otherwise closely related members of subfamilies. 
Members of RhoBTB (RhoBTB1 and RhoBTB2) and Miro (Miro-1 and Miro-2) subfamilies 
are much bigger (~70 kDa) and structurally different from other Rho GTPases (Rivero et al., 
2001; Fransson et al., 2003). They have extensive C-terminal sequences that form additional 
domains (Fig. 1.2) and they do not undergo any post-translational modifications, as they lack the 
CAAX motif. In addition, Miro subfamily members do not contain the characteristic Rho insert 
within the GTPase domain, which sets them apart from all other members of the Rho family. 
Atypical Rho GTPases, unlike classical members of the Rho family (with the exception of 
RhoH), do not influence the actin cytoskeleton or cell morphology (Aspenstrom et al., 2004).  
1.1.2 Regulation of Rho GTPases. 
The biological role of Rho proteins as molecular switches is based on their ability to shuttle 
between an inactive (GDP-bound) and an active (GTP-bound) state in a tightly regulated manner 
(Fig. 1.3).  
Fig. 1.3 Regulation of the GTPase cycle. The role of Rho proteins as ‘molecular switches’ is based 
on their ability to cycle between an inactive GDP-bound form and an active GTP-bound form, in 
which they can interact with different effector molecules. The exchange of nucleotides is regulated by 
GEFs, GAPs and GDIs. The latter are involved in controlling the distribution of Rho GTPases within 
the cell as well. Pi: inorganic phosphate; wavy line: lipid moiety (modified from Aktories and 
Barbieri, 2005). 
GTPases bind nucleotides with high-affinity in the presence of Mg2+ as a cofactor. The 
interaction induces conformational changes of the protein structure, which are confined primarily 
to two highly conserved regions named switch I and II and depend on the type of the bound 
nucleotide. The configuration of switch regions in the GTP-bound state enables interactions with 
a multitude of effector proteins (Vetter and Wittinghofer, 2001). The hydrolysis of GTP to GDP, 
catalysed by an intrinsic GTPase activity, leads to the release of an inorganic phosphate (Pi) and 
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the inactivation of the protein due to remodelling of switch regions. Three types of regulating 
proteins control the exchange cycle: guanine nucleotide-exchange factors (GEFs), GTPase-
activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs).  
In addition, the activity of Rho proteins is regulated through their association with 
membranes and subcellular localisation, which are influenced by post-translational modifications 
of the C-terminus (1.1.1) and interaction with GDIs (1.1.2.3).  
Some Rho GTPases seem to be regulated at the expression level as well. They are expressed 
only in certain tissues (e.g. Rac2 in hematopoietic system) or only when they are needed, in 
response to a specific stimulus (e.g. growth-induced RhoG; (Vincent et al., 1992). 
Transcriptional regulation might be especially important for members of the Rho family, which 
are GTPase-deficient (Rnd1-3, RhoH/TTF) and therefore can not be controlled through the 
classical switch mechanism (Wennerberg and Der, 2004). 
1.1.2.1 GEFs 
In response to diverse extracellular stimuli, GEFs activate Rho GTPases by facilitating the 
exchange of GTP to GDP. The majority of mammalian GEFs belong to the Dbl family, which 
comprises 69 known proteins. They are characterized by the presence of a Dbl homology (DH) 
domain that is essential for the GEF activity.  
With the exception of three conserved regions (CR1, CR2, and CR3), DH domains share 
little sequence homology with each other. However, their three-dimensional structures are very 
similar. CR1 and CR3, together with conserved residues within the C-terminal helix of the DH 
domain, participate in the formation of the GTPase interface surface. It interacts with switch 
regions of GDP-bound Rho GTPases and induces their remodelling. This leads to an alteration of 
the nucleotide-binding pocket and the dissociation of both GDP and Mg2+ cofactor. Because of 
the high intracellular ratio of GTP to GDP, the exposed pocket is preferentially filled with 
GTP·Mg2+, which results in another conformational change of switch regions and the 
dissociation of the GEF-GTPase complex (Cherfils and Chardin, 1999; Rossman et al., 2005).  
Almost all members of the Dbl family contain a pleckstrin homology (PH) domain (adjacent 
and C-terminal to the DH domain), which is thought to mediate the translocation of GEFs to 
membranes and to regulate the activity of the DH domain through allosteric mechanisms. The 
PH domain can also function as a docking site for proteins that are associated with signalling 
cascades regulated by Rho GTPases (Rossman et al., 2005). Apart from the DH–PH module, 
most GEFs contain additional functional domains (e.g. SH2, SH3, Ser/Thr kinase, Ras-GEF, 
Rho-GAP, PDZ or more PH domains). These are likely to be involved in coupling GEFs to 
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upstream receptors and signalling molecules (Schmidt and Hall, 2002). The diversity of protein 
domains and motifs that flank the DH–PH tandem signifies the multitude of different signalling 
pathways, into which Dbl-family members are integrated.  
The DOCK180 family is a genetically distinct group of proteins that have the ability to act as 
GEFs for Rho GTPases. Currently, 11 mammalian Dock180-related proteins are identified and 
only Rac and Cdc42 have been shown to be regulated by them. Dock180 family members do not 
contain the characteristic Dbl homology (DH) domain. Instead, they have a conserved CZH2 
domain, which mediates the nucleotide exchange (Cote and Vuori, 2002; Meller et al., 2002). 
Some members of the Dock180 family need to bind an evolutionarily conserved cofactor ELMO 
in order to activate Rac (Lu and Ravichandran, 2006). 
1.1.2.2 GAPs 
In general, GAPs act as negative regulators of Rho GTPases by stimulating the weak 
intrinsic hydrolytic capacity and thereby promoting the transition into GDP-bound form, which 
results in termination of signalling. The GAP family comprises around 80 proteins, which 
contain a conserved RhoGAP domain. It consists of about 150 amino acids and shares at least 
20% sequence identity between family members, but has no significant resemblance to GAP 
domains of other Ras superfamily GTPases. The RhoGAP domain is sufficient for interacting 
with GTP-bound Rho proteins and accelerating their GTPase activity. However, like GEFs, 
GAPs typically contain additional functional motifs (e.g. Rho-GEF, Arf-GAP, SH2, SH3, 
Ser/Thr kinase or PH domains), which indicate their integration in various signalling pathways. 
Some even seem to facilitate the signalling acting as effectors (Moon and Zheng, 2003). 
The RhoGAP domain interacts with switch regions and acts by inserting a highly conserved 
arginine residue, referred to as “arginine finger”, into the GTPase active site. The direct 
interaction with a conserved glutamine residue in the catalytic center of a Rho protein stabilizes 
the water molecule in a correct position for the phosphoryl transfer and may reduce the energy 
barrier for GTP hydrolysis. The arginine residue also interacts with GTP and a water molecule of 
the hydrated Mg2+ ion to stabilize the configuration of the triphosphate group and the ion, as well 
as to neutralize the charges of the phosphate group (Hakoshima et al., 2003). 
1.1.2.3 GDIs 
In contrast to the abundance of described GAPs and GEFs, only three mammalian RhoGDIs 
have been identified. They differ in the expression pattern, the localization within the cell and the 
specificity of interaction with different members of the Rho family. RhoGDI1 is the most 
abundant and ubiquitous representative, and it is able to form cytosolic complexes with most 
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members of the Rho family. Expression of RhoGDI2 (Ly/D4GDI) is restricted to hematopoietic 
cells and is specific for the Rac subfamily GTPases. RhoGDI3 (RhoGDIγ), which is expressed in 
lung, brain and testis, is associated with the Golgi apparatus and exhibits specificity for RhoB 
and RhoG (DerMardirossian and Bokoch, 2005) 
GDIs were first described as negative regulators of the Rho proteins. They inhibit the 
spontaneous dissociation of GDP and prevent the interaction with GEFs, sequestering inactive 
GTPases in the cytoplasm. In addition, they were shown to be able to bind Rho proteins in the 
active state, blocking the intrinsic GTPase activity and GAP-induced inactivation, as well as 
preventing the interaction with effector proteins.  
However, an equally important function of GDIs seems to be their ability to positively 
influence Rho signalling, by regulating the membrane-cytosol shuttling of GTPases. They are 
thought to be actively targeting Rho proteins to specific locations within the cell through 
interaction with protein complexes or receptors that still remain to be identified (Olofsson, 1999; 
Dransart et al., 2005).  
The GDI structure comprises two structurally distinct regions: the N-terminal flexible 
domain and the C-terminal immunoglobulin-like fold. Both domains contribute to the binding of 
Rho proteins and consequently to the regulatory actions of GDIs through protein–protein and 
protein–lipid interactions The N-terminal domain interacts with the switch regions of the 
GTPases and affects the GDP–GTP cycling. The C-terminal domain accommodates the 
isoprenyl moiety of the GTPase in its hydrophobic pocket, regulating the cytosol-membrane 
shuttling (Dovas and Couchman, 2005). The exact mechanisms of the membrane targeting and 
the extraction of Rho GTPases from the complex with GDIs or from the membrane are still not 
fully understood. 
1.1.3 Signalling through Rho GTPases 
Extracellular stimuli, such as soluble molecules (growth factors, cytokines and hormones), 
adhesive interactions (extracellular matrix and cell-cell adhesion) or mechanical stress (tension, 
compression and fluid shear stress), activate various receptors on the surface of the cell, 
including G-protein-coupled receptors (GPCRs), tyrosine kinase receptors, cytokine receptors 
and adhesion receptors such as integrins or cadherins (Kjoller and Hall, 1999).  
Relayed through GAPs, GEFs and GDIs, those signals influence the activation state of Rho 
GTPases. Once activated, Rho proteins interact with a wide spectrum of effectors to stimulate a 
multitude of downstream signalling pathways (Fig. 1.4).  
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Fig. 1.4 Signalling through small GTPases. 
 
Fi
g.
 1
.4
 S
ig
na
lli
ng
 th
ro
ug
h 
R
ho
 G
TP
as
es
. S
ch
em
at
ic
 re
pr
es
en
ta
tio
n 
of
 v
ar
io
us
 e
xt
ra
ce
llu
la
r s
tim
ul
i, 
w
hi
ch
 in
flu
en
ce
 s
m
al
l G
TP
as
es
 b
y 
ac
tiv
at
in
g 
re
gu
la
to
ry
 G
EF
s 
an
d 
G
A
Ps
, 
as
 w
el
l 
as
 m
aj
or
 d
ow
ns
tre
am
 s
ig
na
lli
ng
 p
at
hw
ay
s 
of
 t
hr
ee
 m
os
t 
ex
te
ns
iv
el
y 
de
sc
rib
ed
 m
em
be
rs
 o
f 
th
e 
fa
m
ily
: 
R
ho
, 
R
ac
 a
nd
 C
dc
42
 (
m
od
ifi
ed
 f
ro
m
 
Sc
hw
ar
tz
, 2
00
4)
. 
Introduction 
18 
Rho-family proteins are involved in regulation of the actin cytoskeleton dynamics, cell 
migration, cell-cell and cell-ECM adhesion, cell-cycle progression, gene transcription, 
phagocytosis, cytokinesis, neurite growth, cellular morphogenesis and polarization, growth and 
cell survival (Braga, 2002; Etienne-Manneville and Hall, 2002; Raftopoulou and Hall, 2004; 
Jaffe and Hall, 2005). In addition, abnormal changes in the activation of Rho GTPases promote 
malignant transformation of cells and their activity is needed to relay Ras transforming signals 
(Sahai and Marshall, 2002; Ridley, 2004). 
RhoA, Rac1 and Cdc42 are the most extensively characterized members of the Rho family 
and the current knowledge about the function of Rho GTPases is based predominantly on data 
obtained during studies of those three members of the family. As other Rho proteins are further 
analysed, some of their functions seem to overlap with those already described, while others are 
clearly distinct, especially in case of the atypical Rho GTPases (Wennerberg and Der, 2004). The 
best described role of the three classic Rho GTPases, which seems to be shared by majority of 
the family members, is their involvement in the actin cytoskeleton regulation. However, their 
respective functions are quite distinct. RhoA regulates the formation of contractile actin/myosin 
stress fibres and the organization of focal contacts (Ridley and Hall, 1992), Rac1 is involved in 
the formation of lamellipodia and focal complexes (Ridley et al., 1992) and Cdc42 triggers the 
formation of filopodia as well as focal contacts (Kozma et al., 1995; Nobes and Hall, 1995). 
Less-analysed members of the Rho family may prove to be involved in biological 
phenomena, which currently are thought to be controlled solely by RhoA, Rac1 or Cdc42, 
because they were the only Rho proteins considered and analysed at the time. In addition, 
dominant-negative (DN) and constitutively active (CA) forms of GTPases, commonly used for 
the analysis, might exert unspecific effects. DN GTPases have higher affinity to GEFs and lower 
affinity to nucleotides than wild-type forms. Therefore, they successfully compete with 
endogenous proteins for GEF-binding and sequester available GEFs by remaining longer in the 
complex (1.1.2.1). Moreover, even if bound with GTP, DN forms are not able to interact with 
effectors. Expression of DN mutants at high enough concentration to ensure complete saturation 
of GEFs is crucial for an effective inhibition of wild-type GTPases. Since many GEFs are not 
specific for a single Rho GTPase, DN mutants may inhibit more then one Rho GTPase, making 
the interpretation of results difficult (Feig, 1999). Therefore, studies using cells with genetically 
induced ablation of GTPases seem to be a good alternative tool to refine the knowledge obtained 
using DN forms. CA mutants lack the intrinsic GTPase activity and are thought to be 
permanently bound with GTP. As their activation can not be controlled endogenously, they may 
cause atypical effects, especially when overexpressed.  
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1.1.4 Crosstalk between Rho GTPases 
In their role as regulators of intracellular processes, Rho GTPases influence downstream 
signalling pathways, not only by controlling their effector molecules, but also through 
modulating the activation of other GTPases. Many examples of crosstalk between members of 
Rho family (Fig. 1.5), as well as with other GTPases from the Ras superfamily have been 
described. There are examples where one family member suppresses the activity of another by 
stimulating a GAP, or elevates it by stimulating a GEF. In addition, there are proteins (e.g. Bcr 
and Abr) that contain both GAP and GEF domains for different Rho members. The interplay 
between family members is also mediated by interactions between their respective downstream 
signalling pathways (Burridge and Wennerberg, 2004). 
Fig. 1.5 Crosstalk between Rho GTPases. Activating signals are shown as black arrows, inactivating 
as red. Direct signals are drawn as solid lines, whereas signals with unknown signalling intermediates 
are drawn as dashed lines. O2•−: superoxide anion; LMW-PTP: low molecular weight protein tyrosine 
phosphatase (modified from Burridge and Wennerberg, 2004). 
The first described example of crosstalk between Rho GTPases was a hierarchical cascade 
linking Rho, Rac and Cdc42. In serum-starved Swiss 3T3 fibroblasts, activation of Cdc42 
induces activation of Rac, which in turns leads to activation of Rho (Ridley et al., 1992; Kozma 
et al., 1995; Nobes and Hall, 1995). In contrast, active Rac inhibits Rho function in growing 
NIH3T3 cells (Sander et al., 1999). A possible mechanism of Rho inhibition was recently 
described (Fig. 1.5). The Rac-mediated production of oxygen radicals causes an inhibition of the 
low molecular weight protein tyrosine phosphatase (LMW-PTP), which in turn leads to the 
activation of p190RhoGAP that stops Rho signalling (Nimnual et al., 2003). 
RhoG was reported to activate Rac1 and Cdc42 (Gauthier-Rouviere et al., 1998) and a 
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signalling pathway influencing Rac1 was recently described (Fig. 1.5). Activated RhoG interacts 
directly with ELMO and forms a ternary complex with Dock180 to induce activation of Rac1 
(Katoh and Negishi, 2003).  
Rnd GTPases can inhibit RhoA signalling by activating p190RhoGAP (Wennerberg et al., 
2003). In addition, Rnd3/RhoE can bind and inactivate Rho Kinase (Riento et al., 2003). RhoH 
was shown to inhibit Rac1, Cdc42 and RhoA induced signalling (Li et al., 2002), while RhoD 
counteracts RhoA activity (Tsubakimoto et al., 1999). 
1.1.5 The Rac subfamily 
The Rac1 subfamily comprises four proteins. Rac1, Rac2 and Rac3 share ~88% sequence 
identity and differ primarily within the last 15 amino acid residues. RhoG is the most divergent 
member of the subfamily and shares 72% of the overall amino acid sequence with Rac1. All 
Rac-related GTPases are able to stimulate the formation of lamellipodia and membrane ruffles, 
but they were shown to have distinct functions as well (Wennerberg and Der, 2004). 
Rac1 is expressed ubiquitously and its constitutive ablation results in embryonic lethality 
around day 8.5 of development (Sugihara et al., 1998). In vitro studies showed that, in addition 
to the involvement in the regulation of the actin cytoskeleton organization (Ridley et al., 1992), 
Rac1 plays a role in the cell-cycle progression (Olson et al., 1995), the activation of the 
JNK/SAPK and p38 MAP kinase cascades (Coso et al., 1995; Minden et al., 1995), the 
regulation of NADPH oxidase activity resulting in the production of superoxide radicals 
(Diekmann et al., 1994) and the activation of NF-κB (Perona et al., 1997). In addition, 
Rac1-mediated signalling was found to be involved in the regulation of tight junction properties 
(Jou et al., 1998; Mertens et al., 2005), cadherin-mediated cell-cell adhesion (Braga et al., 1997; 
Takaishi et al., 1997; Braga et al., 1999; Braga et al., 2000), integrin-mediated cell-matrix 
adhesion (Hotchin and Hall, 1995; Nobes and Hall, 1995; Price et al., 1998) and establishment of 
cell polarity (O'Brien et al., 2001). 
A splice variant of Rac1 was described to be expressed in humans, preferentially in breast 
and colon cancers (Jordan et al., 1999; Schnelzer et al., 2000). Rac1b is generated by an 
alternative exon usage and contains an additional 19-residue insert directly after the switch II 
region. It exhibits properties consistent with a constitutively activated protein as it shows an 
increased intrinsic guanine nucleotide exchange rate, decreased intrinsic GTPase activity and 
enhanced association with the plasma membrane, likely because of its inability to interact with 
GDIs (Matos et al., 2003; Fiegen et al., 2004). In addition, it has different from Rac1 signalling 
properties, as it is unable to stimulate formation of lamellipodia or activation of the protein 
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kinase PAK and the JNK pathway, but retains the ability to activate the NF-κB transcription 
factor (Matos et al., 2003). 
Rac2 is expressed only in hematopoietic cells, where it seems to have specialized functions, 
setting it apart from Rac1. Rac2 deficiency allows for normal development but results in several 
neutrophilic, phagocytic and lymphocytic defects (Roberts et al., 1999; Li et al., 2000; Croker et 
al., 2002; Gu and Williams, 2002). Many of these defects seem to be caused by the lack of 
Rac2-specific activation of NADPH oxidase. Comparison of defects in hematopoietic cell 
function, observed after single and combined ablations of Rac1 and Rac2, demonstrated both 
overlapping and distinct roles of these two related GTPases in hematopoietic cells (Gu et al., 
2003; Walmsley et al., 2003; Benvenuti et al., 2004). 
Rac3 is most highly expressed in the developing nervous system and in adult brain. In 
addition it was described to be upregulated in fibroblasts upon serum stimulation (Haataja et al., 
1997) and to be hyperactive in breast cancers (Mira et al., 2000). Rac3-deficient mice have no 
obvious anatomical or physiological defects. However, they show interesting behavioural 
abnormalities (Corbetta et al., 2005). A study using mice lacking Rac3 showed its stimulatory 
influence on the development of lymphoblastic leukaemia (Cho et al., 2005).  
Transcriptionally regulated expression of RhoG is elevated during the G1 phase of the cell 
cycle, and it has been implicated in cell growth (Vincent et al., 1992). RhoG interacts with some 
but not all of the same effectors as Rac1 (Wennerberg et al., 2002; Prieto-Sanchez and Bustelo, 
2003), and it has also been shown to activate Rac1 and Cdc42 (Gauthier-Rouviere et al., 1998; 
Katoh et al., 2006) (1.1.4). In addition RhoG was reported to play a specific role in the nerve 
growth factor (NGF)-mediated neurite outgrowth in PC12 cells (Katoh et al., 2000). 
1.2 Skin 
The primary purpose of skin and its appendages (i.e. hairs and glands) is to provide the body 
with a barrier against the environment. It protects the body from dehydration, temperature 
changes, radiation, mechanical trauma and infections, as well as mediates the interaction with the 
environment (sensory function). 
The skin can be roughly divided into the outward epidermis and the underlying dermis, 
which are separated by the basement membrane (BM). The mesoderm-derived dermis provides 
mechanical support and nourishment for the avascular epidermis. In addition, it is a source of 
signalling cues inducing the differentiation of the epidermis and the development of hair 
follicles. The dermis consists mostly of fibroblasts, surrounded by an extracellular matrix 
secreted by these cells. The matrix is composed of collagen and elastin fibres, which convey the 
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strength and elasticity of the skin, and of a proteoglycan gel that imparts the capacity to retain 
water. The aqueous portion of the matrix permits diffusion of nutrients, metabolites and 
signalling molecules and creates turgor pressure able to withstand considerable compression 
force (Byrne and Hardman, 2002). Below the dermis lays the subcutaneous layer consisting 
mainly of adipocytes. It provides thermal isolation, cushions the skin, and attaches it to the 
underlying muscle. In mouse skin, thickness of the subcutis changes periodically as it is adjusted 
to the length of the hair follicles.  
The BM originates from components secreted by both keratinocytes (epidermal cells) and 
fibroblasts, which include laminins (5, 6 and 10), nidogen (Nd), collagen IV and heparin 
sulphate proteoglycan (HSPG). Anchoring fibrils, composed of collagen VII, attach the BM to 
the underlying dermis (McMillan et al., 2003), while the epidermis is anchored to the BM 
mainly through integrin receptors. Integrins α2β1 and α3β1 bind collagen IV and laminin 5 (LN5), 
respectively, and connect the BM to the actin cytoskeleton in the cell. The α4β6 integrins form 
hemidesmosomes, which anchor the intermediate filament network inside the keratinocytes to 
LN5 within the BM (Watt, 2002). Attachment to the BM plays a critical role in the establishment 
of epithelial polarity providing a spatial cue for reorganization of cell morphology. 
1.2.1 Epidermis morphology and differentiation 
The epidermis is a stratified squamous epithelium derived from the ectoderm, a single-cell 
sheet of undifferentiated epithelial cells constituting the outer layer of the post-gastrulation 
embryo. The distinct layers of the epidermis represent successive stages of the terminal 
differentiation process, which results in the formation of a cornified protective barrier of the 
body (Fig. 1.6). The ectoderm gives rise not only to the epidermis but to hair follicles (HFs), 
sebaceous glands (SGs) and apocrine glands as well (Byrne and Hardman, 2002).  
Cells attached to the BM form the basal layer of the epidermis and comprise the only 
keratinocytes in the epidermis capable of proliferation. Stem cells, residing in the basal layer 
ensure the continuous self renewal of those transit amplifying cells and thus the whole epidermis 
(Blanpain and Fuchs, 2006). In addition, melanocytes (pigment producing cells) and Merkel cells 
(mechanoreceptors), which constitute 5-10% of all epidermal cells, are located in the basal layer. 
Other non-epithelial cells found in the epidermis are Langerhans cells, immature dendritic cells 
involved in the immunological response to a pathogen infection (antigen uptake, processing and 
presentation). They reside in the spinous layer and constitute around 5% of all epidermal cells.  
Mitotically active keratinocytes express keratins 5 and 14 (K5/K14) (Fuchs and Green, 
1980) and extracellular matrix components (mainly LN5). The latter are secreted at the basal side 
Introduction 
23 
and assembled into the BM by integrin receptors that mediate cell-ECM adhesion of epidermal 
cells (Watt, 2002). Cell-cell adhesion between basal keratinocytes is maintained by desmosomes 
and adherens junctions (cadherin-dependent cell–cell contacts), which are associated with the 
actin cytoskeleton and the intermediate filament network, respectively (1.3). After undergoing a 
limited number of divisions, transit amplifying cells withdraw from the cell cycle. They 
downregulate expression of integrins, matrix components and K5/K14, detach from the BM and 
move upwards starting the terminal differentiation process.  
Fig. 1.6 Schematic representation of the epidermis. Skin, the outer layer of the body, consists of the 
epidermis and the dermis, which are separated by the basement membrane (BM). The epidermis is an 
example of a stratified epithelium and consists of distinct layers of keratinocytes, representing 
successive stages of a terminal differentiation process. Cells in each layer of the epidermis express 
specific keratins (brackets) (modified from Alonso and Fuchs, 2003). 
Suprabasal keratinocytes in the spinous layer express high amounts of K1 and K10 (Fuchs 
and Green, 1980). These keratins are assembled into intermediate filaments, which aggregate 
into resilient bundles. The filament network facilitates an increase in the tensile strength of cells 
by anchoring to desmosomes, which are abundant in the suprabasal layer and enable dissipation 
of tension across the epithelial sheet (Fuchs and Cleveland, 1998). Transition into the granular 
layer is characterized by expression of fillagrin and loricrin (Rothnagel et al., 1987; Mehrel et 
al., 1990). Filaggrin aggregates the keratin filaments into tight bundles, which promote the 
collapse of cells into a flattened shape. Tight junctions are formed between cells in the granular 
layer, contributing to barrier properties of the epidermis (Furuse et al., 2002). Keratinocytes 
complete the differentiation as they form the cornified envelope beneath the plasma membrane, 
which consists of proteins (involucrin, loricrin, trichohyalin) crosslinked by transglutaminases 
and specific lipids on the outside. Finally, terminally differentiated keratinocytes cease 
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transcriptional and metabolic activity, undergo an apoptosis-related cell death and become 
squames that constitute the stratum corneum (cornified layer) (Kalinin et al., 2002; Candi et al., 
2005). Outer squames are shed from the surface of the skin and are constantly replaced by new 
layers of terminally differentiated keratinocytes. In mouse skin, the entire transition process from 
a basal layer keratinocyte to a squame cell takes 10–14 days (Potten, 1975). 
The molecular mechanisms controlling epidermal morphogenesis are still being investigated, 
however the transcription factor p63, Ca2+, Notch and IKKα signalling pathways have been 
shown to play an important role in the differentiation of the epidermis (Koster and Roop, 2004).  
1.2.2 Hair follicle morphogenesis and cycling 
Hair follicles (HFs) vary in size and shape, depending on their location, but they all have the 
same basic structure and follow the same developmental path. After the morphogenesis HFs 
enter a perpetual cycle of deterioration and regrowth (Fig. 1.7).  
The formation of HFs starts during embryogenesis and the precise distribution, number and 
type of HFs are established at the time of the initiation. The morphogenesis of murine pelage 
hairs starts between day 14 and 17 of the embryonic development (depending on the hair type) 
and is completed by day 8 after birth (Schmidt-Ullrich and Paus, 2005).  
The HF development is controlled by the signal exchange between the epidermis and the 
underlying dermal cells (Millar, 2002; Schmidt-Ullrich and Paus, 2005) and it can be divided 
into nine distinct morphological stages (Hardy, 1992; Paus et al., 1999). The signal initiating the 
HF formation comes from the dermis and leads to the activation of basal layer keratinocytes 
(stage 0), which change shape, organize into morphologically distinct hair placodes and signal in 
turn to the underlying fibroblasts, causing them to gather below (stage 1) (Fig. 1.7). The 
signalling crosstalk between the mesenchymal condensate and the epithelial hair placode drives 
proliferation in both structures, causing the downgrowth of the hair germ and a cap-like 
aggregation of fibroblasts at its proximal end (stage 2). Proliferating epithelial cells form the hair 
peg, an elongated column consisting of multiple layers of undifferentiated keratinocytes 
concentrically arranged around the follicular axis. The fibroblast cap transforms into the 
ball-shaped dermal papilla (DP), located in a cavity developed at the proximal end of the column 
(stage 3) (Fig. 1.7). The elongating hair peg forms a bulb-like thickening at the proximal end, 
which starts to engulf the DP. Proliferating keratinocytes in the proximity of the DP, begin to 
terminally differentiate into the inner root sheath (IRS), forming a cone-shaped structure above 
the DP (stage 4). In the subsequent bulbous peg stage (stage 5) (Fig. 1.7) the HF reaches the 
subcutis and the DP is almost completely enclosed by the hair bulb. The melanin-containing hair 
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shaft (HS) begins to form from the matrix cells in the bulb and grows upwards within a rigid 
tube of the keratinized IRS, which extends already halfway up the HF. In addition, in the distal 
part of the HF, first sebocytes develop from epithelial cells and the bulge (follicular stem cells 
niche; Cotsarelis et al., 1990) is formed within the outer layer of the HF, which will become the 
outer root sheath (ORS). 
Fig. 1.7 Key stages of the HF morphogenesis and the hair cycle. Crosstalk between epidermis and 
dermis leads to the formation of the hair germ (placode) and the aggregation of dermal fibroblast 
beneath (stage 1). Downward growth of the placode, with attached at the bottom fibroblasts, results in 
the growth of the hair peg, which proximal end starts to engulf the dermal papilla (DP) formed from 
dermal fibroblasts (stage 3). Signalling form the DP induces the formation of the bulb and the 
differentiation of precursor cells within into the inner root sheath (IRS) and hair shaft (HS) lineages. 
The bulge and first sebocytes appear in the upper part of the bulbous peg (stage 5). Further 
development leads to the formation of a mature HF with the HS emerging through the epidermis 
(stage 8). After the completed morphogenesis, the HF enters a continuous growth-regression cycle, 
which consists of three stages: growth (anagen), involution (catagen) and rest (telogen). The upper 
part of the HF, containing the sebaceous gland (SG) and the bulge, remains intact. After telogen, 
crosstalk between the DP and stem cells residing in the bulge leads to the formation of the 
proliferating hair germ (anagen I) and regrowth of the HF (anagen VI). The entire follicle is 
surrounded by the BM, which is engulfed in turn by the dermal sheath (not shown) (based on Paus et 
al., 1999; Muller-Rover et al., 2001). 
Further development of the HF (stage 6-7) includes: formation of the hair canal 
(infundibulum), organization of sebocytes into the sebaceous gland (SG), elongation of the IRS 
and the HS and final enclosure of the DP by the hair bulb. The morphogenesis ends when the 
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HF, with fully differentiated layers, reaches the subcutaneous muscle and the HS emerges from 
the epidermis. A fully grown HF is accompanied by the erector pilli muscle, attached at the level 
of the bulge (stage 8) (Fig. 1.7) (Paus et al., 1999). The progenitor matrix cells at the base of the 
HF continue to proliferate and differentiate, yielding a period of active hair growth, lasting 
around a week in case of murine pelage hairs. 
When the proliferative potential of bulb cells is exhausted, HFs enter a perpetual cycle of 
growth and regression which affects only the lower part of the HF (Fig. 1.7). It starts from 
catagen, the involution phase, during which the HF structure below the bulge region undergoes a 
controlled, apoptosis-driven degeneration, beginning in the hair bulb and continuing upwards. 
The HS detaches from the proliferative matrix and forms the club hair, which coincides with 
upwards regression of the IRS. Subsequently, the club hair, surrounded by the ORS, is moving 
up to the level of the bulge. An epithelial strand, stretching from the retracting ORS, pulls the DP 
behind, until the base of the permanent segment of the HF, where it rests in the proximity of the 
bulge (Muller-Rover et al., 2001). During late catagen stem cells from the lowermost portion of 
the bulge form the secondary hair germ at the bottom of the permanent part of the HF (Ito et al., 
2004). After 3-4 days, catagen is completed and the HF enters a resting phase, telogen, during 
which it remains relatively dormant (Fig. 1.7). The first telogen in the murine hair cycle last only 
1-2 days, but the following ones are more than two weeks long (Alonso and Fuchs, 2006).  
The transition from telogen to anagen, the growth phase, is initiated by signalling crosstalk 
between the DP and the bulge (Stenn and Paus, 2001). The dormant progenitor cells in the 
secondary hair germ are activated and begin to proliferate forming a growing hair germ, which 
emerges from the bottom of the permanent part of the HF and starts to engulf the DP (anagen I) 
(Fig. 1.7). The further growth and differentiation of the HF resembles the development during 
the HF morphogenesis and results in the reconstitution of the lower part of the HF (anagen VI) 
(Muller-Rover et al., 2001). The duration of anagen determines the length of the hair and is 
dependent upon continued proliferation and differentiation of matrix cells at the follicle base. In 
the mouse pelage it lasts around 3 weeks. 
The mature HF consists of several distinct concentric layers of cells (Fig. 1.8). The most 
outer layer, the ORS, is continuous with the basal layer of the epidermis and surrounds the whole 
HF. It constitutes a single-layered epithelial sheath around the lowermost hair bulb and the DP, 
but is multilayered along the length of the HF. Although the ORS cells exhibit horizontal 
differentiation, they do not become keratinized, with exception of the uppermost section of the 
HF (Stenn and Paus, 2001). In the isthmus (between the insertion of the SG and the bulge) and 
the infundibulum, ORS layers show trichilemmal keratinisation (Pinkus et al., 1981) and 
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epidermal-type terminal differentiation, respectively. The ORS is established during the early 
stages of anagen by the downward growth of the regenerating epithelium and then maintains 
itself, independent of the germinative matrix in the hair bulb, by basal cell growth (Stenn and 
Paus, 2001).  
Fig. 1.8 Distinct hair follicle layers generated in the hair bulb. Several lineages of keratinocytes 
differentiate from the germinative matrix and form concentric layers of the HF and the HS. Stem cells 
migrating from the bulge down along the ORS (darker green) give rise to the germinative matrix as 
well as progenitor cells of the hair matrix and the medulla, directly (arrows). Examples of keratins 
specific for hair follicle compartments are given in brackets (based on Rogers, 2004; Langbein and 
Schweizer, 2005). 
All the other layers differentiate from the germinative matrix, located at the bottom of the 
hair bulb around the dermal papilla. The germinative matrix contains undifferentiated transiently 
amplifying precursor cells derived from bulge stem cells during the formation of the HF. It was 
also shown to be resupplied during the anagen by the stem cells migrating down the ORS from 
the bulge region (Tumbar et al., 2004). The companion layer (CL), whose role is not clear, is a 
single-cell layer separating the ORS and IRS (Rogers, 2004). The function of the IRS, a rigid 
tube-like structure, is to shape and support the HS. It consists of three distinct layers: the Henle 
layer, the Huxley layer and the IRS cuticle, which differ in the thickness and cell organization. 
The cells of the IRS undergo so called soft keratinisation by forming trichohyalin granules and 
are sloughed off after reaching the hair canal. The mature HS is a differentiation product of 
trichocytes, proliferating cells constituting the hair matrix and derived from the germinative 
matrix (Fig. 1.8). Hair matrix cells give rise to the hair cortex and the medulla (present in some 
types of hair). The cortex constitutes the bulk of the hair shaft and becomes fully keratinized in 
the terminal differentiation process. The surface of the HS is formed by the hair cuticle, which 
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comprises a single layer of scale-like keratinized cells, pointing upwards. They interlock with the 
IRS cuticle, composed of scale-like organized cells pointing downwards. As a result, both the HS 
and the IRS move up the HF as a single unit (Stenn and Paus, 2001; Rogers, 2004).  
While many different epithelial (ORS, IRS) or hair (HS) keratins are expressed in the HF, 
keratinocytes of each layer express at least one unique keratin (Fig. 1.8). This feature enables 
detailed analysis of HF differentiation and morphology by using specific antibodies to visualize 
HF compartments. Interestingly, unlike follicular stem cells, transiently amplifying cells in the 
germinative matrix do not express any known epithelial or hair keratins (Langbein and 
Schweizer, 2005). 
The molecular mechanisms controlling morphogenesis and cycling of the HF are not fully 
understood, but the genetic studies in mice showed the importance of Wnt/β-catenin, bone 
morphogenetic protein (BMP), sonic hedgehog (SHH), fibroblast growth factor (FGF), 
epidermal growth factor receptor (EGF), NF-κB, and Notch signalling pathways (Millar, 2002; 
Schmidt-Ullrich and Paus, 2005; Blanpain and Fuchs, 2006). Stem cells residing in the bulb not 
only sustain the HF cycling but are recruited during wound healing to help the repair of the 
epidermis (Ito et al., 2005) and are thought to contribute to the SG lineage (Alonso and Fuchs, 
2003). 
1.3 Epithelial cell-cell adhesion and polarization  
Cell–cell adhesion is essential for the integrity of epithelial sheets, as well as for the 
establishment and maintenance of the polarized epithelial phenotype (Yeaman et al., 1999). In 
the stratified epithelium, adhesion between cells is mediated by three types of junctions: 
adherens junctions, desmosomes and tight junctions. Adherens junctions and desmosomes are 
present between keratinocytes throughout the whole epidermis, while tight junctions are formed 
only in the granulose layer of the epidermis (Perez-Moreno et al., 2003) (1.2.1). 
Both adherens junctions and desmosomes convey a strong cell-cell adhesion. Adherens 
junctions are the earliest contacts established between epithelial cells and are necessary for the 
formation of other adhesive structures. Through their interaction with the actin cytoskeleton, 
adherens junctions play a crucial role in the morphological changes leading to the polarization of 
the epithelium (Braga et al., 2000). Desmosomes provide epithelial sheets with mechanical 
strength, which is required to maintain the integrity of the epidermis, by anchoring the 
intermediate filament network to the sites of cell-cell contacts (Green and Gaudry, 2000). Tight 
junctions control the permeability of the epithelial layers supporting the barrier function of the 
stratified epithelium (Furuse et al., 2002). 
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Adherens junctions are formed by cadherins, transmembrane receptors mediating 
Ca2+-dependent cell-cell adhesion. The extracellular domain of a cadherins is responsible for 
dimerization of receptors. The cytoplasmic tail binds p120-catenin that plays a role in the 
clustering of cadherins, and β-catenin. The interaction of β-catenin with α-catenin conveys the 
association of cell-cell contacts with the actin cytoskeleton after the initiation of adhesion. 
E-cadherin is the main cadherin found in adherens junctions between epidermal keratinocytes 
(Fukata and Kaibuchi, 2001). 
Establishment of the cadherin-mediated cell-cell adhesion comprises several steps that lead 
to the development of the epithelial phenotype (Braga et al., 2000). In the presence of Ca2+, 
dimerized extracellular domains of cadherins change conformation and bind corresponding 
receptors of neighbouring cells. The homophilic interaction induces zipper-like clustering of 
cadherin receptors and engagement of actin filaments by cytoplasmic tail complexes. The 
accumulation of actin filaments at sites of cell–cell contacts stabilizes cadherin clusters and 
increases the strength of adhesion. The reorganization of the actin cytoskeleton (induced by 
anchoring to adherens junctions) and the subsequent rearrangement of the microtubule and 
intermediate filament networks lead to the morphological change characteristic for epithelial 
cells (cuboid shape). Signalling pathways triggered by the formation of cadherin contacts, 
contribute to the establishment of the epithelial phenotype by inducing different cellular 
processes (e.g. establishment of other adhesive structures and distinct membrane domains, 
changes in the vesicle transport, expression of epithelia-specific genes) (Braga, 2002). 
In the epidermis, cell-cell adhesion is a highly dynamic process. As the epithelial sheets 
migrate upwards towards the skin surface during terminal differentiation, epidermal cells must 
constantly change their intercellular interactions. During wound healing, epidermal cells 
transiently downregulate intercellular adhesion concomitant with an increase in cell proliferation 
(Fuchs and Raghavan, 2002).  
All three classical Rho GTPases (Rho, Rac and Cdc42) were shown to be involved in the 
formation and maintenance of adherens junctions and/or in the regulation of other cellular 
processes leading to the establishment of the epithelial phenotype in vitro (Braga et al., 2000; 
Van Aelst and Symons, 2002). 
1.3.1 Role of Rac1 in the epithelial cell-cell adhesion 
The involvement of Rac1 in the regulation of the E-cadherin-dependent cell-cell adhesion of 
epithelial cells was demonstrated by several in vitro studies. However, the precise role of Rac1 in 
the assembly and maintenance of these structures is unclear, due to partially conflicting reports. 
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The presence of DN-Rac1 in both primary human keratinocytes and MDCK cells inhibited 
Ca2+-induced formation of adherens junctions (Braga et al., 1997; Takaishi et al., 1997), 
suggesting that Rac1 activity is necessary for their establishment. In addition, microinjection of 
DN-Rac1 in primary human keratinocytes led to the disruption of adherens junctions (Braga et 
al., 1997), indicating a critical role of Rac1 in the maintenance of those adhesion structures. 
However, the inhibitory effect of DN-Rac1 was dependent on the maturation state of the cell-cell 
contacts as newly formed junctions were more sensitive to the lack of the active Rac1 (Braga et 
al., 1999). Those differences suggested a reduced requirement for Rac1 after the maturation of 
adherens junctions. 
MDCK cells expressing CA-Rac1 or Tiam1 (a Rac1-specific GEF) displayed an increased 
E-cadherin accumulation and actin polymerization at cell-cell contacts (Hordijk et al., 1997; 
Takaishi et al., 1997) indicating that Rac1 promotes the formation of adherens junctions and 
mediates the reorganization of the actin cytoskeleton necessary for stabilization of 
cadherin-dependent adhesions. In contrast, CA-Rac1 microinjected into primary human 
keratinocytes had either no effect on the E-cadherin accumulation at the cell-cell contacts (Braga 
et al., 1997) or caused a specific removal of E-cadherin from adherens junctions at higher 
concentrations (Braga et al., 2000). Wile the initial formation of adherence junctions was not 
prevented by the presence of CA-Rac1, the stability of cadherin receptors was compromised. 
However, the susceptibility of cell-cell contacts to the CA-Rac1-induced disintegration was 
reduced after their maturation (Braga et al., 2000). The discrepancy between the reported effects 
of CA-Rac1 on adherent junctions might have resulted from the differences in the cell type or the 
levels of CA-Rac1 used during the experiments.  
Taken together those data suggested that Rac1 is essential for the formation of 
E-cadherin-dependent cell-cell contacts and plays a role in the maintenance of stable adherens 
junctions. The negative effects of both DN-Rac1 and elevated levels of activated Rac1 on the 
stability of E-cadherin-dependent cell-cell contacts seem to confirm the notion, that the amount 
of active Rac1 must be precisely regulated in the cell in order to fulfil the specific biological 
function.  
Different studies showed that clustering of E-cadherin receptors activated Rac1 and recruited 
it to the sites of cell-cell contacts both in MDCK cells and primary keratinocytes (Nakagawa et 
al., 2001; Noren et al., 2001; Betson et al., 2002). That suggested a feedback signalling model of 
Rac1 involvement in the formation of cell-cell contacts, in which initial adhesion activates Rac1, 
which in turn induces the reorganization of the actin cytoskeleton necessary for the stabilization 
of adherens junctions. Moreover, downstream signalling initiated by Rac1 was proposed to play 
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a role in the establishing of the polarized epithelial phenotype (Braga, 2002). 
1.4 Aims of the project 
Several in vitro studies showed an important function of Rac1 in the regulation of 
cadherin-dependent cell-cell contacts between epithelial cells. These contacts are essential for 
the establishment and maintenance of the polarized cell morphology characteristic for epidermal 
keratinocytes as well as for the integrity of epithelial sheets in the epidermis. However, no 
analysis of the potentially crucial role of Rac1 in the regulation of the cadherin-dependent 
cell-cell adhesion in vivo was performed, before this project was initiated. 
 
Since constitutive deletion of the murine rac1 gene leads to early embryonic lethality, 
preventing the analysis of the Rac1 function in differentiated tissues, the first goal of this project 
was to generate genetically modified mice, which would allow for a conditional deletion of the 
rac1 gene. 
 
The main aim of this work was to investigate the role of Rac1 in the epidermis and hair 
follicles, and thus to explain the function of Rac1 in the regulation of cell-cell contacts between 
epithelial cells in vivo. Therefore, mice with a keratinocyte-specific deletion of the rac1 gene 
were generated and analysed. 
 
A final aim was to study the function of Rac1 in the establishment of cell-cell contacts 
between differentiating cells and its role in the formation of polarized epithelium during early 
embryonic development. Thus, Rac1-deficient embryonic stem cells were generated and their 
ability to from embryoid bodies was analysed.  
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2 MATERIALS AND METHODS 
2.1 Animals 
Mice used in this study were housed under SPF (Specific Pathogen Free) conditions in an 
animal facility of the Max Planck Institute of Biochemistry in Martinsried. They had continuous 
access to drinking water and standard rodent food. Light regime was 12 h of light per day. In the 
course of breeding, offspring were normally weaned 3 weeks after birth. At that time animals 
were ear-marked and tail tips were cut for genotype analysis. When genotyping of younger 
animals was required, they were marked by toe-clipping within 5 days after birth. The 
genotyping was performed by PCR.  
Animals used for experiments were sacrificed by cervical dislocation. Alternatively, very 
young mice (few days after birth) were decapitated or sacrificed using ether. All experiments 
were performed in accordance with German Animal Protection Law. 
2.2 Common materials 
2.2.1 Chemicals 
Basic chemical compounds used in this study were purchased from the following companies: 
Merck, Sigma, Fluka/Riedel-de Haën or Roth.  
Double-distilled water (ddH2O), purified with the Milli-Q-System (Millipore) was preferably 
used to prepare the solutions and buffers. Buffers used in gross quantities (i.e. running buffers) 
were prepared or diluted from stock solutions with normal distilled water (dH2O). In molecular 
biology procedures ddH2O was autoclaved before the use. 
10x PBS 
NaCl ..................................80.1 g 
KCl   ....................................2.0 g 
Na2HPO4×2H2O ................14.4 g 
KH2PO4................................2.0 g 
ddH2O ...........filled up to 1000 ml 
 
→ adjusted to pH 7.4 
→ diluted to working solution (PBS) with ddH2O 
→ autoclaved for 30 min at 120°C (when used for cell culture) 
 
2.2.2 Disposable plastic materials 
• bacteria: plates (10 cm Ø; #662102), tubes (14 cm; #191161) – Greiner Bio-One 
• cell-culture: dishes (6/10 cm Ø), T-flasks with vent caps (25/75/175 cm3) – BD Falcon 
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• plates (6/24/96 well; #3516/26/96) – Corning 
• pipettes (5/10/25 ml; #4487/8/9) – Corning (Costar) 
• syringe filters (0.2 µm; #06-001), syringes (10/20 ml, #300912/629) – Renner GmbH, BD 
• tips (10/200/1000 µl), tubes (1.5/2 ml) – Josef Peske GmbH 
• tubes (0.2 ml; #96.9852, 15/50 ml) – TreffLab, Corning, BD Falcon 
• vacuum filter systems (volume 125 ml, 0.2 µm; no.PV050/3) – Schleicher&Schuell  
• vacuum filter systems (volume 500 ml, 0.22 µm; no. 431097) – Corning 
2.3 Antibodies 
2.3.1 Primary 
Antigen – Coupling Species Application Dilution Company/Source 
BrdU - POD mouse ICH 1:40 Roche 
K6, K10, K14 rabbit IF 1:400 Covance 
loricrin rabbit IF 1:400 Covance 
K6irs2, K6irs4, Hb2 rabbit IF 1:1000 Dr. L.Langbein; GCRC, Heidelberg, Germany 
vimentin guinea pig IF 1:100 Dr. L.Langbein; GCRC, Heidelberg, Germany 
E-cadherin rat IF 1:200 Zymed Laboratories 
α-catenin rabbit IF 1:600 Sigma 
β-catenin rabbit IF 1:500 Sigma 
desmoplakin rabbit IF 1:200 Research Diagnostics 
laminin-5 (γ2 LE4-6) rabbit IF 1:200 Dr. T.Sasaki; MPI, Martinsried, Germany 
laminin γ1 (05-206) rat IF 1:40 Upstate 
laminin α1 rabbit IF 1:200 Dr. P.Yurchenco; UMDNJ-RWJMS, Piscataway, NJ, USA 
nidogen-1 rabbit IF 1:800 Dr. T.Sasaki; MPI, Martinsried, Germany 
p120-catenin – FITC mouse IF 1:50 Sigma 
Mac1 (Ha2/5) – biotin rat IF 1:100 BD Pharmingen 
paxillin mouse IF 1:300 Transduction Laboratories 
vinculin mouse IF 1:500 Sigma 
caspase-3 cleaved (Asp175) rabbit IF 1:100 Cell Signalling 
ZO-1 rabbit IF 1:1000 Zymed Laboratories 
GM130 (clone 35) mouse IF 1:200 Transduction Laboratories 
PECAM-1 rat IF 1:80 BD Pharmingen 
Neurofilamin-M rabbit IF 1:200 Chemicon 
pericentrin rabbit IF 1:200 Covance 
β4-integrin (346-11A) rat IF/FACS 1:100/1:200 BD Pharmingen 
α6-integrin (GoH3) – FITC rat IF/FACS 1:100/1:200 BD Pharmingen 
α1-integrin (Ha31/8) hamster FACS 1:200 BD Pharmingen 
α2-integrin (Ha1/29) – FITC hamster FACS 1:200 BD Pharmingen 
α4-integrin (9C10) – PE rat FACS 1:200 BD Pharmingen 
α5-integrin (5H10-27) – biotin rat FACS 1:200 BD Pharmingen 
αv-integrin (RMV-7) – biotin rat FACS 1:200 BD Pharmingen 
β1-integrin (Ha2/5) – FITC hamster FACS 1:200 BD Pharmingen 
β2-integrin (C71.16) – biotin rat FACS 1:200 BD Pharmingen 
β3-integrin (2C9.G2) – biotin hamster FACS 1:200 BD Pharmingen 
β7-integrin (2C3.G2) – biotin rat FACS 1:200 BD Pharmingen 
Rac1 (clone 102) mouse WB 1:2000 Transduction Laboratories 
Rac1 (clone 23A8) mouse WB 1:1000 Upstate 
Rac2 rabbit WB 1:1000 Santa Cruz 
Rac3 rabbit WB 1:1500 Dr. Ivan de Curtis; SRSI, Milano, Italy 
Cdc42 mouse WB 1:333 Transduction Laboratories 
RhoA (119) rabbit WB 1:5000 Santa Cruz 
c-Myc (N-262) rabbit WB 1:500 Santa Cruz  
IκB-α (C-21) rabbit WB 1:1000 Santa Cruz 
p-Akt (Ser473), Akt rabbit WB 1:1000 Cell Signaling 
p-p38, p38 rabbit WB 1:1000 Cell Signaling 
p-JNK, JNK rabbit WB 1:1000 Biosource, Cell Signaling; Biosource 
tubulin (YL1/2) rat WB 1:10000 Dr. J. Wehland; GBF, Braunschweig, Germany 
GAPDH mouse WB 1:20000 Chemicon 
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2.3.2 Secondary 
Antigen – Coupling Species Application Dilution Company/Source 
mouse IgG – Cy3 goat IF 1:400 Jackson ImmunoResearch 
rabbit IgG – Cy3 donkey IF 1:1000 Jackson ImmunoResearch 
rat IgG – Cy3 goat IF 1:800 Jackson ImmunoResearch 
rat IgG – FITC goat IF 1:200 Jackson ImmunoResearch 
rat IgG2a (RG7/1.30) – FITC mouse FACS 1:250 BD Pharmingen 
hamster IgG (G70-204/G94-56) – FITC mouse FACS 1:250 BD Pharmingen 
mouse IgG – HRP goat WB 1:10000 Biorad 
rabbit IgG – HRP goat WB 1:10000/1:3000 Biorad/Daco 
rat IgG – HRP donkey WB 1:10000 Jackson ImmunoResearch 
phalloidin – Alexa 488/568 – IF 1:600 Molecular Probes 
streptavidin – Cy3 – IF 1:500 Jackson ImmunoResearch 
streptavidin – Cy5 – FACS 1:500 Jackson ImmunoResearch 
2.4 Molecular biology methods 
2.4.1 Plasmids and oligonucleotides 
The pBluescript II KS+ plasmid (pBS; Stratagene), depicted in Fig. 2.1 (obtained from the 
plasmid manual), was used as a parent vector during all cloning steps, as it is a high copy 
number plasmid (300–500 per cell) enabling an efficient amplification of cloned DNA.  
DNA fragments, which were going to be modified (e.g. a selection cassette or a piece of 
genomic DNA), were inserted within the multiple cloning site (MCS) of the plasmid.  
Fig. 2.1 Scheme of the pBS plasmid with a detailed sequence of the MCS (modified from the 
instruction manual provided by the manufacturer). 
All oligonucleotides used in this study are summarized in the table below. Detailed 
description of each application can be found in respective chapters. 
Name Sequence (5’ → 3’) Tm Application 
PAC1 GCG GGA TCC CTT TTC TGA GTT GCC TCT TAC 60°C probe for PAC library screen 
PAC2 GCG GAA TTC AAA TTC CAA ATT CTG GCT GGC 60°C probe for PAC library screen 
AC1 TAA TAA CTT CGT ATA GCA TAC ATT ATA CGA AGT TAT AAG CTT – linker (LloxP site) 
AC2 TAA AGC TTA TTA CTT CGT ATA ATG TAT GCT ATA CGA AGT TAT – linker (LloxP site) 
AC3 TCG AGA GTA CTC TGC AGA T – selection cassette modification 
AC4 CGA TCT GCA GAG TAC TC – selection cassette modification 
AC7 GCG GAA TTC GTA CCC TAA CTC CTG CCT C 60°C internal probe 
AC8 GCG GTC GAC TGC AGA CAG AGG ACA GCA C 60°C internal probe 
AC9 CTA GAT CGA TGA ATT CGC ATG CGC GGC CGC – linker (neo-tk cassette cloning. site) 
AC10 CTA GGC GGC CGC GCA TGC GAA TTC ATC GTA – linker (neo-tk cassette cloning. site) 
AC11 TAG CTC GAG CTC ATG GAG G – sequencing (LloxP site orientation) 
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Name Sequence (5’ → 3’) Tm Application 
AC12 TGA AGT CAA GTA GGT CCA GG – sequencing (linker AC9-10 orientation) 
AC15 GCG GAA TTC CTG AGG TAT AGT TGG AAT GCC 62°C external probe  
AC16 GCG GTC GAC CAC TGG CTC TGC ACA TGC C 62°C external probe 
MG1 GTC TTG AGT TAC ATC TCT GG 58°C mouse genotyping (Rac1 PCR) 
MG2 CTG ACG CCA ACA ACT ATG C 58°C mouse genotyping (Rac1 PCR) 
MG5 TTG ATT TCC ATA AAG CTT ATA AC 58/60°C mouse genotyping (KO PCR) 
MG6 ACC AAG TGC CCA ATC GGC 58/60°C mouse genotyping (KO PCR) 
cre 3’ TTC GGA TCA TCA GCT ACA CC 58°C mouse genotyping (cre PCR) 
cre 5’ AAC ATG CTT CAT CGT CGG 58°C mouse genotyping (cre PCR) 
T3 AAT TAA CCC TCA CTA AAG GG – sequencing (short inserts in pBS) 
T7 GTA ATA CGA CTC ACT ATA GGG C – sequencing (short inserts in pBS) 
RhoG.F1 TTC CTA CCC TCA GAC CAA CG 60°C real-time PCR 
RhoG.R1 CAG GAG GAT AGG CAC GTC AG 60°C real-time PCR 
RhoG.F2 CTG AGA GCC CAG CCT GAT AC 60°C real-time PCR 
RhoG.R2 ATC GGT GTT GGG TTA AGC AC 60°C real-time PCR 
RhoG.F3 CTG TTT CTC CAT TGC CAG TC 60°C real-time PCR 
RhoG.R3 CTG GGC TCT CAG GTC CTT C 60°C real-time PCR 
GAPDH CAC CAC CCT GTT GCT GTA GCC GTA T 60°C real-time PCR 
GAPDH TCG TGG ATC TGA CGT GCC GCC TG 60°C real-time PCR 
 
2.4.2 Bacteria culture 
2.4.2.1 Strains, growth conditions, media, selection and storage 
The DH5α strain of E. coli bacteria was used during all cloning steps, unless stated 
otherwise. Liquid cultures, for plasmid DNA preparation, were grown at 37°C in a standard 
Miller's LB medium (LB) and incubated at ~200 rpm in a bacteria shaker (Buchner Laboratories) 
for 8-16 h. For selection purposes bacteria were distributed on LB-Agar plates and incubated 
O/N at 37°C (Heraeus). 
LB medium 
NaCl ....................................5.0 g 
Tryptone-peptone.................5.0 g 
Yeast extract.........................2.5 g 
ddH2O .............filled up to 500 ml 
LB-Agar (plates) 
Bacto-agar........................... 7.5 g 
LB medium ....................... 500 ml 
 → amount for 20-25 plates 
Antibiotics 
Ampicillin (100 mg/ml) .....1:1000 (100 µg/ml) 
Additives 
X-gal (20 mg/ml)...............1:1000 (100 µg/ml) 
X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) is a colour-changing compound commonly 
used in a blue-white colony screening. The method is based on a presence of a fragment of the lacZ gene, 
encoding the first 146 amino acids of β-galactosidase within a cloning vector. The coding sequence contains a 
MCS. When an empty vector (e.g. pBS) is introduced into bacteria strain expressing the C-terminal fragment 
of β-galactosidase (e.g. DH5α), an active enzyme, capable of processing X-gal, is synthesized 
(α-complementation) (Ullmann et al., 1967). X-gal, cleaved by the enzyme, gives a water-insoluble, blue 
product that marks bacteria colonies. After the introduction of an insert within the MCS, lacZ becomes 
interrupted and transformed bacteria remain white. 
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LB medium was autoclaved for 30 min at 120°C and stored at 4°C. Before use, it was 
supplemented with ampicillin, unless stated otherwise. LB-Agar medium was autoclaved, cooled 
down to ~50°C, supplemented with ampicillin and X-gal, and poured into plastic Petri dishes 
(10 cm Ø). After the medium solidified, plates were stored at 4°C. 
Small-volume liquid bacteria cultures for analytical plasmid isolation (2.4.3.1) and plates 
with colonies (sealed with Parafilm®; ANC Co.) were stored at 4°C up to one week. For long-
time storage, glycerol stocks were prepared (600 µl of fresh bacteria culture mixed with 400 µl 
of autoclaved 87% glycerol) and kept at -20°C or -80°C (1.5 ml tubes). 
2.4.2.2 Preparation of competent bacteria 
Bacteria used for transformation were chemically pre-treated to enhance the uptake of a 
plasmid DNA. Modified LB medium (5 ml M-LB) was inoculated with 50 µl of E. coli (DH5α) 
glycerol stock and incubated O/N at 37°C/200 rpm. The following day, 1 ml of the starter culture 
was added to 150 ml of pre-warmed M-LB medium and incubated at 37°C/200 rpm until OD600 
reached 0.3-0.4 (~2 h). Subsequently, the culture was cooled down on ice for 10 min, transferred 
to 50 ml tubes (~37.5 ml/tube) and centrifuged for 10 min at 6000g (4°C). Bacteria were 
resuspended carefully in 37.5 ml of ice-cold TFB1, incubated on ice for 10 min and pelleted 
again (same conditions). Each pellet was resuspended in 3 ml of ice-cold TFB2, aliquoted into 
1.5 ml tubes (50 µl) and shock-frozen in a dry-ice/isopropanol bath. Competent bacteria were 
stored at -80°C for several months. 
TFB1 
5 M K-Ac (potassium acetate) ..1 ml (25 mM) 
1 M MnCl2...........................10 ml (50 mM) 
1 M RbCl.............................20 ml (100 mM) 
1 M CaCl2 .............................2 ml (10 mM) 
ddH2O ...............................132 ml 
 → adjusted to pH 5.8 (with 0.2 M CH3COOH) 
 → sterile filtered (MnCl2 oxidizes if autoclaved) 
+ 
87% glycerol (sterile) ......34.5 ml (15%) 
TFB2 
1 M MOPS, pH 7.0 ............ 500 µl (10 mM) 
1 M CaCl2........................ 3.75 ml (75 mM) 
1 M RbCl ........................... 500 µl (10 mM) 
87% glycerol .................... 8.75ml (15%) 
ddH2O............................... 36.5ml 
 → autoclaved for 30 min at 120°C 
M-LB medium 
1 M Mg2SO4.......................... 4 ml (20 mM) 
1 M KCl ................................ 2 ml (1 mM) 
LB medium ..... filled up to 200 ml
 
2.4.2.3 Transformation 
Plasmid DNA was introduced into bacteria by a heat-shock transformation. Aliquots of 
competent bacteria (2.4.2.2) were thawed on ice and mixed with 10 µl of a post-ligation solution 
(2.4.4.7) or a suspension of purified plasmid containing an insert. Control transformations were 
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performed with 10 µl of ddH20 (negative) or 2 ng of empty plasmid (positive). 
After 30 min incubation on ice, tubes were transferred for 90 s to 42°C (dry heat block, 
Thermomixer compact; Eppendorf), cooled down on ice for 5 min and filled with 1 ml LB 
medium (w/o antibiotics) (2.4.2.1). Subsequently, bacteria were transferred to 14 ml polystyrene 
round-bottom tubes and incubated for 45-60 min at 37°C/200 rpm. After transferring back into 
1.5 ml tubes, cells were spun down for 30 s at 20.000g (microcentrifuge; Microcentrifuge 
Eppendorf 5417C) and ~800 µl LB medium were removed. Bacteria were resuspended in 
remaining 200 µl of medium and distributed on LB-Agar plates (2.4.2.1) using a Drigalski 
spatula (sterilised with a Bunsen burner). Inverted plates were incubated at 37°C. Colonies 
usually appeared within 12-16 h. 
2.4.3 Plasmid DNA preparation 
2.4.3.1 Analytical amounts – miniprep 
After transformation (2.4.2.3), single white colonies were picked with a pipette tip (200 µl) 
and inoculated in 2-3 ml LB medium (2.4.2.1), in 14 ml tubes. Cell suspension was transferred to 
a 1.5 ml tube and centrifuged for 30 s at 20,000g. Remaining bacteria were stored at 4°C until 
clones carrying the desired plasmid were identified.  
The bacteria pellet was resuspended in 200 µl of P1 buffer and mixed with 200 µl of P2 
buffer by vigorous shaking. After 5 min lysis at RT, 200 µl of ice-cold P3 buffer were added to 
neutralize the solution and precipitate everything but plasmid DNA. The suspension was 
thoroughly mixed, kept on ice for 5 min and subsequently spun down for 5 min at 20,000g. The 
supernatant was transferred to a new 1.5 ml tube, mixed with 500 µl of isopropanol in order to 
precipitate DNA and centrifuged again for 5 min at 20,000g. The supernatant was carefully 
removed (vacuum pump) and the pellet was washed with 1 ml of 70% EtOH. The subsequent 
centrifugation step was performed two times to remove all the residual alcohol. Plasmid DNA 
was resuspended in 50 µl of ddH2O or TE buffer. 
P1 buffer 
Tris-HCl, pH 8.0 ...............50 mM 
EDTA ................................10 mM 
RNase A .......................100 µg/ml 
P2 buffer 
NaOH..............................200 mM 
SDS   ............................ 1% (w/v) 
P3 buffer 
3 M K-Ac, pH 5.5 
TE buffer 
Tris-HCl, pH 8.0 ...............10 mM 
EDTA ..................................1 mM 
 
 
Alternatively, QIAprep Spin Miniprep Kit (Qiagen) was used for plasmid DNA purification. 
The procedure was performed following the supplied protocol, starting from 2-3 ml of bacteria 
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culture obtained as described above. DNA was eluted with 50 µl of ddH2O or TE buffer. 
Miniprep plasmid DNA was stored at -20°C and used for restriction digest analysis (2.4.4.1) 
and sequencing (2.4.4.8). Average yield of a high copy plasmid isolated from 1.5 ml of bacteria 
culture was 5-10 µg. 
2.4.3.2 Preparative amounts – maxiprep 
Big scale preparation of a plasmid DNA was conducted with QIAGEN Plasmid Maxi Kit 
(Qiagen). Bacteria for the isolation were prepared by inoculation of 200 ml LB-medium with 
200 µl of a glycerol stock or a miniprep culture. Subsequently, the purification protocol supplied 
with the kit was followed. Plasmid DNA was dissolved in 200-300 µl ddH2O or TE buffer 
(depending on the size of a pellet) and stored at -20°C.  
The concentration of purified DNA was determined by spectrophotometric measurement at 
260 nm (GeneQuant II RNA/DNA Calculator; Amersham Pharmacia Biotech). Average yield of 
a high copy plasmid isolated from 200 ml of bacteria culture was 300 µg. 
2.4.4 DNA cloning 
2.4.4.1 Restriction enzymes digestion 
Restriction enzymes were employed while generating the targeting construct and screening 
of bacteria or ES cell clones. Those enzymes recognize different palindromic sequences of 
nucleotides and cut DNA molecule at specific site within those sequences by hydrolyzing 
phosphodiester bounds. The cut ends after digestion can be “blunt” (no 5´or 3´ overhang) or 
“sticky” (5´and 3´overhangs). The latter can be ligated (2.4.4.7) only with compatible ends, with 
a much higher efficiency than non-discriminative blunt ends. In this study only enzymes creating 
overhangs were used. 
Restriction enzymes were purchased from New England Biolabs together with optimized 
reaction buffers. If double digestion was performed, a suitable buffer was chosen in which the 
highest possible activity of both enzymes was obtained. Different concentrations of enzymes 
(stock), depending on the application, were used; 5-10 U/µl during the cloning steps and 
100 U/µl for genomic digest of ES cell DNA. Generally, around 5 U of an enzyme for 1 µg of 
cut DNA were utilized. The reaction mix was supplemented with 0.1 µg/µl BSA, in case of 
genomic digest or when enzymes requiring it for an optimal activity were used. 
All digestion reactions were performed at 37°C (dry-heat block). A standard digestion 
(cloning and bacteria screening) was carried out for 1.5-2 h and the cutting of genomic DNA 
(Southern blot screening of PAC library, ES cell clones and mice) was conducted for 16-20 h. 
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Standard reaction mix: 
Miniprep DNA.........................2 µl 
Enzyme 1 (5-10 U)................0.5 µl 
Enzyme 2 (5-10 U)................0.5 µl 
BSA (2 µg/µl) ..........................1 µl 
NEBuffer (10x) ........................2 µl 
ddH2O ....................................14 µl 
 20 µl 
Genomic digest reaction mix: 
DNA ...................................... 20 µl 
NEBuffer (10x)........................ 3 µl 
BSA (10 µg/µl)..................... 0.3 µl 
Enzyme (100 U) ................... 0.4 µl 
ddH2O................................... 6.3 µl 
 30 µl
 
2.4.4.2 Gel electrophoresis 
DNA fragments after digestion (2.4.4.1) were routinely separated by an agarose gel 
electrophoresis in TAE buffer. Depending on the sizes of separated fragments, different 
concentrations of agarose, 0.7-2.0% (w/v), were used for the 
gel preparation. Agarose (Invitrogen) was dissolved in TAE 
buffer by heating in the microwave until the boiling point. 
Before pouring the solution into a casting tray, ethidium 
bromide (EtBr, Roth) was added. Samples were mixed with a 
6x loading buffer, pipetted into the wells and the run in the 
gel with 3-6 V/cm (small; 23 cm chamber) or 1-3.5 V/cm 
(big; 35 cm chamber). The 1 Kb DNA Ladder (Invitrogen 
#15615-016) was standardly used as a size reference 
(Fig. 2.2). DNA was visualized under UV light and results 
archived with a LCD camera. 
50x TAE 
Tris-base ............................. 242 g (2 M) 
Glacial acetic acid ........... 57.1 ml 
0.5 M EDTA...................... 100 ml (50 mM) 
ddH2O ...........filled up to 1000 ml 
Fig. 2.2 The distribution pattern of 
the 1 Kb DNA Ladder. Fragments 
were separated in 0.9% agarose gel 
DNA loading buffer (6x) 
Glycerol ....................... 60% (v/v) 
EDTA ................................60 mM 
Bromophenol blue.......0.1% (w/v) 
Orange G ....................0.2% (w/v) 
Xylene cyanol FF....... 0.1% (w/v) 
Tris-HCl, pH 7.6* .............10 mM 
 → (*) optional 
 → choice of the dye depends on the size of separated 
fragments 
 
The dyes differ in the  colour and the migration rate. 
In 1% agarose gels bromophenol blue (navy blue) 
migrates with 300 bp, orange G (orange) – with 50 bp 
and xylene cyanol FF (light blue) –  with 4000 bp 
DNA fragments. 
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Additives 
EtBr (10 mg/ml) .............1:20,000 (5 µl/100 ml) 
Ethidium bromide is DNA intercalating agent commonly used as a non-radioactive marker for visualizing 
nucleic acids. When exposed to ultraviolet light, it fluoresces with a red-orange light, intensifying almost 20-
fold after binding to DNA. EtBr is a powerful mutagen. 
2.4.4.3 DNA extraction from agarose gel 
After an electrophoretic separation of preparative amounts of DNA, gel pieces containing 
fragments of the correct size were cut out and weighed. DNA was isolated from the gel and 
purified using preferably QIAquick Extraction Kit (QIAGEN) according to the supplied 
protocol. QIAquick columns contain a silica membrane which binds DNA in high-salt buffer. 
Washing steps remove primers, nucleotides, enzymes, salts, agarose, ethidium bromide and other 
impurities from DNA sample. Afterwards DNA is released from the column with low-salt buffer 
or water. Purified DNA was usually eluted with 30 µl ddH2O and 2 µl of the solution were run in 
an agarose gel to confirm the size and to assess the concentration (a standard size marker was 
used as a reference). 
Alternatively, GENECLEAN® III Kit (Qbiogene, Inc.) or QIAEX II Gel Extraction Kit 
(Qiagen) was used, according to manufacturers’ protocols. Those kits utilise DNA-adhesive 
silica-gel particles in suspension, which are added to a dissolved gel slice and then collected by a 
brief centrifugation step. After washing, pure DNA fragments are eluted with Tris buffer or 
water. In this study DNA was usually recovered with 20 µl ddH2O and checked by running 2 µl 
of the suspension in an agarose gel. 
Additionally, above methods were used to purify DNA fragments in suspension; e.g. 
miniprep DNA before sequencing. 
2.4.4.4 DNA precipitation 
When sample concentration was too low or dried DNA was required (e.g. for sequencing), 
DNA was precipitated. DNA solution was mixed with 3 M Na-Ac and EtOH as described below 
and incubated for 20 min at -80°C. 
Precipitation recipe 
DNA solution ........................1 vol. 
3 M Na-Ac, pH 5.2.............0.1 vol. 
100% EtOH........................2.5 vol. 
 
Afterwards, the sample was centrifuged for 10 min at 20,000g and the supernatant was 
discarded. DNA pellet was washed with 500 µl of 70% EtOH, which was completely removed 
with two centrifugation steps. To obtain dried DNA, the pellet was additionally dried under 
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vacuum. Otherwise, DNA was resuspended in the appropriate amount of water or TE buffer. 
2.4.4.5 Phosphorylation and annealing of oligonucleotides 
Before introducing an oligonucleotide linker into a cloned construct, primers were 
phosphorylated on the 5’-end and annealed to each other. The reaction was conducted according 
to a protocol described below and 2-3 µl of product solution were taken for one ligation reaction. 
Reaction mix: 
Primer 1 (100 pmol).................1 µl 
Primer 2 (100 pmol).................1 µl 
T4 PNK buffer (10x)................1 µl 
10 mM ATP .............................1 µl 
ddH2O ......................................5 µl 
T4 DNA kinase (PNK).............1 µl 
 10 µl 
→ 60 min incubation at 37°C 
 
Next added: 
ddH2O.................................... 17 µl 
0.5 M NaCl.............................. 2 µl 
 30 µl 
→ 10 min incubation at 80°C (dry heat block) 
→ slow cooling down (heat block switched off and 
samples taken out when 30°C is reached; 3-3.5 h) 
 
2.4.4.6 Dephosphorylation of 5`- ends  
If vector was digested with only one enzyme (linearized), phosphate groups from the 5’ ends 
of the cut DNA were removed to prevent re-ligation. Calf intestinal phosphatase (CIP; Roche 
#713023) was added directly to the digestion reaction mix after a normal incubation time. The 
mixture was incubated with 5 U of the enzyme for 30 min at 37°C and subsequently for 30 min 
in 56°C. Both incubation steps were repeated after addition of fresh CIP. DNA was separated in 
an agarose gel (2.4.4.2) and purified before the ligation (2.4.4.3). 
2.4.4.7 Ligation of DNA fragments 
DNA fragments which had compatible ends, created e.g. with restriction enzymes (2.4.4.1), 
can be combined with T4 DNA ligase (Invitrogen #15224-041). This enzyme catalyzes the 
formation of a phosphodiester bond between 5'-phosphate and 3'-hydroxyl ends of double-
stranded DNA molecules. 
At least a 3:1 molar ratio of insert to vector was used in the reaction solution. Small inserts 
are incorporated easier; therefore in such case reaction was incubated for 1-2 h at RT. When 
large fragments where combined, ligation was performed O/N at 16°C (water-bath in 4°C). 
Usually, two control ligations were performed: negative and positive. In each case only vector 
was included in the mix, cut either with two enzymes (the same as for the insert ligation) or with 
only one, respectively. The resulting mixture was directly used for transformation (2.4.2.3). 
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Reaction mix: 
Vector DNA .................10 - 100 ng 
Insert DNA... 3-5x (vector amount) 
Ligase buffer (5x).................... 4 µl 
T4-DNA-ligase (1 U/µl).......... 1 µl 
ddH2O ..................................... x µl 
 20 µl 
5x ligase buffer (supplied w/ligase): 
Tris-HCl, pH 7.6 .............250 mM 
MgCl2................................50 mM 
ATP  ...................................5 mM 
DTT  ...................................5 mM 
PEG 8000 ................... 25% (w/v)
 
2.4.4.8 Sequencing 
After every cloning step, the modified DNA fragment was sequenced to confirm that correct 
changes, but no unwanted alterations, were introduced. Fragments of interest were amplified by 
one-primer PCR according to the Big-Dye Pre-Mix protocol. Reaction products were sent for the 
sequencing to a specialized facility. Sequences of good quality were usually 500-1000 bp long. 
Standard T3 and T7 primers, which have binding sites on the opposite ends of multi-cloning 
site of pBS, were used for amplification if the manipulated insert was short or the changed site 
was close to the insert’s end. Otherwise, custom primers were designed, homologous to a 
sequence located close to the modified site (2.4.1). 
2.4.5 Isolation of genomic DNA  
2.4.5.1 DNA isolation from tissues 
Genomic DNA for mice genotyping was extracted from clipped tails or toes. Tissue 
fragments were placed in 1.5 ml tubes and incubated in 500 µl lysis buffer O/N at 55°C (at least 
6 h). Lysates were stored at -20°C or directly processed. 
DNA for genotyping PCR was isolated according to the short protocol. The suspension was 
centrifuged for 10 min at 20,000g (microcentrifuge) and the supernatant was transferred to a new 
1.5 ml tube with 500 µl isopropanol. After short, vigorous shaking DNA became visible and was 
subsequently spun down for 5 min at 20,000g. The supernatant was discarded and the DNA 
pellet was washed with 1 ml of 70% EtOH. Two centrifugation steps, 5 min at 20,000g each, 
were performed to completely remove the alcohol and tubes were left open for 5 min to air-dry 
the pellet. DNA was resuspended in 300 ml ddH2O and incubated O/N at 55°C (at least 5-6 h) 
and 2 µl of the suspension were taken for a PCR reaction (2.4.6.1). 
DNA for southern blot analysis was isolated by phenol-chloroform extraction. Tissue was 
lysed as described above. After remnants were spun down, the supernatant was transferred to a 
new tube with 500 µl of phenol/chloroform/isoamylalcohol [25:24:1] solution (Roti; Roth 
#A156) and mixed by vigorous shaking. Phases were separated by 5 min centrifugation at 
Materials and Methods 
44 
20,000g and the aqueous phase containing DNA (upper) was transferred to a new tube with 
500 µl chloroform. The sample was mixed and centrifuged, and again the upper phase was 
transferred to a new tube. After thorough mixing with 500 µl isopropanol, DNA became visible 
and was further purified as in the short protocol. After diluting in 300 µl ddH2O, 20 µl of DNA 
suspension were taken for a genomic digest (2.4.4.1). 
Lysis buffer: 
1 M Tris, pH 8.5................ 100 ml (100 mM) 
5 M NaCl ............................ 40 ml (200 mM) 
0.5 M EDTA........................ 10 ml (5 mM) 
20% SDS ............................. 10 ml (0.2%) 
ddH2O ...........filled up to 1000 ml 
 
 → stored at RT; shortly before use supplemented 
with: 
Proteinase K (10 mg/ml).....1:100 
 → stock solution stored at -20°C. 
 
2.4.5.2 DNA isolation from cells 
Isolation of DNA from cultured cells was performed during the screening of ES cell clones 
(2.6.3.3). After cells were sufficiently expanded, 500 µl of the lysis buffer (2.4.5.1) were added 
to each well and incubated further at 37°C. As not all clones were ready at the same time, the 
lysis was initiated for 3 consecutive days, with the last group of clones lysed for at least 8 h. 
Afterwards, 500 µl isopropanol were added to each well and plates were shaken with 300 rpm 
for at least 8 h at RT (usually O/N), until DNA became visible (white web-like structure). DNA 
precipitates were fished with a small metal fork, transferred to 1.5 ml tubes containing 100 µl 
ddH2O and incubated for 24 h at 55°C. Resuspended DNA was stored at -20°C. 
2.4.6 Polymerase chain reaction – PCR 
PCR is a quick and easy method to amplify fragments of DNA using two specific primers 
flanking the desired sequence. It may be used for analytical purposes or to obtain preparative 
amounts of a plasmid or a genomic DNA fragment.  
2.4.6.1 Mice genotyping 
Genotyping of mice was routinely performed by PCR analysis. Genomic DNA isolated from 
mouse tissues (2.4.5.1) was amplified with specific primers designed to recognize changes 
introduced into the rac1 gene or the presence of the cre transgene (2.4.1). Reaction solutions 
were prepared in 0.2 ml tubes and run with the standard touch-down program after placing in a 
pre-heated thermocycler (hot start; T3 Thermocycler, Biometra). Annealing temperature 
depended on the used primer pair. Assuming that the calculated melting temperature was equal 
Tm, it started from Tm + 5°C and dropped to Tm – 5°C after 10 cycles. After the reaction was 
finished, the samples were analysed by agarose gel electrophoresis (2.4.4.2). 
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Genotyping PCR – reaction mix: 
DNA template ...................... 2.0 µl 
Primer 1 (100 pmol) ............. 0.2 µl 
Primer 2 (100 pmol) ............. 0.2 µl 
PCR buffer (10x).................. 2.0 µl 
50 mM Mg2+......................... 0.6 µl 
10 mM dNTP ....................... 0.4 µl 
Taq DNAPoly (5 U/µl) ........ 0.1 µl 
ddH2O ................................ 14.5 µl 
 20 µl 
Touch-down PCR program (Tm= 60°C): 
1. denaturation.......... 94°C for 30 s 
2. annealing .............. 65°C for 30 s 
3. elongation ............. 72°C for 30 s 
→ steps 1-3 – 10 cycles; annealing temperature 
reduced by 1°C every cycle; 
4. denaturation.......... 95°C for 30 s 
5. annealing .............. 55°C for 30 s 
6. elongation ............. 72°C for 30 s 
→ steps 4-6 – 35 cycles; 
7. pause...........................4°C for ∞ 
 
2.4.6.2 Preparative PCR 
Higher amounts of a PCR product were required if the amplified fragment was to be 
subcloned into a vector. To facilitate cloning, primer pairs with different restriction sites at 
5’-ends were designed. After a two-enzyme digestion (2.4.4.1), the PCR product was combined 
with the plasmid in a correct orientation by a sticky-end ligation (2.4.4.7). Amplification was 
performed with a touch-down program (2.4.6.1), with each steps being 60 s long. 
Genomic PCR – reaction mix: 
DNA template ...................... 2.0 µl 
Primer 1 (100 pmol) ............. 1.0 µl 
Primer 2 (100 pmol) ............. 1.0 µl 
PCR buffer (10x)................ 10.0 µl 
50 mM Mg2+......................... 4.0 µl 
10 mM dNTP ....................... 2.0 µl 
Taq DNAPoly (5 U/µl) ........ 1.0 µl 
ddH2O ................................ 14.5 µl 
 100 µl 
 
Additionally, genomic PCR was used to obtain high amounts of Southern blot probes for 
labelling. 
2.4.7 Southern blot analysis 
The Southern blot technique is used for a precise identification of DNA fragments which 
contain a specific sequence. The method utilizes short single-stranded DNA fragments which are 
complementary to the sequence of interest. Electrophoretically separated fragments of analysed 
DNA samples are immobilised on a membrane and incubated with the labelled probe. The 
visualized pattern of hybridization shows, which DNA samples contain the particular sequence 
and what is the size of the DNA fragment containing it. 
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In this study Southern blot analysis was performed during screening of the PAC library 
(2.6.2.2) and ES cell clones (2.6.3.3), as well as for genotyping of mice (2.6.6). 
2.4.7.1 DNA processing and transfer to the membrane 
Genomic DNA was digested with an appropriate restriction enzyme (2.4.4.1) and separated 
by gel electrophoresis in 0.7% agarose gel (2.4.4.2) until the bromophenol blue dye travelled for 
~15 cm (6-8 h at 3.5 V/cm). Due to the high amount of restriction fragments generated during 
the genomic digest, DNA after gel electrophoresis appeared as a smear rather than a set of 
discrete bands. The gel was photographed with a ruler placed next to the marker lane for a later 
band size reference. As only single-stranded DNA can hybridise with the probe, separated DNA 
was denatured in the denaturation solution. After 30 min incubation at RT, with a delicate 
agitation on a rocker, the gel was rinsed with dH2O and incubated for 30 min in the 
neutralization solution. 
Fig. 2.3 Scheme of a Southern blot transfer stack. 
DNA was subsequently transferred to a positively charged nylon membrane (Hybond-XL; 
Amersham Biosciences) by the capillary transfer method, using a setup shown in Fig. 2.3. The 
transfer buffer was drawn from a reservoir and forced through the gel by capillary action 
facilitated by a stack of dry paper towels placed on top. DNA fragments were carried along and 
became deposited on the membrane surface. As air bubbles trapped between blotting papers 
(3MM Chr; Whatman), gel and membrane would have interfered with the transfer, they were 
carefully removed during the assembly of the stack by rolling a plastic pipette over each layer. 
The outside of the gel was surrounded with Parafilm® (ANC Co) to prevent the buffer from 
migrating around it, which would also drastically decrease blotting efficiency. 
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The transfer was conducted in 10x SSC buffer at RT for 16-20 h. Positions of loading wells 
were marked on the membrane during the stack disassembly. The membrane was subsequently 
exposed to 254 nm UV-light (120 mJ/cm2; UV Stratalinker 1800; Stratagene) to induce the 
formation of covalent bonds between amino groups of the nylon and thymines of the DNA. 
Afterwards, the membrane was baked for at least 2 h at 80°C and stored at RT.  
Denaturation solution 
NaCl ................................438.8 g (1.5 M) 
NaOH...............................100.0 g (0.5 M) 
dH2O ............filled up to 5000 ml 
Neutralization solution 
NaCl ................................438.8 g (1.5 M) 
Tris-base ..........................302.9 g (0.5 M) 
dH2O ............filled up to 5000 ml 
 → adjusted to pH 8.0
20x SSC 
NaCl ................................876.5 g (3.0 M) 
Na3Citrate ........................441.0 g (0.3 M) 
dH2O ............filled up to 5000 ml 
 → adjusted to pH 7.0 
 
2.4.7.2 Generation and radioactive labelling of the probe 
After a region which should be recognized by a Southern blot probe had been selected, 
specific primers, which flanked that fragment, were designed. A chosen fragment was amplified 
by a genomic PCR (2.4.6.2) and subcloned into the pBS vector. The correct sequence of the 
probe was confirmed by sequencing (2.4.4.8). Prior to the labelling, the probe was released from 
the plasmid by a restriction digestion (2.4.4.1) or amplified by a preparative PCR (2.4.6.2) using 
the plasmid as a template. 
For one labelling reaction, 2.5-25 ng of a probe DNA was diluted in 45 µl ddH2O or TE 
buffer, denatured for 5 min at 95°C and snap-cooled for 5 min on ice. The solution was spun 
down and transferred to a Rediprime II reaction tube (Amersham Biosciences), containing a 
buffered mixture of nucleotides (dATP, dGTP, dTTP), exonuclease-free Klenow enzyme and 
random primers in a dried, stabilised form. Next, 5 µl of [32P]dCTP (10 mCi/ml; Easytides; 
PerkinElmer) were added and mixed thoroughly by pipetting up and down. After ~30 min 
incubation at 37°C, the reaction solution was transferred on a Sepharose column (see below) and 
spun down for 2-3 min at 1000 rpm (Minifuge2; Heraeus). The labelled probe was collected in 
1.5 ml tube placed under the column. 
The column was made from Sepharose G-50 in a fine dosage syringe (1 ml; Braun or BD) without a piston. A 
piece of a glass microfibre filter (GF/C, 1.2 µm; Whatman #1822025) was placed at the bottom of a syringe 
to prevent the beads from leaking out, before it was placed in a 15 ml centrifugation tube and filled with 
Sepharose G-50/TE buffer suspension. After 2-3 min centrifugation at 1000 rpm (Allegra 6R; Beckman 
Coulter) most of the liquid was spun down leaving beads behind. If necessary, the procedure was repeated 
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until beads reached the 0.8 cm3 mark. The column was transferred to a new 15 ml tube with an open 1.5 ml 
screw-cup tube inside. It was directly used or sealed with Parafilm® and stored at 4°C (up to 1-2 weeks). 
Around 100 µl of a probe solution was usually recovered after the centrifugation. To asses 
the labelling efficiency, 1 µl was transferred to a scintillation vial and the amount of counts per 
minute (cpm) was determined in a multi-purpose scintillation counter (LS 6500; Beckman). 
Around 100 µl of a labelled probe with a concentration of 300,000-500,000 cpm/µl were used 
for hybridization of 2-3 big membranes (30 DNA samples per filter). 
2.4.7.3 Hybridization, washing and signal detection 
A membrane with immobilized DNA was soaked in 2x SSC and placed, with the DNA-side 
facing inwards, in a glass hybridization bottle (3.5 x 30 cm) filled with 2x SSC. Subsequently, 
the membrane was pre-hybridized with 15 ml of Church buffer for 60 min at 65°C. The labelled 
probe was denatured for 5 min at 95°C, snap-cooled on ice for 3 min and mixed with Church 
buffer in the hybridization bottle. 
Sodium Phosphate buffer (1 M) – NaPi 
Na2PO4×2H2O......................89 g 
85% H3PO4 ...........................4 ml 
ddH2O ..........filled up to 1000 ml 
Church buffer 
NaPi ................................. 500 ml 
BSA   .................................... 10 g 
20% SDS........................... 350 ml 
0.5 M EDTA.......................... 2 ml 
salmon ssDNA (10 mg/ml).. 10 ml 
ddH2O........... filled up to 1000 ml 
 
The membrane was incubated with the probe for 16-20 h at 65°C in a hybridization oven 
(Mini Hybrydization Oven; Appligene). Afterwards, the buffer containing unbound probe was 
discarded and the membrane was washed twice for 30 min at 65°C, with the following buffer. 
Washing buffer: 
20x SSC............................... 20 ml (0.4%) 
20% SDS ............................. 50 ml (1%) 
ddH2O ...........filled up to 1000 ml 
The lower the content of SSC is, the more stringent the buffer. Washing with 1% SDS solution would strip a 
membrane. 
 
The washed membrane was wrapped in a plastic foil and placed in a radiographic cassette 
with a sheet of a radiographic film. The film was exposed for around 24 h at -80°C and 
developed to asses the strength of the signal. If necessary, a new film was exposed for a shorter 
or a longer period of time to obtain optimal signal intensity. 
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2.5 Cell culture materials and techniques 
2.5.1 Embryonic stem cells (ES cells) 
ES cells are derived from the inner cell mass of the blastocyst and can undergo an unlimited 
number of symmetrical divisions without differentiating (long term self-renewal). They are 
pluripotent and can give rise to all differentiated cell types. Therefore, when introduced into a 
blastocyst, ES cells can integrate into all developing tissues, including the germ line. These 
features are utilized during generation of genetically modified mice. A chimeric mouse can pass 
on a modified gene to its offspring, starting a new strain. In this study R1 ES cells were used. 
They were derived from 3.5-day blastocyst obtained from F1 (129X1/SvJ x 129S1) mating 
(Nagy et al., 1993). 
Maintaining ES cells in an undifferentiated proliferative state and thus sustaining their 
potential to integrate into germ line is crucial for obtaining chimeric mice and the transmission of 
a modified gene to offspring. Therefore, great care must be taken while handling these cells in 
culture and special conditions are required. ES cells form colonies instead of a single-cell layer 
and changes in the shape and colour of the colonies are an indicator of differentiation. 
2.5.1.1 Culture condition, medium 
ES cells were grown on a subconfluent feeder layer of mitotically inactivated primary mouse 
embryonic fibroblasts (MEFs; 2.5.2) in ES medium at 37°C, in 5% CO2 air with 95% humidity. 
Feeder cells provide a surface to attach, release nutrients to the medium and produce leukaemia 
inhibitory factor (LIF) that prevents differentiation of ES cells. The growth medium was 
additionally supplemented with LIF to guarantee its optimal concentration. No antibiotics were 
used as they might mask mycoplasma infections, which accompany bacterial infections but are 
resistant to antibiotics and can not be detected under a light microscope. Medium was replaced 
every day and pre-warmed to 37°C before the exchange. 
ES medium: 
D-MEM (High Glucose) .............. 400 ml  [Gibco #31966-021] 
FCS  ............................................ 100 ml  [Gibco #10270-106] 
Non-Essential Amino Acids.............. 5 ml  [Gibco #11140-035] 
LIF    ............................................500 µl (1000 U/ml) [ESGro, Gibco] 
β-mercaptoethanol .........................3.5 µl (0.1 mM) 
 → FCS was heat-inactivated by 30 min incubation at 56°C   
 → D-MEM contains: GlutaMAX™ I, 4500 mg/l D-glucose and sodium pyruvate. 
 
 
Materials and Methods 
50 
2.5.1.2 Passaging, freezing and thawing 
When the culture becomes too dense, ES cells start to differentiate. Therefore, they were 
passaged every 2-3 days (before colonies were starting to fuse and got brownish in the middle). 
The growth medium was changed 2 h before splitting. Cells were washed two times with PBS 
(volume of growth medium) and incubated with 1x trypsin/EDTA solution (diluted with PBS 
from 10x stock: 0.5% Trypsin, 0.2% EDTA·4Na [5,3 mM], 0.85% NaCl, pH 7.4; Gibco #15400-
054) for 3-5 min at 37°C, until they could be easily detached from the surface. Colonies were 
dispersed by pipetting up and down with 5-7 ml ES medium and cells were spun down for 5 min 
at 500g. ES cells were resuspended in growth medium and usually split 1:3-1:5 into a new 
dish/flask. Splitting ratio was not exceeding 1:7 as ES cells should not be seeded too sparse. 
Depending on the area of the new flask, an appropriate amount of feeder cells was co-seeded. 
The number of passages can have a negative effect on ES cells properties. Therefore, 
multiple aliquots of new clones were frozen as soon as possible. When ES cell colonies reached 
optimal density for splitting, cells were trypsinized as described above and resuspended in 
ice-cold ES medium supplemented with 10% DMSO (dimethysulfoxide; Sigma #8779). The cell 
suspension was transferred to cryo-vials (Corning #430489) in 1 ml aliquots, frozen on dry-ice 
and stored in -80°C. For long-time storage, ES cells were transferred to liquid nitrogen. One 
frozen aliquot contained enough cells to repopulate a well in a 6 well plate or a small T-flask 
(see table below). 
Container Growth  medium volume 1x TR/EDTA Cryo-vials 
6 well 3-4 ml 0.5 ml 1 
Small – T/flask (25 cm2) 5-6 ml 1.0 ml 3-4 
Medium – T/flask (75 cm2) 8-10 ml 1.5 ml 7-8 
10 cm Ø dish 8-10 ml 1.5 ml 8-10 
Big – T/flask (175 cm2) 18-20 ml 2.5 ml 15-18 
 
 
ES cells were thawed fast to reduce the exposure to toxic DMSO. A cryo-vial was removed 
from the freezer or liquid nitrogen and placed in a warm water bath (37°C). As soon as the 
medium thawed, the cell suspension was transferred to 5 ml of ES medium and spun down for 
5 min at 500g to wash away DMSO. After discarding the supernatant, ES cells were resuspended 
in the growth medium and seeded together with an appropriate amount of feeder cells in a 6-well 
plate or a small T-flask. 
2.5.2 Preparation of feeder cells 
Feeder cells are prepared from MEFs isolated from transgenic mice carrying a neomycin 
resistance gene; therefore they can be used during ES cells selection steps. They are mitotically 
inactivated either by γ-irradiation or mitomycin C treatment. Feeder cells are seeded one day 
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before or together with ES cells (2.5.1) and can be used for around 10 days.  
A pregnant female was sacrificed at day 13.5 or 14.5 post coitum (day 0.5 – the day when 
the plug is observed) and placed in a sterile hood (on several paper tissues). After washing the 
belly with 70% EtOH, the uterus was carefully dissected out and placed in a Petri dish (6 cm Ø) 
filled with 2 ml PBS. Embryos were released from the amnions and transferred to a new dish 
containing 2 ml PBS. Heads were cut off and all internal organs removed with a forceps. The 
remaining tissue was cut into small pieces and incubated in 1x trypsin/EDTA solution 
(1 ml/embryo) for 10 min at 37°C. The tissue was broken up by up-and-down pipetting, 
incubated for 10 min more at 37°C and fragmented again (with a smaller volume pipette). 
Afterwards, cells were resuspended in EF medium (D-MEM with 10% FCS; 2.5.1.1), seeded in 
10 cm Ø dishes (1 embryo/dish) and incubated O/N at 37°C to check for potential contamination. 
The following day, the content of each dish was split into two big T-flasks. Afterwards, MEFs 
were grown without changing medium at 37°C, in 5% CO2 air with 95% humidity and the 
density of cells was checked every day. After cells became confluent, they were cultured for 3 
more days. 
Next, MEFs were washed with PBS (15 ml/flask), trypsinized for 10 min at 37°C 
(1x trypsin/EDTA; 2.5 ml/flask) and thoroughly resuspended with 2.5 ml EF medium. Part of the 
cell suspension (0.5 ml) was reseeded in the flask and fresh EF medium was added (20 ml/flask). 
Remaining cells were collected in 50 ml tubes and centrifuged for 10 min at 500g. Medium was 
discarded (leaving just a thin layer of liquid to prevent cells from drying) and pellets were 
γ-irradiated with 40-60 Greys. Feeder cells were resuspended in ice-cold D-MEM medium 
supplemented with 10% DMSO and 20% FCS and frozen down on dry-ice. Three 1 ml aliquots 
were frozen from every T-flask (6 vials from an embryo). Reseeded cells were expanded and the 
procedure was repeated (omitting the reseeding step), 3 days after they reached confluency. 
Feeder cells were stored at -80°C. When used for ES cell culturing, one vial was usually seeded 
in a 10 cm Ø dish.  
2.5.3 Embryoid bodies (EBs) 
2.5.3.1 Culture conditions  
Prior to the formation of EBs, ES cells were expanded in a standard growth medium (2.5.1) 
on a confluent feeder-cell layer (2.5.2). During passaging, colonies were carefully trypsinized in 
order to obtain small aggregates of ES cells instead of a single-cell suspension. When tightly 
packed colonies were covering about 70 % of a 10 cm Ø dish surface, they were best suited for 
the generation of EBs.  
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Cell aggregates optimal for differentiation into EBs (~5 cells/cluster) were obtained with a 
trypsin/EDTA treatment (0.25% Trypsin, 0.53 mM EDTA; 2 ml/dish). The process was 
monitored under the microscope and stopped when balls of ES cell colonies started to detach 
from the surface (~3-5 min). After neutralisation with 4 ml of EF medium, cells were transferred 
to a tube and let to sediment for 10 min. The supernatant, containing single ES and feeder cells, 
was discarded. After adding 2 ml of EB medium (ES medium w/o LIF, 2.5.1.1) colonies were 
dispersed into clusters of 2-5 cells, using a fine-tipped Pasteur pipette (outer Ø ~0.2 mm). 
ES cells were placed in tissue culture dishes and incubated for 1-3 h at 37°C to selectively 
remove feeder cells, which adhere much faster (panning). Next, the aggregates were transferred 
carefully into bacteriological Petri dishes (10 cm Ø) and cultured in EB medium for 7 to 14 days. 
The medium was changed the first time after 3 days and every other day thereafter. 
The size of cell clusters is critical for an efficient development of EBs. Too large cell 
aggregates differentiate in a disorganized fashion. Single cells grow too slowly in suspension and 
usually fail to form EBs. An optimal density of EBs is very important and should not be higher 
than 1000 clusters/dish. Usually one dish of ES cells can be distributed into 6-8 bacterial dishes. 
After approximately 3 days of growing in a suspension culture, the endoderm and the BM are 
developed within EBs. 
2.5.3.2 Analysis of EBs structure 
IF staining and ultrastructural analysis of developing EBs was conducted by Dr. Shaohua Li 
in Dr. Peter Yurchenco’s group (Department of Pathology and Laboratory Medicine, University 
of Medicine and Dentistry of New Jersey [UMDNJ], Robert Wood Johnson Medical School, 
Piscataway, NJ, USA), according to published protocols (Li and Yurchenco, 2006). 
At selected time points EBs were collected in a 15 ml tube and allowed to sediment by 
gravity. Medium was removed and cells washed once with 0.5% BSA/PBS (resuspended and 
sedimented again). 
For IF analysis, EBs were fixed in 3% PFA/PBS for 30 min at RT, incubated in 
7.5% sucrose/PBS for 3 h at RT and subsequently in 15% sucrose/PBS, O/N at 4°C. Next, EBs 
were embedded in Tissue-Tek OCT (Miles, Inc.) and 4 µm section were cut with a cryotome. 
Primary antibodies were incubated for 1 h at RT, after 20 min blocking with 5% goat or donkey 
serum. Slides were mounted with 50 mM Tris-HCl buffer (pH 8.5) with 6% DABCO and 50% 
glycerol. 
For EM analysis, EBs were fixed in 0.5% glutaraldehyde and 0.2% tannic acid in PBS for 
1 h at RT, washed with 0.1 M Na-cacodylate buffer (3 × 5 min). Next, they were transferred to a 
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modified Karnovsky’s fixative and subsequently post-fixed in 1% OsO4 (osmium tetroxide) for 
1 h, dehydrated and embedded in Epon. Sections were cut with a diamond knife on an 
ultramicrotome. Thick sections (1 µm) were stained with 1% methylene blue/1% borax/ddH2O 
for the light microscopy analysis. Thin sections (90 nm) were stained for 20 min with saturated 
uranyl acetate followed by 2-5 min wash with 0.2% lead citrate and rinsing with ddH2O. Images 
were photographed with an electron microscope (JEM-1200EX; JEOL USA, Inc.). 
2.5.3.3 Analysis of the ES cells differentiation potential 
After 6 days in a suspension culture, EBs were transferred into uncoated chamber slides 
(Nunc) and cultured in EB medium for 7 or 14 days to allow for further differentiation into 
different types of cells. Spontaneously developed tissues were identified by IF analysis of marker 
proteins, performed according to a standard staining protocol (2.5.4.4).  
2.5.4 Primary keratinocytes 
2.5.4.1 Culture conditions 
After the isolation (2.5.4.3), primary keratinocytes were seeded on a plastic or glass surface, 
coated with collagen I and fibronectin (Col/FN) or a LN5-rich matrix (LN), and cultured in a 
special medium at 34°C in 5% CO2 air with 95% humidity. The growth medium was changed 
one day after seeding and every 2-3 days afterwards. Keratinocytes were grown without splitting 
until control cells became fully confluent (7-10 days). 
Keratinocyte Medium: 
MEM .............................................. 500 ml  [Sigma #M8167] 
Chelated FCS................................... 40 ml (8%) 
Insulin (5 mg/ml in 4 mM HCl).......500 µl (5 μg/ml) [Sigma #I5500] 
EGF (200 μg/ml)* ...............................5 µl (10 ng/ml) [Sigma #E9644] 
Transferrin (5 mg/ml)* ................. 1000 µl (10 μg/ml) [Sigma #T8158] 
10 mM Phosphoethanolamine*.......500 µl (10 μM) [Sigma #P0503] 
10 mM Ethanolamine*....................500 µl (10 μM) [Sigma #E0135] 
Hydrocortisone (5 mg/ml in EtOH) ..36 µl (0.36 μg/ml) [Calbiochem #386698] 
200 mM L-Glutamine (100x).............. 5 ml  [Gibco # 25030-024] 
Penicillin/streptomycin (100x)........... 5 ml  [PAA Laboratories #P11-010] 
 → medium was sterile filtered (0.22 µm) before adding antibiotics 
 → marked compounds (*) where diluted in PBS 
 
Before adding to the medium, FCS (Gibco #10270-106) was depleted of Ca2+ ions, which 
induce differentiation of keratinocytes. Chelex resin (Biorad #142-2832) was suspended in 5 l 
ddH2O (40 g/l) and adjusted to pH 7.4 with HCl. Afterwards the suspension was filtered through 
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a paper filter (Schleicher&Schuell #314856) and the buffered resin was gently stirred with 
500 ml of a heat inactivated FCS, O/N at 4°C. Chelex beads were removed by filtering and 
subsequent centrifugation (5 min, 8000 rpm). FCS was sterilized with a vacuum filter system 
(Corning #431097), aliquoted (40 ml) and stored at -20°C. 
2.5.4.2 Surface coating 
The Col/FN-coated surface was prepared by incubating dishes/plates/chamber slides with the 
coating medium for 2-4 h at 37°C. Afterwards, containers were directly used or sealed with 
Parafilm (ANC Co) and stored at 4°C. Before seeding cells, coating medium was removed and 
the dishes were washed with PBS. 
Coating medium 
MEM ...............................(21.5 ml) 25 ml  [Sigma #M8167] 
BSA, pH 7.0 (1 mg/ml)* ...............  2.5 ml (0.1 mg/ml) [PAA Laboratories #K41-001-100] 
1 M Hepes, pH 7.3 ........................ 500 μl (20 mM) [Sigma #H0887] 
Vitrogen-collagen I (3 mg/ml) ......250 µl (30 µg/ml) [Cohesion #FXP-019/Nutacon #5409] 
Fibronectin (1 mg/ml).................   250 μl (10 µg/ml) [Invitrogen #33016-015] 
100 mM CaCl2* ............................ 290 μl (1 mM) 
 → fibronectin was diluted in sterile ddH2O 
 → marked compounds (*) where diluted in PBS and sterilized by filtration (0.2 µl) 
 
The LN matrix was deposited by RAC-11P/SD squamous cell carcinoma cells (Sonnenberg 
et al., 1993) and prepared according to a previously published protocol (Delwel et al., 1993), 
with modifications. In short, cells were seeded in a dish/plate/chamber slide and grown until 
confluency in D-MEM containing 10% FCS. Afterwards, cells were washed three times with 
PBS and incubated O/N at 4°C with sterile 20 mM EDTA/PBS solution supplemented with 
protease inhibitor cocktail tablets (cOmplete, Mini, EDTA-free tablets; Roche #11836170001). 
The following day, cells were removed as a single sheet by short pipetting (along the walls of the 
dish). The matrix was washed once and stored in PBS at 4°C until use. 
2.5.4.3 Isolation of primary keratinocytes from adult mice 
Isolation of epidermis keratinocytes from older mice was carried out according to a modified 
protocol of Romero and colleagues (Romero et al., 1999). Sacrificed mice were shaved and 
sequentially washed in an iodine solution, distilled water and 70% EtOH (~60 s in each). After 
limbs were cut off, the skin was peeled off from the trunk and placed in a sterile Petri dish 
(10 cm Ø). The subcutaneous layer was removed very thoroughly with a scalpel (scraped off), as 
any remaining fat would drastically reduce the activity of trypsin. Skin was cut into fragments 
(~3-5 cm2) and placed (epidermis down) in a dish filled with 25 ml of antibiotics-containing PBS 
Materials and Methods 
55 
for 5-10 min. Afterwards, skin fragments were transferred (epidermis up) to a new dish filled 
with 25 ml of 0.8% trypsin/PBS (Trypsin 1:250; Invitrogen #27250-018) and incubated for 
50 min at 37°C. Epidermis was separated with forceps, transferred to the DNase medium (MEM 
supplemented with 0.25 mg/ml DNase I [deoxyribonuclease; Sigma #DN25] and 8% chelated 
FCS; 2.5.4.1; sterile filtered – 0.2 µm) and incubated with shaking for 30 min at 37°C in a water 
bath. Afterwards, the suspension was filtered through a 70 µm cell strainer (BD Biosciences). 
Collected cells were spun down (5 min, 500g) and washed once with the DNase medium. 
Subsequently cells were resuspended in the growth medium (2.5.4.1), counted and seeded on a 
coated surface (2.5.4.2) at a density of ~6×106 cells per dish (10 cm Ø), 1-1.5×106 cells per well 
(6 well plate) and 2-4×105 cells per chamber slide well. 
Antibiotics-PBS 
PBS   ........................................... 500 ml 
Penicillin/streptomycin (100x)....... 10 ml [PAA Laboratories #P11-010] 
Nystatin (10000 U/ml).................... 10 ml [Sigma #N1638] 
Fungizone (250 µg /ml).................. 10 ml [Gibco # 15290-026] 
2.5.4.4 Immunofluorescence staining of cells 
Cells intended for IF analysis were grown on glass chamber slides (Nunc) coated with a 
suitable substrate. At chosen time points they were briefly rinsed in PBS and fixed for 10 min in 
freshly prepared cold 3.7% PFA/PBS. A permeabilization with 0.1% Triton X-100/PBS was 
performed for 15 min before 60 min blocking with 2% BSA/PBS. Alternatively Triton X-100 
was added to the blocking solution. After rinsing with PBS, primary antibodies were applied and 
incubated for 60 min at RT. The rest of staining procedure was performed as described for skin 
IF (2.7.2.1). Slides were dried O/N at RT and stored at 4°C. Staining results were analysed using 
a fluorescence microscope (DM RA2; Leica) and archived with a digital camera (OrcaER; 
Hamamatsu). 
2.5.4.5 Adhesion assay 
Wells for the adhesion assay (96-well plate) were coated with substrates used for standard 
keratinocyte culture. The Col/FN coating was obtained by incubating a surface with PBS 
containing 30 µg/ml collagen I and 10 µg/ml fibronectin O/N at 4°C. The LN matrix was 
prepared as described in chapter 2.5.4.2. Before seeding cells, plates were washed with PBS, 
blocked with 1% BSA/PBS (PAA Laboratories) for 90 min at 37°C and washed again.  
After isolation from adult mice, keratinocytes were resuspended in a standard growth 
medium (2.5.4.1) without FCS and seeded in 100 µl at a density of 105 cells/well. Three maximal 
value samples were transferred to a 1.5 ml tube (3×105 cells in 300 µl). Cells seeded on the plate 
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were incubated for 1-2 h at 37°C. Afterwards non-attached cells were removed by washing 
3 times with PBS and 50 µl of substrate buffer were added to each well. Keratinocytes in the 
tube were spun down, resuspended in 150 µl of the substrate buffer and transferred to 3 empty 
wells (50 µl/well). The plate was incubated O/N at 37°C. The following day, 75 µl of the stop 
buffer were added to each well and the absorbance was measured at 405 nm with a plate reader 
(Dynatech MR5000). 
Substrate buffer 
A: 
NPAG (Sigma #N9376).............. 25.7 mg 
0.1 M Na-citrate, pH 5.0................ 10 ml 
B: 
Triton X-100...................................0.5 % 
 → both buffers prepared in ddH2O 
 → A + B mixed [1:1] and stored at -20°C 
Stop buffer 
Glycine, pH 10.4.......................... 50 mM 
EDTA............................................. 5 mM 
 → prepared in ddH2O 
 
2.5.4.6 Time-lapse video microscopy and cell spreading analysis 
Live cell recordings of freshly isolated keratinocytes (from 8-months-old mice) were 
performed using a Zeiss Axiovert 200 M microscope with a motor-controlled CCD camera 
(OrcaER, Hamamatsu). Images of cells were captured every 20 min for 42 h (at 37°C, 5% CO2). 
The recording was started immediately after keratinocytes were seeded on Col/FN coated plastic 
(6-well plates). The cell size for spreading analysis was assessed by measuring the pixel area of 
30-40 randomly picked cells in pictures taken at indicated time points. Evaluation and processing 
of images were performed with the Metamorph software (Universal Imaging Corporation). 
2.5.4.7 Isolation of primary keratinocytes from 3d old mice 
Epidermis of 3-day-old mice was isolated according to a modified protocol previously 
described by Caldelari and co-authors (Caldelari et al., 2000). In short, mice were sacrificed 
using ether (10-15 min) and washed in an iodine solution and 70% EtOH (60 s in each). After 
limbs and the tail were cut off, the skin was peeled off and placed, dermis up, in a Petri dish 
(6 cm Ø) filled with 4-5 ml of 10 µg/ml gentamicin/PBS solution (stock: 5 mg/ml; Sigma 
#G1397). The washing step was performed for 5-10 min, twice. Subsequently, the skin was 
transferred, epidermis up, to a dish containing 4-5 ml of dispase-II solution and incubated O/N 
at 4°C. 
The following day epidermis was separated from dermis and torn into pieces using forceps. 
Fragments were placed in 15 ml tube with 10 ml of 5x trypsin/EDTA solution (Gibco 
#15400-054; 2.5.1.2) and incubated for 10 min at 37°C. During the trypsinization, the suspension 
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was mixed a few times to keep the tissue pieces afloat. Afterwards, part of the cell suspension 
(~5 ml) was transferred to a new tube, avoiding the epidermis pieces. K-SFM medium 
containing 10% FCS (5 ml) was added to the remaining part, mixed and transferred again. Cells 
were spun down for 5 min at 1000g, resuspended in the medium for counting and washed with 
PBS before the lysis.  
Dispase II solution: 
K-SFM (not supplemented) ............ 45 ml  [Gibco #10744-019] 
Dispase II...................................... 0.25 g (5 mg/ml) [Roche #165859] 
Penicillin/streptomycin (100x)......... 5 ml  [PAA Laboratories #P11-010] 
 → solution was sterile filtered (0.2 µm) before adding antibiotics; 
2.6 Generation of a conditional knock-out mouse 
Conditional knock out of the murine rac1 gene in the epidermis was generated in this study 
using the Cre-loxP system and following the guidelines published by Talts and co-authors (Talts 
et al., 1999). 
2.6.1 Cre-loxP system 
The Cre-loxP system is a widely used tool, which enables tissue-specific and/or time-
specific ablation of the gene of interest. It is very useful for studying the function of a gene in 
differentiated tissues, when a conventional knock-out leads to an early embryonic death. 
Cre recombinase is a 38 kDa protein from bacteriophage P1 which mediates an 
intramolecular (excisive or inversional) and an intermolecular (integrative) site specific 
recombination between loxP sites (Sauer, 1993). 
The loxP site (Fig. 2.4) consists of two 13 bp inverted repeats (black) separated by an 
asymmetric spacer region (8bp; red). The recombination (cross-over) occurs in the asymmetric 
spacer region, which determines the directionality of the site. Two loxP sequences in an opposite 
orientation to each other invert the DNA fragment between them. Two sites in a direct 
orientation dictate excision of the intervening DNA between them, leaving one loxP site behind.  
Fig. 2.4 LoxP site consensus sequence. Flanking parts (black) create a palindromic sequence 
separated by asymmetric region (red) determining the direction of the site. 
Two mouse lines are required for a conditional gene deletion. First, a transgenic mouse line 
with a Cre recombinase expression restricted to a specific tissue or cell type and second, a mouse 
strain carrying a modified target gene (endogenous gene or transgene) with a fragment flanked 
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by loxP sites in a direct orientation ("floxed gene"). An excision leading to the gene inactivation 
occurs only in cells expressing Cre recombinase and the target gene remains intact in all the 
other cells and tissues. 
2.6.2 Targeting construct preparation 
2.6.2.1 Modification of the selection cassette 
The selection cassette used in this study contained genes encoding neomycin resistance (neo) 
and Herpes Simplex Virus thymidine kinase (TK). The product of the neo gene expressed in 
eukaryotic cells inactivates G418 (a gentamicin-related antibiotic). Therefore, a positive 
selection for cells carrying the gene is possible using medium containing G418. Cells expressing 
TK can be eliminated by a negative selection using FIAU (1-2'-deoxy-2'-fluoro-b-D-
arabinofuranosyl-5-iodouracil). This compound is transformed by TK into an analogue of 
thymidine, which gets incorporated into DNA, effectively killing cells expressing the enzyme. 
The selection cassette (4.7 kbp) was subcloned into the MCS of the pBS vector (3 kbp; 
Fig. 2.1) between EcoRI and HindIII sites as shown in Fig. 2.5A. Before inserting the cassette 
into the targeting construct, SalI site located within the cassette had to be removed, as SalI was 
later used to linearize the plasmid before the electroporation (2.6.2.3). In the first step, DNA was 
cut with ClaI/XhoI and ligated with an oligonucleotide linker (primers AC3+AC4; 2.4.1), which 
resulted in the removing of SalI site from the MCS of the vector (Fig. 2.5B). The incorporation 
was confirmed by PstI and ScaI digestions. Next, the plasmid was cut with SalI and the resulting 
overhangs filled in. After a blunt re-ligation, the absence of SalI site was confirmed with BamHI 
and SalI/BamHI digestions. The modified selection cassette (Fig. 2.5C) was cut out with 
NotI/ClaI digestion and combined with the targeting construct. 
Fig. 2.5 Modification steps of the selection cassette. (A) The unmodified neo-TK selection cassette 
subcloned in the pBS between EcoRI/HindIII sites of the MCS (underlined). (B) Modification of the 
MCS sequence (red). (C) The final selection cassette. NotI and ClaI sites used for subcloning into the 
targeting vector are marked in red. 
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2.6.2.2 Cloning of the targeting construct 
An EcoRI–SalI fragment of the rac1 gene (11.7 kbp), containing exons 2 and 3 was isolated 
from a 129/Sv PAC library clone (Geneservice Ltd.; (Osoegawa et al., 2000) and subcloned into 
the pBS vector (3 kbp; Fig. 2.6A). The correct PAC clone was identified in a Southern blot 
screening of the library. A piece of the Rac1 gene containing exon 3 sequence was used as a 
probe. It was generated with primers PAC1 and PAC2 (2.4.1) as described earlier (2.4.7.2).  
Fig. 2.6 Generation of the targeting construct. (A) A fragment of the rac1 gene subcloned into the 
pBS vector between EcoRI and SalI sites (underlined). (B-D) Results of consecutive cloning steps 
described in the text. Changes marked in red. (E) The final targeting construct with SalI site used for 
linearization marked in red. 
In the first step of the gene sequence modification, an oligonucleotide linker containing a 
HindIII site and the loxP sequence (primers AC1+AC2; 2.4.1) was introduced at NdeI site 
(Fig. 2.6B). The insertion was verified with HindIII digestion and the orientation of the loxP site 
was checked by sequencing with primer AC11 (2.4.1). Next, NotI and SpeI sites within the MCS 
were removed. After cutting with NotI/EcoRI, overhangs were filled in and the plasmid was re-
ligated (blunt). The resulting sequence, depicted in Fig. 2.6C, was confirmed by digestion with 
SpeI/EcoRI. Before the selection cassette introduction, NotI and ClaI sites had to be created 
downstream of exon 3. An oligonucleotide linker (primers AC9+AC10; 2.4.1) was introduced in 
SpeI site as shown in Fig. 2.6D. The correct orientation was verified by sequencing with primer 
AC12 (2.4.1). 
ClaI is a methylation-sensitive restriction enzyme. Therefore, before the final cloning step, 
plasmids carrying both the unfinished targeting construct (Fig. 2.6D) and the selection cassette 
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(Fig. 2.5C) were transformed into JM110 strain of E. coli, which is deficient for methylases 
(Dam and Dcm). DNA purified from these bacteria was not methylated and could be cut by 
NotI/ClaI digestion. Both fragments were then combined to form the final targeting construct 
(19.4 kb; Fig. 2.6E). 
2.6.2.3 Preparation of DNA for the electroporation 
For an efficient uptake of a targeting construct and its successful integration in the genomic 
DNA, the plasmid must be completely linearized and purified. 
The targeting construct was cut with SalI for 6-7 h at 37°C and the efficiency of digestion 
was checked with an agarose gel electrophoresis by the comparison with an uncut vector. 
Targeting construct linearization: 
DNA..................................~100 µg 
SalI NEBuffer (10x)...............20 µl 
BSA (10 µg/µl) ......................10 µl 
SalI (160U)...............................8 µl 
ddH2O ......................................x µl 
 200 µl 
 
After digestion, the DNA suspension was mixed with 200 µl of phenol/chloroform solution 
[1:1] and centrifuged for 5 min at 20,000g. The upper phase (aqueous), containing DNA, was 
transferred to a new tube, mixed with 200 µl chloroform and centrifuged. Again, the upper phase 
was transferred to a new tube. To precipitate DNA, 20 µl of 3 M Na-Ac (pH 5.2) and 500 µl of 
100% EtOH were added and thoroughly mixed. White, coiled DNA was transferred to a sterile 
1.5 ml screw-cup tube filled with 1 ml of 70% EtOH. The tube was inverted several times to 
sterilize DNA and the inside of the tube. DNA was stored at -20°C until the electroporation day. 
Shortly before the electroporation, EtOH was carefully removed (pipette with a 1000 µl tip) 
and DNA was air-dried in a sterile hood for 5-10 min (at RT). The pellet was resuspended in 
700 µl PBS and incubated at 37°C until DNA dissolved completely. 
2.6.3 Homologous recombination of the targeting construct 
The modified part of gene can be inserted into ES cells (2.5.1) genome by utilizing a 
homologous recombination event, in which transfected DNA is exchanged with a 
complementary fragment within the chromosome sequence.  
Electroporation is routinely used to introduce plasmid DNA into mammalian cells. In this 
procedure, a large electric pulse temporarily disturbs the cell membrane, allowing polar 
molecules, such as DNA, to pass into the cell. 
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2.6.3.1 Electroporation of ES cells 
Usually, 4×107 ES cells were electroporated with ~100 µg of a linearized targeting construct 
and 360 clones were picked to screen for homologous recombinants. If a lower number of clones 
was going to be screened, only 2×107 ES cells were used for the electroporation. 
When 4×107 ES cells were going to be electroporated, 8 dishes (10 cm Ø) with subconfluent 
layers of feeder cells (2.5.2) were prepared. Feeders were thawed and seeded (1 vial/dish) several 
hours or a day before the electroporation. Alternatively, cells were thawed shortly before the 
electroporation, resuspended in ES medium and co-seeded with electroporated ES cells. 
An aliquot of ES cells, from the passage previously checked for a germ-line transmission 
capability, was thawed and expanded to obtain sufficient amount of cells. Before the 
electroporation, ES cells were trypsinized and thoroughly resuspended in 10 ml ES medium to 
obtain a single-cell suspension. Cells were counted and washed twice with 10 ml PBS (5 min at 
500g). After the last centrifugation, PBS was decanted and the pellet (~4×107 cells) was 
resuspended by flicking the tube with a finger. ES cells were mixed with 700 µl of the DNA 
suspension (2.6.2.3) and transferred with a Pasteur pipette to a sterile electrocuvette (0.4 cm; 
BioRad #165-2088). The electroporation was performed at RT with a Gene Pulser (model 
1652077; BioRad) at 0.8 kV/3 µF, with the time constant (decay of the electric field) of 0.04 ms. 
Immediately afterwards, cells were carefully transferred to ES medium and seeded in 8 cell-
culture dishes (10 cm Ø) with previously prepared feeder cells. ES cells were incubated in 
8 ml/dish of the growth medium at standard conditions. 
2.6.3.2 Selection and picking of clones after the recombination 
The positive selection was started ~24 h after the electroporation. ES medium was 
supplemented with 500 µg/ml G418 Sulphate (Geneticin; Gibco #01811), which selectively kills 
cells without neomycin resistance gene. Therefore, only successfully electroporated ES cells, 
which had the targeting vector incorporated into the genome, were able to survive. The selection 
medium was changed every day. After 6 days, when resistant ES cells had formed big enough 
colonies, 360 clones were picked. 
Clones were grown in 24-well plates on a feeder layer prepared the previous day or few 
hours earlier. Feeder cells (2.5.2) were thawed (1 vial/plate), seeded in plates and incubated in 
EF medium at 37°C. Shortly before picking, EF medium was exchanged for G418 containing 
ES medium (1 ml/well). If feeder cells were thawed on the day of picking, they were seeded 
directly in ES medium with G418. Trypsin/EDTA solution (1x) was aliquoted into 96-well plates 
(150 µl/well) and pre-warmed to 37°C. 
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Picking of selected ES cells clones was conducted under the stereomicroscope (Stemi SV6; 
Zeiss) placed in a laminar flow hood. Single colonies were lifted from the feeder cell layer with a 
sterile tip (200 µl) and transferred to the trypsin solution. After 24 clones were picked, the plate 
was incubated for 5-10 min at 37°C. Next, each colony was dispersed by pipetting with 150 µl of 
G418 supplemented ES medium and transferred to a 24-well plate with prepared feeder cells. A 
full plate was placed in an incubator and the next 24 clones were picked. ES cells were grown at 
standard conditions. The medium was changed only once, on the following day. 
When, after 3-5 days, the medium started to turn yellow, ES cell clones were frozen. Cells 
were washed twice with PBS and incubated with ~150 µl of 1x trypsin/EDTA solution, for 5 min 
at 37°C. Ice-cold freezing medium was added to each well (1 ml/well) and cells were 
resuspended thoroughly. For each clone, 0.5-0.6 ml of the cell suspension were transferred to a 
cryo-vial and placed immediately on dry-ice (in a freezer-box). Full boxes were transferred to 
-80°C. ES medium (w/o G418) was added to remaining cells (1.5 ml/well) and exchanged the 
following day (1 ml/well) to remove residual DMSO. ES cells were grown until medium turned 
yellow in order to isolate sufficient amount of DNA for screening (2.6.3.3).  
2.6.3.3 Screening of ES cell clones 
When ES cell clones were expanded after freezing (2.6.3.2), DNA was extracted (2.4.5.2) 
and screened by a Southern blot analysis (2.4.7). Homologously recombined clones were 
identified after HindIII digestion with the external probe (0.33 kbp), which was created (2.4.7.2) 
using primers AC15 and AC16 (2.4.1). Positive clones were checked for random integration of 
the targeting construct with Southern blot analysis of HindIII digested DNA using the internal 
probe (1.2 kbp) obtained with primers AC6 and AC7 (2.4.1). 
2.6.4 Removal of the selection cassette 
Before injecting into the blastocysts, the selection cassette was removed from ES cell clones 
with a successfully recombined allele. Transient expression of the Cre recombinase led to an 
excision of DNA fragments between loxP sites. As the modified gene contained three loxP sites 
(3loxP), different fragments could have been removed: only exon 3, only the selection cassette 
(resulting in the conditional allele) or both (resulting in the null allele) (Fig. 3.2). The presence of 
HSV-tk gene in the selection cassette enabled a negative selection. ES cells not recombined after 
cre transfection or still carrying the cassette were eliminated with FIAU treatment. 
Two different rac13loxP/+ clones were thawed and expanded to obtain ~1×107 cells (full 
25 cm2 T-flask). After trypsinization, the fifth part of cells was electroporated with PBS alone as 
a control and plated with feeder cells in a dish (10 cm Ø). The remaining cells were 
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electroporated (2.6.3.1) with 20 µg of pIC-Cre plasmid in PBS (Gu et al., 1993) (gift from Dr. 
Werner Müller, University of Cologne, Germany) and seeded with feeder cells in four 10 cm Ø 
dishes. After 2 days cells were trypsinized and the fifth part from each dish was reseeded. The 
selection was started 24 h later. ES medium containing 0.2 µm FIAU was applied and changed 
every day (twice a day during the death peak). After 5-6 days, ES cell colonies were picked, 
expanded and frozen as described earlier (2.6.3.2). To identify the ES cell clones with the 
conditional or the null allele, a Southern blot analysis of BamHI-digested genomic DNA was 
conducted with the internal probe (2.6.3.3).  
2.6.5 Blastocyst injection 
Clones selected for injection were thawed and grown in 6-well plate for 1-2 days. ES cells 
were trypsinized, resuspended in 3 ml of [1:1] mixture of ES medium and flush medium 
(10% FCS D-MEM buffered with 20 mM HEPES, pH 7.4), and kept on ice until the injection 
procedure. Blastocyst injections were performed by Dr. Michael Bösel (Transgenic Service, Max 
Planck Institute of Biochemistry, Martinsried). 
As mentioned before (2.5.1), R1 ES cells used in this study are derived from blastocyst from 
129/Sv mouse strain. They have a male genotype (XY) and carry the dominant coat-colour 
marker agouti. Blastocysts used for the injection, derived from C57BL/6 mouse strain, were 
carrying the recessive coat-colour marker black and had a random genotype. ES cells (10-15) 
were injected into the cavity of blastocysts, which were transferred afterwards into the uterus of 
a pseudo-pregnant mouse (foster mother). Both type of cells contributed to developing foetuses 
resulting in a birth of chimeric mice. The ratio of the ES cells contribution was roughly assessed 
by the percentage of the agouti-coloured coat. 
2.6.6 Breeding schemes 
Male chimeras with the highest contribution of ES cells were mated with C57BL/6 females. 
As agouti mice could only develop from ES-cell-derived sperm, the coat colour of the offspring 
was a first indicator of germ-line transmission. Offspring carrying the conditional allele were 
identified by PCR genotyping (2.4.6.1) with primers designed to distinguish between the wild 
type and the floxed allele (Fig. 3.2, blue arrows). The results were confirmed by a Southern blot 
analysis with the internal probe. Heterozygote mice were mated to obtain homozygote animals. 
After the lack of a phenotype in rac1fl/fl mice was confirmed, they were intercrossed with mice 
carrying cre transgene to obtain tissue specific deletion of Rac1 protein.  
Transgenic mice, which were used in this study, express Cre recombinase under the control 
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of the K5 promoter (K5-Cre) (Ramirez et al., 2004), which is activated in HFs (ORS, bulge and 
SGs) and in the epidermis (basal keratinocytes), as well as in other stratified epithelia (i.e. 
tongue, esophagus, forestomach) (Byrne and Fuchs, 1993). An efficient recombination of a 
floxed gene in the back skin of mice carrying the cre transgene was shown from day 15.5 of the 
embryonic development onwards (Ramirez et al., 2004). The presence of the cre transgene 
during breeding of mice was confirmed with Cre PCR. 
The final breeding scheme used to obtain mutant and control animals for experiments is 
shown in Fig. 2.7. Females carrying K5-Cre were not used for breeding because the expression 
of Cre recombinase occurs in late-stage oocytes. The protein presence persists into a developing 
embryo leading to a constitutive recombination of the gene (Ramirez et al., 2004). 
Fig. 2.7 Mating scheme used to obtain mice with a skin-specific Rac1 deletion.  
Presence of the null allele in mice carrying both the rac1 conditional allele and the cre 
transgene was confirmed with KO PCR (Fig. 3.2, pink arrows). All primers used for mice 
genotyping are summarized in chapter 2.4.1.  
 
2.6.7 Generation of knock-out ES cells. 
Rac1-deficient ES cells – Rac1 (−/−) – were obtained from rac1−/+ clones generated during 
Cre induced elimination of selection cassette (2.6.4). Cells with one null allele were expanded 
and electroporated again with the targeting construct (2.6.3). After identification of 
homologously recombined rac13loxP/− clones, second round of Cre transfection and FIAU 
selection was performed (2.6.4) and surviving clones were screened for rac1−/− and rac1fl/− 
genotypes. The latter were used as control clones − Rac1 (fl/−). 
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2.7 Skin phenotype analysis 
2.7.1 Histology 
2.7.1.1 Skin isolation and embedding 
At selected time points, skin was isolated for the analysis of the epidermis and HF 
morphology. Mutant and control mice were sacrificed and the fur on the back was shaved, if 
necessary (older control animals). A fragment of back skin (Fig. 2.8A) was separated at the 
subcutis level (below the subcutaneous muscle) and spread on a nylon membrane (Hybond-XL; 
Amersham Biosciences). The skin piece was cut along the midline (spine) and then divided into 
smaller fragments as shown on Fig. 2.8B. Pieces from one side were fixed before the subsequent 
embedding in paraffin (2.7.1.3). Remaining fragments were immediately cryo-embedded 
(2.7.1.2). During the final setting into a block (paraffin or cryomatrix), skin samples were 
positioned perpendicular to the cutting plane with the midline edge directed towards it 
(Fig. 2.8C). Samples were embedded with the membrane to prevent folding and wrinkling of 
skin fragments. 
Fig. 2.8 Schematic presentation of the skin isolation procedure. Detailed description in the text. 
Red arrow points out the midline. 
2.7.1.2 Cryo-embedded sections preparation 
Skin fragments were isolated as described above (2.7.1.1). Plastics cryo-molds (Tissue-Tek; 
Sakura) were placed on a copper plate laying on dry-ice. Each sample was thoroughly covered in 
Shandon Cryomatrix compound (Thermo Electron Corporation) before placing in a pre-cooled 
plastic form. When the skin fragment (positioned as shown in Fig. 2.8C) was stabilized, the 
container was filled up with the cryomatrix. Frozen blocks were stored at -80°C. Before cutting, 
samples were warmed up to -20°C. 
Frozen tissue was cut with a cryotome (Cryostat HM500OM; Microm) into 10 µm thick 
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sections. They were collected on positively charged glass slides (SuperFrost Plus; 
Menzel-Gläser), air-dried for ~30 min at RT and stored at -80°C. 
2.7.1.3 Paraffin sections preparation 
Skin fragments were isolated as described above (2.7.1.1) and fixed in a fresh 4% PFA/PBS 
solution O/N at 4°C. The following day, samples were dehydrated in consecutive baths with a 
gradually increasing concentration of EtOH: 50%, 70% and 80% for 60 min, 90% – O/N and 
100% – 3 × 60 min. The whole procedure was conducted at RT. Next, skin fragments were 
placed in xylol for 2 × 15 min and subsequently transferred to a container with liquefied paraffin 
(kept at 56°C in an oven). To remove all traces of xylol, paraffin solution was changed twice 
during the incubation time (60 + 60 + 90 min). In the end, skin fragments were set in paraffin 
blocks using an embedding station (Shandon Histocentre2; Thermo Electron Corporation). 
Samples were stored at 4°C. Before cutting, they were cooled down on ice or in a -20°C freezer. 
Paraffin embedded tissue was cut using a microtome (HM355S, Microm) into 6 µm thick 
sections. They were collected on positively charged glass slides (SuperFrost Plus; Menzel–
Gläser) and stored at RT or 4°C. 
2.7.1.4 Hematoxylin-eosin (HE) staining  
The skin morphology was visualized with a commonly used histological technique – HE 
staining, in which tissue components are stained on the basis of their charge. Hematoxylin has an 
affinity for negatively charged molecules and therefore reveals, with a blue/purple staining, 
acidic tissue components, such as nucleic acids or acidic proteins. Eosin stains, in pink/red, 
alkaline tissue components, e.g. collagens or keratins. The staining was performed manually 
at RT, as described below, or using an automated system (Shandon Linistain GLX; Thermo 
Electron Corporation). 
Paraffin was removed from sections with xylol (2 × 5 min). Samples were rehydrated by 
consecutive incubations in a graded series of EtOH dilutions – 100%, 100%, 95%, 90%, 
80% and 70% (2-3 min in each) – followed by 2-3 min wash in ddH2O. Sections were stained for 
60 s in [1:3] Mayer’s hemalaum/ddH2O solution (Merck) and differentiated by rinsing in tap 
water. Subsequently, slides were incubated for 60 s in 0.1% eosin solution (Eosin Y; Merck) and 
rinsed again in tap water. Sections were dehydrated in a reversed EtOH row, washed 2 × 5 min 
with xylol and mounted with Entellan (Entellan New; Merck). Pictures of tissue were taken 
using a phase contrast microscope (Axioskop; Zeiss) with Leica DC500 camera. 
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2.7.2 Immunohistochemistry 
2.7.2.1 Detection of marker proteins in skin using immunofluorescence 
Immunofluorescence (IF) staining was performed on cryo-sections. Control and mutant 
samples were warmed up to RT for 60 min and fixed for 20 min in fresh 4% PFA/PBS solution 
(in case of antibodies against HF-specific markers: 10 min in MeOH at -20°C). Subsequently, 
sections were washed 3 × 5 min in PBS and permeabilized with 0.1% Triton X-100/PBS for 
5 min on ice. Tissue was blocked with 2-3% BSA/PBS solution, either for 60 min in RT or O/N 
at 4°C. After short rinsing with PBS, each section was circled with a hydrophobic barrier pen 
(ImmEdge™ Pen; Vector Laboratories) and a primary antibody solution was applied. All 
antibodies used in this study are summarized in chapter 2.3, along with a dilution, a source 
species and a provider. They were diluted in 1% BSA/PBS and ~80 µl were applied on each 
section. Incubations were carried out in a humidified atmosphere at RT, in the dark (metal box 
with wet paper-lining). Primary antibodies were incubated for 90 min. As a rule, one section on 
each slide was incubated with a dilution buffer only, as a negative control. After 3 × 5 min 
washing with PBS, secondary antibodies were applied on all sections and incubated for 60 min. 
In case of a double staining, when a cross-reaction was excluded, primary and subsequently 
secondary antibodies were applied at the same time. Otherwise, staining was done sequentially. 
Primary antibodies conjugated with a dye were applied together with secondary antibodies, to 
avoid unnecessary bleaching. Nuclear DNA was visualized with DAPI (4',6-Diamidino-2-
phenylindole dihydrochloride; Sigma #D9542). The 0.1 µg/ml DAPI/PBS solution was applied 
on sections for 5 min after the last antibody incubation. Afterwards sections were washed 
3 × 5 min in PBS, mounted with Elvanol and stored at -20°C. Stained tissue was analysed and 
pictures taken using a confocal microscope (Leica TSC SP2) with inverted stage (DM IRE2; 
Leica). 
Elvanol 
Mowiol 4-88 (Roth #0713)....12 g 
ddH2O .................................30 ml 
 → mixed for 10 min (in glass) 
 → incubated for 2-3 h at RT 
0.2 M Tris-HCl, pH 8.5.......60 ml 
87% glycerol .......................30 ml 
 → mixed for 2-3 h at 65°C and spun down for 25 min at 2000g 
 → the supernatant was transferred to a glass flask 
supplemented with: 
DABCO (Sigma #D2522) ............2 g (2.5%) 
 → mixed for 10 min and kept O/N at 4°C to remove bubbles, 
 → aliquoted and stored at -20°C  
2.7.2.2 BrdU incorporation assay 
Bromodeoxyuridine (BrdU) is a thymidine analogue, which is incorporated into DNA. This 
feature is utilized to analyse proliferation of cells in vivo. Upon introducing into the organism, 
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BrdU is used by cells during DNA synthesis, in the S-phase of the cell-cycle. Cells that have 
incorporated BrdU can be later visualized using an anti-BrdU antibody. In this study, the BrdU 
incorporation assay was used to analyse proliferation of keratinocytes in the epidermis.  
Mice at selected age were sacrificed 2 h after an intraperitoneal injection of BrdU solution 
(50 µg/g [body weight]) and paraffin sections (2.7.1.3) were prepared from isolated back skin 
(2.7.1.1). Tissue was hydrated as described earlier (2.7.1.4; all steps 5 min) and fixed for 20 min 
in 4 N HCl solution (37% HCl/ddH2O, mixed [1:2]). After 5 min washing with ddH2O, slides 
were incubated in a pre-warmed 0.1% trypsin/0.1% CaCl2/ddH2O solution for 20 min at 37°C 
and washed again with ddH2O (5 min). Endogenous peroxidases were inactivated with [75 ml 
MeOH + 2.5 ml of 30% H2O2] solution by 10 min incubation at RT. Subsequently, sections were 
washed with PBS (3 × 5 min), blocked with 0.5% BSA/0.1% Tween20/PBS solution (3 × 5 min) 
and each section was circled with a hydrophobic barrier pen (ImmEdge™ Pen, Vector 
Laboratories). Anti-BrdU antibody, conjugated with the horseradish peroxidase (POD), was 
diluted in the blocking buffer and incubated O/N at 4°C. After washing with PBS (3 × 5 min), 
sections were incubated for 5-10 min in DAB solution (in the dark at RT) until clearly visible 
colour developed. The intensity of the staining was controlled under the microscope and the 
reaction was stopped with ddH2O (10 min wash). Tissue was counterstained with [1:5] Mayer’s 
hemalaun/H2O solution (Merck/tap water). Slides were dipped in the solution (5-8 × 10 s) and 
washed with tap water in between. The staining progress was controlled under the microscope. 
When the intensity of staining became optimal, sections were washed in tap water for 10 min. 
After dehydration with EtOH (95%, 2 × 100%, 5 min each) and xylol (2 × 5 min), slides were 
mounted with Entellan New (Merck # 1.07961) and stored at RT. 
DAB solution: 
ddH2O .................................45 ml 
1 M Tris-HCl, pH 7.4..........50 ml 
Stock I (DAB)........................5 ml 
Stock II ...............................120 µl 
 → both Stock solution are prepared just 
before use 
Stock I 
DAB (Sigma #D5637)........ 27 mg 
ddH2O................................... 5 ml 
 → keep in the dark 
Stock II 
30 % H2O2 ...........................20 µl 
ddH2O................................100 µl 
The horseradish peroxidase conjugated with the ant-BrdU antibody catalyzes an oxidation reaction of 
diaminobenzidine (DAB) in the presence of hydrogen peroxide. The reaction product is brown and insoluble 
in EtOH or H2O. DAB solution is very toxic. 
2.7.2.3 Apoptosis analysis 
Cleavage of the genomic DNA during apoptosis results in a formation of small double-
stranded fragments or single strand breaks (“nicks”) within the helix. Free 3’-OH ends can be 
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labelled with the TUNEL technique (terminal deoxynucleotidyl transferase -mediated dUTP nick 
end-labelling). In this study, apoptotic cells in skin were visualized using In Situ Cell Death 
Detection Kit (Roche #11684817910). Labelling was performed on cryo-sections according to a 
protocol provided by the manufacturer. Pictures were taken using a confocal microscope. 
2.7.2.4 FACS cytometry analysis 
Flow cytometry is a technique which enables a multi-parametric analysis of single cells 
flowing in a stream through a detection system. Cells can be described, counted and sorted based 
on the measurements of scattered and fluorescent light, which is collected when a suspension of 
cells is passing through the light beam. Scattered light gives information about size and physical 
complexity of cells. As several „colours” of fluorescent light can be measured at the same time, 
the simultaneous use of different dye-conjugated antibodies enables description of biochemical 
or physiological properties. Distinct subpopulation of cells can be distinguished and their 
lineage, maturation stage or activation state described, based on differences in surface molecules 
expression. In this study, expression of integrins on the surface of freshly isolated keratinocytes 
was investigated by FACS. 
Staining was performed in 96-well round bottom plate and 1% BSA/PBS buffer was used 
during all steps. Samples were always kept on ice and centrifuged at 4°C to prevent the receptor 
internalization of integrins. For each combination of antibodies, 106 cells were used. When 
primary antibodies were conjugated with biotin or not directly labelled, additional samples 
(106 cells each) were stained with secondary compounds only as negative controls. All used 
antibodies are summarized in chapter 2.3. 
After isolation (2.5.4.3), keratinocytes were counted, resuspended in an appropriate amount 
of the buffer, distributed into the wells (200 µl/well) and spun down for 5 min at 1500 rpm 
(Allegra 6R; Beckman Coulter). Supernatants were carefully removed and cells were 
resuspended in 50 µl of a primary antibody solution; negative control samples were resuspended 
in the buffer only. After 30 min incubation (in the dark), cells were washed with 200 µl of the 
buffer, spun down and 50 µl of a secondary antibody and/or streptavidin-Cy5 solution were 
added. The incubation was conducted for 15 min (in the dark). Afterwards cells were washed 
(200 µl), resuspended in 200 µl of the buffer and transferred into FACS tubes (Alpha 
Laboratories Ltd.). Dead cells were stained with propidium iodide (1:40; stock: 1 mg/ml) directly 
before FACS analysis. The measurements were conducted using FACSCalibur Flow Cytometry 
System (BD) and results analysed with the CellQuest software (BD). 
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2.7.3 Electron microscopy (EM) 
Electron microscopy analysis of the epidermis was performed by Dr. Fabio Quondamatteo 
(Department of Histology, Georg-August University of Göttingen, Göttingen, Germany).  
Small fragments of back skin were isolated and immediately immersed in a buffer. Skin was 
quickly cut into small fragments (~1 mm3) and placed in a fixation solution. Some samples were 
dissected in PBS and fixed in 0.2 M Sörensen’s buffer (pH 7.4) containing 3% PFA and 
3% glutaraldehyde. After at least 24 h incubation, pieces were washed for 20 min in 0.2 
Sörensen’s buffer and post-fixed in 1% OsO4 (osmium tetroxide) in PBS. For more detailed 
analysis of desmosomes and adherent junctions, samples were dissected in 0.1 M Na-cacodylate 
buffer supplemented with 2 mM CaCl2 and subsequently fixed for at least 24 h in a mixture of 
2% glutaraldehyde and 4% PFA in (0.1 mM Na-cacodylate + 2 mM CaCl2) buffer. After 
washing, skin was post-fixed in 1% OsO4 in (0.1 mM Na-cacodylate + 2 mM CaCl2) buffer. 
Fixed samples were dehydrated in a graded EtOH series and embedded in Epon. For 
orientation purposes, semithin sections (1 µm) were cut and stained with Richardson's solution 
(1% azure II/ddH2O + 1% methylene blue/1% borax/ddH2O, mixed [1:1]; (Richardson et al., 
1960). Ultrathin sections (90 nm) were cut with a ultramicrotome (Reichert-Jung), collected on 
formvar-coated nickel grids, stained with uranyl acetate for 10 min and subsequently with lead 
citrate for 7 min. Samples were examined with an electron microscope (LEO 906E, Zeiss). 
2.7.4 Analysis of the tamoxifen influence on skin 
Effects of 4-hydroxy-tamoxifen (4OHT) on the epidermis were analysed in a 2-3 months-old 
control and mutant skin. Clipped area of back skin 1-2 cm2 was treated every third day for 
15 days with 250 µl acetone or 250 µl 4OHT/acetone solution (10 mg/ml; Sigma #H6278). 
Fragments of the treated skin were isolated 1 day or 2 weeks after the last application and HE 
staining of paraffin sections was performed. 
2.7.5 Wound healing analysis  
Wound healing studies were conducted in collaboration with Dr. Ingo Haase’s group (Dept. 
of Dermatology and Center for Molecular Medicine, University of Cologne, Cologne, Germany). 
The experiments were performed by Michael Tscharntke and carried out after obtaining an 
approval of local authorities.  
Wounds were created in back skin of anaesthetised control and mutant mice using a 4 mm 
biopsy punch. Five days after the wounding, animals were sacrificed and wounded areas, with 
surrounding margins, were excised. Samples were fixed in 4% PFA O/N, bisected and embedded 
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in paraffin (the dissection edge placed at the beginning of a block). The first complete section 
(4 µm) from each half of the respective wound was HE stained and used for the analysis. 
Morphometric measurements were performed using Leica DM 4000 B microscope (Leica) 
equipped with KY-F75U digital camera (JVC) and Diskus software (Carl H. Hilgers, 
Technisches Büro, Germany). 
For visualization of proliferating keratinocytes in the wound tissue, mice were injected 
intraperitoneally with 3.2 mg of BrdU solution (2 h before killing). Detection of the incorporated 
BrdU was performed on 4 µm paraffin sections (2.7.2.2). Results were expressed in the average 
number of BrdU+ cells per microscopic field.  
2.8 Biochemical methods 
2.8.1 Protein isolation 
2.8.1.1 Preparation of protein lysates from ES cells 
ES cells were grown in Petri dishes (10 cm Ø) in normal conditions until they reached high 
density. Prior to the lysis, feeder cells were removed using a panning technique. In short, cells 
were trypsinized, seeded in a new dish and incubated at 37°C. After 30 min, medium with still 
unattached cells was collected and transferred to a new dish. The procedure was repeated 3 times 
and resulted in separation of fibroblasts, which adhere much faster than ES cells. The suspension 
contained almost exclusively ES cells, which were counted, seeded in a new dish (1-2×107 cells 
per dish) and incubated O/N at 37°C. The following day cells were washed once with ice-cold 
PBS and incubated for 30 min in 750 µl of the modified RIPA lysis buffer on ice. Next, lysed 
cells were collected using a rubber cell scraper (Costar) and the suspension was centrifuged at 
20,000g for 15 min at 4°C. The cleared lysate was aliquoted, frozen on dry-ice and stored at 
-80°C. A small aliquot was used for a protein concentration assay. 
Modified RIPA lysis buffer (10 ml) 
10% TritonX-100 ............ 1000 µl (1%) 
10% Na-deoxycholate* ... 1000 µl (1%) 
20% SDS ............................. 50 µl (0.1%) 
1 M HEPES, pH 7.4 .......... 500 µl (50 mM) 
5 M NaCl........................... 300 µl (150 mM) 
87% glycerol ................... 1150 µl (10%) 
1 M NaF.......................... 1000 µl (100 mM) 
100 mM Na4P2O7 ............ 1000 µl (10 mM) 
1 M MgCl2........................... 15 µl (1.5 mM) 
50 mM EGTA.....................200 µl (1 mM) 
100 mM Na3VO4 ................100 µl (1 mM) 
ddH2O..............................3685 µl 
 → supplemented with 1 tablet of protease 
inhibitors (cOmplete Mini EDTA-free; Roche) 
 →marked compound (*) was prepared shortly 
before use 
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2.8.1.2 Preparation of epidermal lysates 
Depending on the age of mice, epidermal lysates were prepared by following different 
isolation protocols. Epidermal keratinocytes from 3-day-old mice were isolated as described in 
chapter 2.5.4.7. Keratinocytes from adult mice were obtained as described earlier (2.5.4.3), with 
modified last steps. After separation from the dermis, cells were placed in 25 ml of DNase 
medium, mixed thoroughly by a vigorous shaking and incubated for 5 min at 37°C. The 
suspension was filtered through a 70 µm cell strainer (BD Biosciences) and collected 
keratinocytes were washed once with cold PBS.  
Pelleted cells were resuspended in an ice-cold lysis buffer and incubated for 30 min on ice. 
Cell debris was spun down at 20,000g for 15 min at 4°C. Cleared lysate was aliquoted into 
1.5 ml tubes, immediately frozen down on dry-ice and stored at -80°C. A small aliquot was used 
for a protein concentration assay. 
Alternatively, the epidermis from 3-day-old mice was placed in the lysis buffer directly after 
separation (2.5.4.7) and homogenized with Ultra-Turrax® T 8 (IKA-Werke GmbH). The 
suspension was cleared by centrifugation and stored as described above. 
Lysis buffer: 
Tris-HCl (pH 7.6) .............50 mM 
NaCl ...............................150 mM 
NaF  ...................................1 mM 
Na3VO4................................1 mM 
EDTA ..................................1 mM 
Triton X-100............................1% 
 → supplemented with protease inhibitors: 1 tablet/10ml (cOomplete Mini EDTA-free; Roche) 
 
2.8.2 Protein concentration assay 
Concentration of proteins in cell and epidermal lysates was assessed using a colorimetric 
assay based on the biuret reaction and presence of bicinchoninic acid (BCA™ Protein Assay Kit; 
Pierce). Under alkaline conditions, peptide bonds reduce Cu+2 to Cu+1 in a concentration-
dependent manner. Bicinchoninic acid selectively chelates Cu+1 ions [2:1] forming water-
soluble, purple-coloured complex. Absorbance at 562 nm is directly proportional to the protein 
concentration and increases nearly linearly over a broad working range (20-2,000 µg/ml). The 
protein concentration in samples is determined using a reference curve obtained by measuring in 
the same test a set of standard protein dilutions with known concentrations.  
BSA stock solution (20 µg/µl) was used to prepare a series of standard dilutions from 
2.0 µg/µl to 0.031 µg/µl, in the sample lysis buffer. Next, 10 µl of each solution (analysed 
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samples, standard dilutions and the lysis buffer) were transferred into a 96-well plate. Reagents 
A and B were mixed shortly before use (50+1) and 190 µl were added to each well. Samples 
were incubated for 15-20 min at 37°C and the absorbance was measured at 550 nm with a plate 
reader (Dynatech MR5000) using a well with the lysis buffer as a blank control. 
2.8.3 Western blot analysis 
2.8.3.1 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated elecrophoretically according to their molecular weight in 
SDS-polyacrylamide gels using Mini PROTEAN 3 System (Bio-Rad). Gels consisted of stacking 
(5% acrylamide) and separating part (10% or 12% acrylamide). Acrylamide content in the latter 
depended on sizes of separated proteins. Standardly, 1.5 mm thick gels with 10 sample wells 
were prepared.  
After the electrophoresis apparatus was assembled and filled with the running buffer, combs 
were removed and wells were washed using a pipette. Samples containing 15-20 mg protein 
were mixed with loading buffer, incubated at 99°C for 5-10 min and loaded into the wells. As a 
size reference, 10-20 µl of the standard protein solution (SDS-PAGE Molecular Weight 
Standards, Broad Range; Biorad #161-0317) (Fig. 2.9) were run with analysed samples. 
Electrophoresis was carried out until bromophenol blue reached the bottom of the separating gel. 
 
Separating gel (10%/12%) – for 2 gels 
30% acrylamid mix* ....6.7/8.0 ml 
1.5 M Tris, pH 8.8..............5.0 ml 
ddH2O ..........................7.9/6.0 ml 
10% SDS ........................... 200 µl 
10% APS ........................... 200 µl 
TEMED (Sigma #T22500) .... 8 µl 
 →* Proto-Gel; National Diagnostics #EC-890 
Stacking gel (4%) – for 2 gels 
30% acrylamid mix*.......... 1.3 ml 
1.0 M Tris, pH 6.8.............. 1.0 ml 
ddH2O................................ 5.5 ml 
10% SDS..............................80 µl 
10% APS..............................80 µl 
TEMED..................................8 µl
Loading buffer (4x) 
Tris-HCl, pH 6.8 .............200 mM 
EDTA ..................................4 mM 
Glycerol ............................... 40% 
SDS   ..................................... 8% 
β-mercaptoethanol* ............... 4% 
Bromophenol blue........0.1 mg/ml 
 → * added shortly before use 
 
Running buffer (10x) 
Tris-base ............................ 30.3 g 
Glycine............................. 144.0 g 
SDS   .................................... 10 g 
ddH2O........... filled up to 1000 ml
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Molecular Weight Standards, Broad Range 
Myosin ........................ 200.0 kDa 
ß-galactosidase ........... 116.2 kDa 
Phosphorylase b............ 97.4 kDa 
Serum albumin .............. 66.2 kDa 
Ovalbumin .................... 45.0 kDa 
Carbonic anhydrase...... 31.0 kDa 
Trypsin inhibitor ........... 21.5 kDa 
Lysozyme....................... 14.4 kDa 
Aprotinin........................  6.5 kDa 
 
Fig. 2.9 Broad range molecular weight standards for 
SDS-PAGE. Proteins were separated in 4-20% gradient 
gel and stained with Coomassie R-250. 
 
2.8.3.2 Transfer of proteins to the membrane 
Separated proteins were transferred to a PVDF membrane (Immobilon-P, Milipore 
#IPVH00010) using Mini Trans-Blot electrophoretic transfer cell (Borad). The membrane was 
activated with MeOH (5-10 s), rinsed with water and equilibrated in the blotting buffer for 
5-10 min. Afterwards, the transfer sandwich was assembled (Fig. 2.10) and air bubbles were 
carefully removed from between layers, especially from between the gel and the membrane. The 
cassette was placed in an electrode module (black side towards the cathode). The blotting was 
conducted for 90 min at 100 V or O/N at 25 V. Subsequently, the sandwich was disassembled 
and the membrane was stained with Ponceau-S red solution (Sigma #P7170) to visualize bound 
proteins. The membrane was cut if necessary and protein standard bands were marked. 
Afterwards, the membrane was washed several times with TBS-T to remove the dye. 
Fig. 2.10 Scheme of the western blot transfer sandwich. 
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Blotting buffer (10x) 
Tris-base ............................30.2 g (0.25 M) 
Glycine................................144 g (1.92 M) 
ddH2O ...........filled up to 1000 ml 
 → working solution (1x) contained 20% MeOH 
TBS (10x) 
Tris-base ............................24.2 g (0.2 M) 
NaCl ..................................88.0 g (1.5 M) 
ddH2O ...........filled up to 1000 ml 
 → adjusted to pH 7.6 
TBS-T 
10x TBS .............................100 ml 
Tween 20 ...............................1 ml 
ddH2O .......... filled up to 1000 ml 
2.8.3.3 Protein detection on the membrane 
The membrane with bound proteins was blocked to prevent non-specific background binding 
of antibodies. The standard blocking buffer contained 5% non-fat milk (Skim Milk Powder, 
Fluka) and was incubated with the blot for 60 min at RT. If antibodies required blocking with 
BSA/TBS-T solution, the concentration suggested by manufacturer was used. Primary antibodies 
were generally diluted in a respective blocking buffer and incubated O/N at 4°C (unless 
suggested otherwise in a data sheet). If a different buffer was used for dilution, the membrane 
was washed after blocking with TBS-T (3 × 5 min). Afterwards, the membrane was washed 
again (3 × 5 min) and incubated for 90 min at RT with the appropriate HRP-conjugated 
secondary antibody (horse radish peroxidase) diluted in TBS-T containing 5% non-fat milk. All 
antibodies used in western blot analysis are summarized in chapter 2.3. After the final washing 
(3 × 5 min), bound antibodies were visualized with Western Lightning Chemiluminescence 
Reagent (Perkin Elmer) following the manufacturer’s protocol. The signal was captured on 
Hyperfilm film (Amersham Biosciences). 
If several different proteins were sequentially detected on one membrane, it had to be 
stripped in between. When primary antibodies were obtained from the same species (e.g. rabbit), 
complete removal of bound antibodies was necessary. In that case, the membrane was incubated 
for 30 min at 55°C in stripping buffer, washed with TBS-T (3 × 10 min) and blocked in an 
appropriate buffer before applying the next primary antibody. 
Stripping buffer 
1 M Tris-HCl, pH 6.7.................. 31.2 ml (62.5 mM) 
20% SDS ........................................ 50 ml (2%) 
ddH2O ........................ filled up to 500 ml 
 → shortly before use added: 
β-mercaptoethanol............ 0.7 ml/100 ml 
 
 
Otherwise, the membrane was incubated for 30 min with 15% H2O2 at RT, rinsed with 
MeOH (5-10 s) and washed with TBS-T (5-10 min), before continuing with blocking. If MeOH 
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wash was not performed, the blocking step was skipped as well. 
2.8.4 GTPase activity assay  
GTPase activity assay (pull-down) was conducted with freshly isolated keratinocytes 
(2.8.1.2). Cells were lysed in 750 µl of the NP-40 lysis buffer containing a biotinylated PAK-
CRIB peptide – Cdc42/Rac interactive binding motif from PAK1B (gift from Dr. J. Collard; 
Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The 
Netherlands) (Price et al., 2003). Lysates were clarified by 10 min centrifugation at 20,000g 
(4°C) and then incubated with GST-Rhotekin (fusion protein of the Rho-binding domain of the 
Rho effector protein) coupled to glutathione conjugated sepharose beads (Glutathione Sepharose 
4 Fast Flow; Amersham Biosciences #17-5132) for 45 min at 4°C (with gentle rotation). The 
lysate was subsequently incubated with streptavidin conjugated agarose beads (Sigma #S1638) 
for 30 min at 4°C to sequester Cdc42-PAK-CRIB. Beads with bound RhoA and Cdc42 where 
washed 3 times with the lysis buffer and resuspended in 2x SDS sample buffer (2.8.3.1). The 
protein content was analysed by Western blotting. 
NP-40 lysis buffer 
Tris-HCl, pH 7.4 .......................... 50 mM 
NaCl .......................................... 100 mM 
MgCl2............................................. 2 mM 
NaF  .............................................. 1 mM 
Na3VO4........................................... 1 mM 
Igepal CA-630 (Sigma #I8896)..........1% 
Glycerol ...........................................10% 
 → supplemented with protease inhibitors: 1 tablet/10 ml (cOmplete Mini EDTA-free; Roche) 
2.9 Analysis of mRNA expression 
2.9.1 RNA isolation  
Total RNA was extracted from ~107 freshly isolated keratinocytes (2.8.1.2) using the TRIzol 
Reagent (Invitrogen #15596-026) and following the provided protocol. In short, cells were 
resuspended in the reagent and homogenized by pipetting. After a chloroform extraction, RNA 
was precipitated with isopropanol and dissolved in 50 µl of DEPC (diethylpyrocarbonate) treated 
ddH2O. The concentration was measured spectrophotometrically at 260 nm (GeneQuant II 
RNA/DNA Calculator; Amersham Pharmacia Biotech) and the quality of obtained RNA was 
checked in a gel electrophoresis (2.9.1.1). 
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DEPC-ddH2O 
DEPC (Fluka #32490) ..........1 ml 
ddH2O .............................1000 ml 
 
 → mixed and incubated in the dark O/N at RT  
 → autoclaved 
 
 
2.9.1.1 RNA gel electrophoresis 
After isolation, RNA was checked for degradation by an electrophoresis in a special agarose 
gel. For a small gel (23 cm chamber, 12 lanes) 8 g of agarose was dissolved in exactly 81 ml 
ddH2O (evaporation during heating was compensated). Before pouring in a cast, 2.5 ml of 
40x MOPS and 16.5 ml of 37% formaldehyde were added. A small aliquot of isolated RNA 
(1 µl) was mixed with 6 µl of DEPC-ddH2O and 12 µl of the denaturation buffer. After 15 min 
incubation at 55°C, 1 µl of 1 mg/ml EtBr solution and 2 µl of the RNA loading buffer were 
added and RNA was loaded on the gel and run for 2 h with 3.5 V/cm in 1x MOPS/ddH2O. 
Denaturation buffer 
40x MOPS....................................... 2.5 ml 
DEPC-ddH2O.................................. 2.5 ml 
37% formaldehyde ........................... 35 ml 
Formamide (Invitrogen #15515).... 100 ml 
RNA loading buffer (10x) 
Glycerol (Fluka #49767) ................. 50% 
EDTA (ph 8.0) ............................. 10 mM 
Bromophenol blue ........................ 0.25% 
 → prepared in DEPC-ddH2O 
40x MOPS (pH 7.0) 
MOPS.......................................... 167.4 g 
Na-Ac .......................................... 16.48 g 
0.5 EDTA, pH 7.0-8.0 .................... 80 ml 
DEPC-ddH2O........... filled up to 1000 ml 
2.9.2 Reverse transcription of total RNA  
First-strand synthesis of cDNA was performed with SuperScript III reverse transcriptase 
(Invitrogen #18080) according to the protocol provided with the enzyme. 
RT-PCR 
Random primers ...................... 1 µl 
10 mM dNTP ......................... 1 µl 
Total RNA...............................1 µg 
ddH2O ................. filled up to 13 µl 
→ 5 min incubation at 65°C 
→ 1 min incubation on ice 
Next added: 
5x First strand buffer ............... 4 µl 
0.1 M DTT............................... 1 µl 
RNase OUT ............................. 1 µl 
Super Script III RT .................. 1 µl 
→ 5 min incubation at 25°C 
→ 60 min incubation at 55°C 
→ 15 min incubation at 70°C 
→ filled up with 20 µl of DEPC-ddH2O 
 
 
Obtained cDNA was used as a template in a standard PCR reaction and a real time PCR 
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analysis (2.9.3). Primers used for amplification are summarized in chapter 2.4.1.  
PCR reaction 
cDNA....................................2.0 µl 
Primer 1 (100 pmol)..............0.2 µl 
Primer 2 (100 pmol)..............0.2 µl 
PCR buffer (10x)...................5.0 µl 
50 mM Mg2+..........................1.5 µl 
10 mM dNTP ........................1.0 µl 
Taq DNAPoly (5 U/µl) .........0.2 µl 
ddH2O ................................37.9 µl 
 20 µl 
PCR program: 
1. denaturation........ 94°C for 180 s 
2. denaturation.......... 94°C for 30 s 
3. annealing .................. Tm for 30 s 
4. elongation............. 72°C for 90 s 
→ steps 2-4 – 35 cycles; 
5. elongation........... 72°C for 300 s 
6. pause........................... 4°C for ∞ 
 
 
Products of a qualitative PCR reaction were analysed by agarose gel electrophoresis 
(2.4.4.2). 
2.9.3 Real-time PCR 
Real-time PCR was performed for quantitative analysis of mRNA expression, using 
iQ SYBR Green Supermix (Biorad). The cDNA obtained in a first-strand synthesis (2.9.2) was 
amplified with primers specific for analysed genes (2.4.1). At the same time a reaction with 
primers for the reference gene (GAPDH) was conducted for each sample.  
Reaction mix: 
cDNA....................................0.5 µl 
iQ SYBR Green Supermix ..12,5 µl 
Primer 1 (100 pmol).................1 µl 
Primer 2 (100 pmol).................1 µl 
ddH2O ....................................10 µl 
 25 µl 
 
Triplicate repeats were prepared for each primer set and samples were transferred to a 
special 96-well plate. The amplification progress was monitored in iCycler (Biorad) and results 
were evaluated using software provided with the thermocycler. 
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3 RESULTS 
3.1 Generation of mice with a keratinocyte-restricted deletion of the 
rac1 gene. 
The constitutive deletion of the murine rac1 gene leads to embryonic death around day 8.5 
of the development (Sugihara et al., 1998). Therefore, a conditional knock-out approach was 
employed in this study, which enabled the analysis of Rac1 function in vivo by circumventing 
the lethal phenotype. A tissue specific ablation of the rac1 gene was obtained using the Cre-loxP 
system (2.6.1). 
3.1.1 The rac1 gene structure and the conditional knock-out strategy 
The murine rac1 gene is located on chromosome 5 and consists of 6 exons, with the 
translation start codon located in exon 1 (Fig. 3.1). No splice variants have been reported to date. 
Fig. 3.1 Schematic presentation of the rac1 gene exon structure.  
A common approach used to obtain an efficient deletion of the targeted protein, including 
the absence of any truncated forms, is the removal of the ATG-containing exon that ensures the 
lack of mRNA translation. However, exon 1 was not selected for the deletion in this study in 
order to avoid the risk of interfering with gene regulation, resulting from the insertion of the loxP 
site within the gene promoter.  
The absence of exon 2 could lead to an alternative splicing of exon 1 into exon 3, which 
would result in an in-frame transcript, due to a compatible codon phasing (Table 3.1). While the 
hypothetical protein would lack 24 amino acids, it might potentially retain some functionality. 
Exon Size [bp] Start phase End phase
1 196* + 35 − 2 
2 72 2 2 
3 118 2 0 
4 63 0 0 
5 160 0 1 
6 131 + 1493* 1 − 
Table 3.1 Summary of the size and phase of rac1 gene exons. 
Marked numbers (*) correspond to UTR parts of the transcript. 
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Fig. 3.2 Strategy of the conditional knockout of the rac1 gene. 
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Therefore, exon 3 was selected for the deletion and flanked by loxP sites. It encodes amino 
acids 37-75 which form a part of the core effector domain (primary site for interaction with 
effectors) and the complete switch II region (1.1.2). A theoretical splicing of exon 2 into exon 4, 
exon 5, or exon 6 would result in a frame-shifted transcript (Table 3.1) and only unrelated amino 
acids would be added after the first 36 correct residues during the translation. Such fusion 
proteins would be terminated prematurely, as stop codons would be present after amino acids 39, 
68 and 102, respectively. The truncated forms could not exert Rac1 functions, as they would lack 
domains essential for interaction with effector molecules (i.e. core domain, switch II, Rho insert 
domain). Moreover, they could not have a dominant negative effect, as they would lack the 
domain essential for interaction with GEFs (switch II). 
The approach used to obtain the conditional ablation of the rac1 gene is schematically 
depicted in Fig. 3.2.  
3.1.2 Modification of the rac1 gene and generation of mutant mice 
The wild type allele of rac1 was altered in ES cells by a homologous recombination with the 
targeting vector containing a modified fragment of the gene (2.6.2). Electroporation of the 
plasmid into cells and the subsequent selection for neomycin resistant cells resulted in obtaining 
ES cell clones carrying a modified rac1 allele (2.6.3). Homologously recombined alleles 
contained either both modifications, the loxP site upstream and the floxed selection cassette 
downstream of exon 3 (3loxP; Fig. 3.2, targeted allele), or only the floxed selection cassette, 
created after a partial recombination event (2loxP). They were identified by Southern blot 
analysis (2.4.7) with the external probe (Fig. 3.3A). The presence of additional copies of the 
targeting construct, randomly incorporated into the genome of rac13loxP/+ ES cell clones, was 
checked by the hybridization with the internal probe (Fig. 3.3B). 
Fig. 3.3 Screening of ES cell clones. Results of Southern blot analysis of HindIII-digested DNA 
hybridized with (A) the external probe to check for the homologous recombination or (B) the internal 
probe to check for the possibility of a random integration of the targeting construct. 
Bands: wt (+) - 14.4 kbp, 2loxP - 10.8 kbp, 3loxP - 9.1 kbp. (C) After cre transfection, genomic DNA 
from ES cell clones was cut with BamHI and hybridized with the internal probe to check for the 
presence of the conditional or the null allele, generated by Cre-mediated recombination. Bands: 
wt (+) - 10.0 kbp, null (–) - 8.3 kbp, fl - 6.1 kbp. 
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The selection cassette was removed from rac13loxP/+ clones in vitro by a transient transfection 
of a Cre-recombinase-expressing plasmid, followed by FIAU treatment (2.6.4). Clones carrying 
the conditional allele (rac1fl/+) were identified by Southern blot analysis with the internal probe 
(Fig. 3.3C) and used for the generation of germ line chimeras by a blastocyst injection (2.6.5). 
Clones carrying the null allele (rac1–/+) were used for generation of Rac1 (–/–) ES cells (2.6.7, 
3.8). 
Breeding of male chimeras with wild type C57BL/6 females resulted in rac1fl/+ offspring 
that were subsequently mated to obtain rac1fl/fl animals. The presence of the conditional allele 
was confirmed with Southern blot analysis (Fig. 3.4A). Both heterozygous and homozygous 
animals were fertile and phenotypically indistinguishable form wild type littermates. Mice with 
keratinocyte specific ablation of Rac1 were obtained by intercrossing rac1fl/fl animals with 
K5-Cre transgenic mice (2.6.6).  
Mice were routinely genotyped by Rac1 PCR and Cre PCR (Fig. 3.4B) (2.4.6.1). KO PCR 
was performed to confirm in vivo recombination of the conditional allele into the null allele in 
the presence of K5-Cre recombinase.  
Fig. 3.4 Genotyping of mice. (A) Southern blot analysis. Tail DNA was digested with BamHI and 
hybridized with the internal probe recognizing the wild type (+: 10.0 kbp) and the conditional 
(fl: 6.1 kbp) allele of the rac1 gene. (B) PCR analysis. Rac1 PCR gave rise to two products: 318 bp 
from the wild type (+) and 236 bp from the conditional allele (fl). Cre PCR resulted in 420 bp product, 
when the cre transgene was present, and KO PCR gave rise to 302 bp product, when the null allele 
was present. 
3.1.3 Gross phenotype after the K5-Cre induced loss of Rac1 
An almost complete loss of Rac1 protein in the epidermis of rac1fl/fl,cre (KO) mice was 
confirmed by Western blot analysis (2.8.3) of epidermal lysates (2.8.1.2) from 3-day-, 14-day- 
and 8-month-old mice (Fig. 3.5). Control littermates – rac1fl/+,cre (ctrl) – expressed normal 
amounts of Rac1 protein.  
Rac1-deficient mice were born close to the Mendelian ratio (~18%) and were 
indistinguishable from control littermates at birth. Mutant mice showed no increased lethality, 
were fertile and had no evident health problems.  
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Fig. 3.5 Western blot analysis showed almost complete absence of Rac1 
protein in the epidermis of rac1fl/fl,cre mice. Two different monoclonal 
antibodies were used to analyse Rac1 content in epidermal lysates obtained from 
control and mutant mice at 3 days, 14 days and 8 months of age. Tubulin and 
GAPDH levels were used as a loading control.  
Within few days after birth, a difference in the pelage appearance between rac1fl/fl,cre and 
control mice became evident. Mutant mice displayed a reduced hair growth (Fig. 3.6A) 
combined with an early onset of a progressive hair loss, which led to a nearly complete lack of 
fur at 2 months of age (Fig. 3.6B). No additional defects, such as spontaneous wounds or 
blistering, were observed in the skin of rac1fl/fl,cre mice. The hair loss was permanent and no 
regrowth of fur was detected up to 24 months of age (Fig. 3.7). The vibrissae of rac1fl/fl,cre mice 
were lost along with the pelage hair.  
Fig. 3.6 Control and mutant mice at (A) 14 days and (B) 2 months of age. Rac1-deficient mice 
grew less hair and showed a progressive hair loss, but did not develop any other skin defects. The fur 
of mutant animals looked dull and faded. 
Shortly after birth, rac1fl/fl,cre mice started to show about 20% reduction of body mass, 
when compared to control littermates, which persisted throughout the whole life span (81.1 ± 
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8.5%; n=27/23). An almost complete lack of the fat tissue under the skin of adult mutant mice, 
which was always observed during dissection, most likely contributed to the weight difference. 
The lower amount of fat tissue was likely a secondary effect of the hair loss, resulting from 
increased energy requirements to maintain normal body temperature, as housing conditions were 
adjusted to accommodate mice with fur. 
Fig. 3.7 Control and mutant mouse at 2 years of age. The apparent difference in size was mainly a 
result of a nearly complete lack of fur (KO). In addition, rac1fl/fl,cre mice had almost no fat tissue, 
which normally accumulates under the skin of older mice (observed during dissection). The loss of 
vibrissae is clearly visible. 
 
Fig. 3.8 (A) Evenly-spaced, frail hairs were often observed in adult mutant mice (arrow). They 
were usually present for several months after birth, while their amount was gradually reduced. 
However, in some mice they were sustained throughout the whole life span. Age: 2.5 months. (B) 
Abnormal blackening of the lower back skin. The change in the colour and texture of skin was 
sometimes observed in old mutant mice. Age: 2 years. 
Interestingly, a small amount of evenly-spaced hairs was sustained in Rac1-deficient mice 
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after the general loss of pelage (Fig. 3.8A). The remaining hairs were frail, matt and greyish. 
Their amount was progressively reduced and the majority of old mice did not retain any fur at 
all. While the density of remaining hairs was varying from mouse to mouse, in general, females 
seemed to have more of them. 
Sometimes, an unusual blackening and hardening of the lower back skin was observed in 
several-months-old rac1fl/fl,cre mice; mostly males (Fig. 3.8B). Similar changes of the tail skin 
were detected more frequently in both, male and female several-months-old mutant mice 
(Fig. 3.7). 
3.2 Analysis of the hair follicle (HF) phenotype in the absence of Rac1 
3.2.1 Defective HF morphogenesis 
A histological analysis of skin was carried out to investigate the HF morphogenesis in the 
absence of Rac1. Fragments of back skin were isolated from control and mutant mice at different 
ages and HE staining of paraffin sections was performed (2.7.1).  
The comparison of samples from 3-day-old control and mutant mice showed no apparent 
differences in shape, length and the amount of HFs at that stage (Fig. 3.9).  
Fig. 3.9 HE staining of back skin sections from 3-day-old control and mutant mice. No obvious 
changes in the morphology of Rac1-deficient HFs were observed. Bar: 100 µm. 
Morphological aberrations of Rac1-deficient HFs became evident by day 9 after birth 
(Fig. 3.10). Many HFs displayed constrictions (arrowhead) or a kinked follicle shape (white 
arrow). Also, some hair shafts (HSs) showed abnormal structure. While the majority of hair 
bulbs looked rather normal, some had an unusual shape (black arrow). However, mutant HFs 
were only slightly shorter then control HFs and the skin thickness (from the epidermis to the 
subcutaneous muscle layer) was similar in control and mutant samples. 
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Fig. 3.10 HE staining of back skin sections from 9-day-old control and mutant mice. Arrows 
point out aberrations of the HF (white arrow, arrowhead) and the hair bulb (black arrow) morphology. 
Bar: 100 µm. 
The phenotype became drastically aggravated by day 14 after birth, when almost all 
Rac1-deficient HFs were defective and had lost the normal appearance (Fig. 3.11).  
Fig. 3.11 HE staining of back skin section from 14-day-old control and mutant mice. 
Rac1-deficient HFs displayed severe changes in morphology: abnormal widening of the follicle, 
deformation of HSs (white arrowheads), abrupt ending of the outer layers (arrows) and a presence of 
unusual cells within some mutant HFs (black arrowheads). Bar: 100µm. 
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Mutant HFs became widened shortly below the sebaceous glands (SGs) and almost no hair 
bulbs were present. In many cases the follicles looked "open", as the outer layers ended abruptly 
(arrows). The cells in the lower regions of HFs were disorganized and seemed to be less 
compact. Unusual, large cells were observed within many HFs (black arrowheads). Hair shafts 
(HSs) had an irregular pigmentation pattern and majority of them were misshapen or entirely 
absent (white arrowheads). The skin thickness of rac1fl/fl,cre mice was significantly reduced, 
most likely due to the reduced length of HFs. 
The degeneration of HFs progressed and resulted in almost complete loss of non-permanent 
regions of HFs in the skin of adult rac1fl/fl,cre mice. No regrowth of anagen HFs was observed in 
the absence of Rac1. Surprisingly, the upper parts of the HFs were maintained throughout the 
whole life span. However, while infundibula looked quite normal, SGs became abnormally 
enlarged in time (Fig. 3.12, arrowheads). This suggests that the bulge regions containing stem 
cells were also preserved, as they contribute to the SG renewal. Occasionally, a mild fibrosis 
could be observed locally in the skin of some adult mutant mice. 
Fig. 3.12 HE staining of back skin sections from 13-month-old control and Rac1-deficient mice. 
Accumulations of melanin (arrows) and abnormally large SGs (arrowheads) were characteristic for 
older Rac1-deficient skin. The inset picture was taken with the same magnification as the rest of the 
figure. Bar: 100µm. 
Accumulations of melanin, which were most likely remnants of disintegrated HFs, were 
frequently detected in the dermis and in the subcutis of adult rac1fl/fl,cre mice (Fig. 3.12, 
arrows). The presence of melanin clumps in the mutant skin was likely the cause of an abnormal 
colour of the dermis, which was consistently observed during the isolation of the epidermis and 
could explain the characteristic grey colour of the mutant skin (2.5.4.3).  
Interestingly, all adult rac1fl/fl,cre mice had enlarged axial and inguinal lymph nodes, which, 
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in addition, had an unusual black colour (Fig. 3.13). That phenotype was most likely the result of 
an accumulation of dendritic cells, which transported the remnants of disintegrated mutant HFs, 
including melanin particles, from the skin.  
Fig. 3.13 Axial and inguinal lymph nodes of rac1fl/fl,cre mice were black and noticeably enlarged. 
A picture of axial lymph nodes isolated from adult control and mutant mice shows a difference in size 
and colour between both organs.   
3.2.2 Loss of the HF specific differentiation 
The HF consists of distinct cell layers, which can be identified by the expression pattern of 
specific epithelial and hair keratins (1.2.2). In order to investigate changes of the HF morphology 
in more detail, the expression of several marker proteins was analysed using IF staining and 
confocal microscopy techniques (2.7.2.1).  
Basal keratinocytes of the outer root sheath (ORS), a HF layer adjacent to the basement 
membrane (BM), express a number of ECM proteins (e.g. laminins) and epithelium-specific 
ECM-binding receptors (e.g. integrins). One such a characteristic molecule is α6 integrin, 
normally localized to the basal side of ORS keratinocytes attached to the BM, throughout the 
whole length of the HF. This property makes it a good marker, which can be used to identify the 
surface of the ORS and to visualize the outline of HFs. 
In the skin of 9-day-old rac1fl/fl,cre mice, the expression of α6 integrin was normal in a great 
majority of mutant HFs (Fig. 3.14-Fig. 3.17). At day 14 after birth, the layer consisting of 
α6-positive keratinocytes ended abruptly shortly below SGs (white arrowheads) and the pattern 
of expression confirmed dramatic changes in the morphology of mutant HFs observed earlier 
during the histological analysis (3.2.1).  
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Fig. 3.14 K6 and α6 integrin IF staining of back skin sections from 9-day-old and 14-day-old 
control and mutant mice. Expression of both proteins was normal at day 9 after birth, with only local 
loss of K6 in some mutant HFs (black arrowheads). At day 14 after birth, K6 and α6 integrin were 
present only in upper regions of Rac1-deficient HFs (black arrows). Cell layers expressing those 
proteins were unexpectedly interrupted shortly below the SGs (white arrowheads). In some HFs, 
scattered K6-positive clusters were found below α6-positive regions (white arrow). Bar: 50 µm. 
K6 is a keratin expressed in the companion layer (CL) directly underlying the ORS of the 
HF (Rothnagel and Roop, 1995) (1.2.2).  
While K6 expression was mostly normal in the mutant skin at day 9 after birth, a local loss 
of K6 was already displayed in some HFs (Fig. 3.14, black arrowheads). At day 14 after birth, 
K6 was still expressed in cells neighbouring α6-positive keratinocytes (black arrows), but it was 
absent or present only in scattered clumps below these regions (white arrow). 
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Fig. 3.15 K6irs2 and α6 integrin IF staining of back skin sections from 9-day-old and 14-day-old 
control and mutant mice. At day 9 after birth both proteins were expressed normally in the absence 
of Rac1. In 14-days-old mutant HFs, K6irs2 was almost completely absent; only few Kirs2-positive 
spots were observed (arrow). Expression of α6 integrin was discontinued shortly below SGs 
(arrowhead). Bar: 50 µm. 
K6irs2 and K6irs4 are expressed respectively in the cuticle and the Huxley layer of the inner 
root sheet (IRS), which is underlying the companion layer of the HF (Langbein et al., 2003) 
(1.2.2).  
At day 9 after birth their distribution in Rac1-deficient HFs was not obvioulsy changed, 
when compared to control samples (Fig. 3.15 and Fig. 3.16). However, no normal expression of 
K6irs2 and K6irs4 was detected in 14-day-old mutant skin, indicating the complete absence of 
the IRS. Only scattered clumps of these keratins were present below α6-positive regions in few 
of distorted HFs (arrows).  
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Fig. 3.16 K6irs4 and α6 integrin IF staining of back skin sections from 9-day-old and 14-day-old 
control and mutant mice. At day 9 after birth the expression of K6irs4 and α6 integrin was normal in 
the absence of Rac1. The layer expressing α6 integrin was abruptly terminated shortly below SGs 
(arrowheads) and only small clumps of K6irs4-positive cells were detected in the lower region 
(arrows) in the 14-day-old mutant skin. Bar: 50 µm. 
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Fig. 3.17 Hb2 and α6 integrin IF staining of back skin sections from 9-day-old and 14-day-old 
control and mutant mice. Normal expression of Hb2 at day 9 after birth was replaced by its 
complete absence in 14-day-old mutant HFs. Expression pattern of α6 integrin showed abnormal 
termination of the ORS layer (white arrowheads) at day 14 after birth. Unspecific staining of the HSs 
revealed occasionally a "naked" hair, not surrounded by any HF layers (black arrowhead). Bar: 
50 µm. 
Hb2 is one of the hair keratins expressed by the cuticle, which constitutes the outer layer of 
the HS (Langbein et al., 2001) (1.2.2).  
In 9-day-old Rac1-deficient HFs the distribution of Hb2 was not obviously altered. 
However, no expression of the keratin was detected in the mutant skin at day 14 after birth 
(Fig. 3.17).  
Interestingly, in 14-day-old mutant HFs, normal-looking HSs were occasionally observed 
below regions expressing α6 integrin and other layer specific markers (Fig. 3.17, black 
arrowhead). They were not surrounded by any follicle-like structures. 
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Fig. 3.18 K14 and LN5 IF staining of back skin section from 14-day-old control and mutant 
mice. Expression pattern of both proteins shows unexpected termination of ORS layer in 
Rac1-deficient HFs. Some of ORS keratinocytes lost polarization (lack of LN5 expression) but still 
expressed K14 (arrowheads). Bar: 50 µm. 
Laminin 5 (LN5) is one of the BM components deposited by basal ORS keratinocytes, which 
express K14 along the whole length of the HF (Fig. 3.18). As in case of α6 integrin, the 
expression pattern of K14 showed an abrupt termination of the ORS layer in 14-day-old mutant 
skin. The BM was discontinued in majority of HFs together with the ORS. However, cells 
expressing K14 but not LN5 were found in some HFs, suggesting that fully differentiated ORS 
keratinocytes have lost the ability to deposit BM and thus the polarization.  
E-cadherin is an epithelial marker and an adhesion protein expressed in all ORS cells of the 
HF (Fig. 3.19). While it was still present in 9-day-old Rac1-deficient HFs, the expression pattern 
revealed changes in the normal shape of HFs (black arrowheads) and distortions of hair bulbs 
(arrows). At day 14 after birth, no E-cadherin-positive keratinocytes were detected below 
α6 integrin-positive regions of the mutant HFs (white arrowheads). Also, a normal expression 
pattern of β-catenin, another cell-cell adhesion molecule, was lost in the lower regions of 
Rac1-deficient HFs (Fig. 3.20). 
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Fig. 3.19 E-cadherin and α6 integrin IF staining of back skin sections form 9-day-old and 14-
day-old control and mutant mice. At day 9 after birth E-cadherin was present along the whole 
length of Rac1-deficient HFs, however the staining showed first changes of the HF shape (black 
arrowheads) and deformations of some hair bulbs (arrows). 14-day-old ORS keratinocytes lost 
E-cadherin expression together with α6 integrin expression (arrowheads). Bar: 50 µm. 
While there was almost no detectable expression of epithelial or HF markers, a presence of 
nucleated cells in the lower regions of mutant HFs was confirmed with DAPI staining (Fig. 3.20 
and Fig. 3.21, arrows). The location of those cells and the apparent continuity with the upper 
parts of HFs suggested that they once belonged to the HF structure, even though they seemed to 
have lost HF-specific differentiation.  
Expression pattern of vimentin, a mesenchymal intermediate filament, was analysed to 
determine the lineage of cells in the lower parts of mutant HFs. Interestingly, IF staining showed 
that vimentin-negative cells, which seemed to be derived from HF structures (Fig. 3.21, arrows), 
surrounded by a great number of mesenchymal cells. No accumulation of vimentin-positive cells 
Results 
95 
was observed around the lower parts of control HFs. 
Fig. 3.20 β-catenin and α6 integrin IF staining of back skin sections from 14-day-old control and 
mutant mice. Nucleated cells were observed in the lower regions of mutant HFs, although expression 
of both β-catenin and α6 integrin was lost. DAPI was used to visualize nuclei. Bar: 50 µm. 
 
Fig. 3.21 Vimentin and α6 integrin IF staining of back skin sections from 14-day-old control and 
mutant mice. Cells in the lower parts of HFs, which were not enclosed by α6 integrin-expressing 
ORS keratinocytes, did not contain vimentin (arrows). However, they seemed to be surrounded by 
mesenchymal cells. Nuclear DNA was visualized with DAPI. Bar: 50 µm. 
Taken together, the results of the IF analysis of the HF-specific protein expression indicated 
that keratinocytes within the HF are not able to sustain their differentiated state in the absence of 
Rac1. 
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3.2.3 Removal of the lower part of mutant HFs by macrophages. 
Pathological changes in morphology of HFs can cause an increased infiltration of phagocytic 
cells as was previously shown for example in the β1-integrin-deficient skin (Brakebusch et al., 
2000). The absence of the lower parts of HFs in the adult skin of rac1fl/fl,cre mice could have 
been a result of such an increased phagocytic activity. Therefore, the back skin of 9-day-old and 
14-day-old control and mutant mice was analysed for the presence of macrophages and 
granulocytes. 
Fig. 3.22 Mac1 and α6 integrin staining of back skin sections from 9-day-old and 14-day-old 
control and mutant mice. Only a few macrophages were found in the skin of 9-day-old and 
14-day-old control mice (arrowheads). In the 9-day-old mutant skin, no increased number of 
macrophages was detected, even around distorted hair bulbs (black arrows). At day 14 after birth, 
many Mac1+ cells infiltrated the Rac1-deficient skin and accumulated around the lower parts of the 
HFs, below the regions where α6 integrin was still expressed in the outermost layer (white arrows). 
Fluorescently labeled streptavidin, used as a secondary reagent, non-specifically recognized SGs 
(stars) and subcutaneous fat cells. Nuclear DNA was visualized with DAPI. Bar: 50 µm, 
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Only a few, evenly scattered, Mac1-positive cells were observed in the control skin 
(Fig. 3.22, arrowheads), which was consistent with the normal presence of macrophages in the 
skin. Also, no increase in the amount of macrophages was detected in samples form 9-day-old 
rac1fl/fl,cre mice, even though some HFs were already showing changes in the morphology 
(black arrows). However, there was a massive infiltration of macrophages in the skin of 
14-day-old mutant mice (white arrows). The phagocytic cells were concentrated around the 
lower parts of mutant HFs, which suggested that macrophage-attracting signals were released by 
cells in that region.  
Granulocytes (Gr+), which are present in the skin only in pathological conditions, were not 
detected in either control or mutant skin of 14-day-old mice (data not shown). This result was 
consistent with the lack of apparent fibrosis in the absence of Rac1.  
Phagocytes are attracted by apoptotic cells (Lauber et al., 2004). Therefore, a TUNEL 
staining was performed (2.7.2.3) to determine if cells in the lower regions of Rac1-deficient HFs 
are dying, thereby causing the phagocytic removal. However, no increase in the amount of cells 
undergoing apoptosis was detected in the mutant HFs, when compared to the control samples 
(Fig. 3.23).  
Fig. 3.23 TUNEL staining of back skin sections from 14-day-old control and mutant mice. No 
increase in the amount of TUNEL+ cells was detected in the lower regions of 14-day-old mutant HFs 
when compared to normal HFs. Bar: 50 µm. 
Those results showed that, while Rac1-deficient cells in the lower parts of HFs attracted 
macrophages, the programmed cell death was not the cause of the infiltration.  
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3.3 Phenotype analysis of the Rac1-deficient epidermis 
In contrast to the severe HF phenotype, the epidermis of rac1fl/fl,cre mice seemed to be not 
affected by the loss of Rac1 (3.1.3 and Fig. 3.9-Fig. 3.12). The histological analysis (2.7.1) of the 
14-day-old mutant skin did not reveal evident defects, such as an increased amount of layers or 
detachment of the Rac1-deficient epidermis form the dermis (Fig. 3.25, HE).  
Fig. 3.24 Normal morphology and proliferation of the Rac1-deficient epidermis. HE staining of 
back skin sections from 14-day-old control and mutant mice showed no defects of the epidermis in the 
absence of Rac1. No changes in the proliferation of basal keratinocytes as well as no abnormal 
proliferation of suprabasal cells were detected with a BrdU-incorporation assay in the mutant 
epidermis. Bars: 25 µm. 
Mitotic activity of epidermal cells in the 14-day-old skin was analysed using a BrdU 
incorporation assay (2.7.2.2). The proliferation rate of basal keratinocytes in the mutant 
epidermis was similar to the control value (ctrl: 10.3% BrdU+ cells; KO: 11.4% BrdU+ cells). 
Also, no proliferation of Rac1-deficient suprabasal cells was detected (Fig. 3.24, BrdU). Those 
results were in agreement with the normal morphology of the Rac1-deficient epidermis.  
In some older mice, regions with a slight thickening of the epidermis were observed, 
suggesting a local increase in the proliferation. 
3.3.1 Normal differentiation of the epidermis 
A normal layer composition of the epidermis in the absence of Rac1 was confirmed by the 
IF expression analysis of differentiation-specific keratins (2.7.2.1). Distribution patterns of K14 
and K10, which are typical for basal and suprabasal keratinocytes, respectively (1.2.1), were 
comparable in the 14-day-old control and mutant epidermis (Fig. 3.25, K14 and K10). Also the 
presence of loricrin, which is normally expressed in terminally differentiated keratinocytes, was 
restricted to the cornified layer of the epidermis as in control samples (Fig. 3.25, loricrin). 
The expression of K6 is induced in the epidermis only when the normal biology of 
keratinocytes is disturbed, e.g. under hyper- or hypoproliferative conditions (Dominey et al., 
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1993; Sellheyer et al., 1993). However, as in control samples, no K6 expression was detected in 
the mutant epidermis (Fig. 3.25, K6), further indicating that the absence of Rac1 does not lead to 
pathological changes. 
Fig. 3.25 Normal differentiation of the epidermis in the absence of Rac1. IF staining of back skin 
sections from 14-day-old control and mutant mice were carried out for K14, K10, loricrin and K6 to 
analyse differentiation of the epidermis. A counterstaining for α6 integrin was performed to visualize 
the dermal-epidermal junction. Nuclei were visualized with DAPI. Bars: 25 µm. 
3.3.2 Normal expression of adhesion and ECM proteins 
In vitro studies with primary keratinocytes showed that Rac1 is required for the 
establishment and maintenance of the cadherin-mediated cell–cell adhesion (Braga et al., 1997; 
Braga et al., 1999). Surprisingly, IF staining of junctional proteins showed normal expression 
patterns and the intracellular distribution of E-cadherin, β-catenin, α-catenin and desmoplakin in 
the 14-day-old mutant epidermis (Fig. 3.26) giving no indication of a defect in the cell-cell 
adhesion between Rac1-deficient keratinocytes in vivo.  
Furthermore, Rac1 was shown to be necessary for the assembly of laminin at the basal side 
and for the establishment of cell polarity in MDCK epithelial cysts grown in collagen (O'Brien et 
al., 2001). However, the deposition of BM components such as LN5 and nidogen (Nd) was not 
altered in the 14-day-old mutant skin and remained restricted to the dermal-epidermal junction 
(Fig. 3.27, LN5 and Nd). Like in the control skin, the BM was linear and continuous. 
In addition, integrins α6 and β4 were present mainly at the basal side of keratinocytes 
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adherent to the BM, in both control and mutant epidermis, demonstrating that basal keratinocytes 
were polarized normally in the absence of Rac1 (Fig. 3.27, β4). 
Fig. 3.26 Normal expression of cell-cell contact components in the Rac1-deficient epidermis. IF 
staining of back skin sections from 14-day-old control and mutant mice was carried out for E-cadherin 
(E-cad), β-catenin (β-cat), α-catenin (α-cat) and desmoplakin (desm) to analyse the expression of 
adhesion proteins in the epidermis. A counterstaining for α6 integrin was performed to visualize the 
dermal-epidermal junction. Bars: 25 µm. 
 
Fig. 3.27 Normal deposition of the BM and polarization of basal keratinocytes in the absence of 
Rac1. IF staining of back skin sections from 14-day-old control and mutant mice was carried out for 
LN5 and Nd to analyse the deposition of BM components. Polarization of basal keratinocytes was 
shown by visualizing the expression pattern of integrin α6β4. Bars: 25µm. 
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3.3.3 Normal formation of cell-cell and cell-ECM contacts 
An ultrastructural analysis of back skin (2.7.3) was performed to study in more detail the 
structure of cell-cell contacts and the attachment of basal keratinocytes to the BM.  
EM pictures showed a normal presence of desmosomes (Fig. 3.28A and B, black arrows) 
between Rac1-deficient basal keratinocytes (K), which were accompanied by adherens junctions, 
as in the control epidermis (Fig. 3.28B, white arrowheads). Those results further indicated that 
the cell-cell adhesion between basal keratinocytes in vivo is not affected by the absence of Rac1.  
Fig. 3.28 No apparent defects of cell-cell and cell-ECM contacts in the Rac1-deficient epidermis. 
(A) EM pictures of back skin sections from 14-day-old control and mutant mice confirmed a normal 
presence of desmosomes (black arrows) between Rac1-deficient basal keratinocytes (K) attached to 
the BM (black arrowheads). Bar: 1 µm. Higher magnification EM pictures showed: (B) normal 
adherens junctions (white arrowheads) formed next to desmosomes (black arrows) and (C) normal 
hemidesmosomes (white arrows) formed between basal keratinocytes and the BM (black arrowheads) 
in the absence of Rac1. Bars: 0.5 µm. 
The intercellular distance between some mutant basal keratinocytes was slightly increased, 
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when compared to control samples. However, that seemed to have no influence on the 
maintenance of adhesion structures. 
The EM analysis confirmed a normal deposition of the BM in the absence of Rac1 
(Fig. 3.28A and C, black arrowheads). In addition, higher magnification EM pictures showed a 
presence of hemidesmosomes in both control and mutant skin (Fig. 3.28C; white arrows). No 
detachment of the epidermis from the underlying BM was observed in the Rac1-deficient skin, as 
expected from the histological analysis.  
Those data showed that adhesion capability of mutant keratinocytes in vivo was either not 
affected at all by the absence of Rac1 or, at the least, that it was not altered enough to cause a 
noticeable defect. 
3.4 Biochemical analysis of signalling pathways in the absence of Rac1 
3.4.1 No significant changes in the c-Myc expression 
Recently it has been shown that an induced loss of Rac1 in keratinocytes in vivo leads to an 
increased expression of c-Myc resulting in the depletion of epidermal stem cells (Benitah et al., 
2005). In contrast to that report, Western blot analysis (2.8.3) of c-Myc protein levels in 
epidermal lysates (2.8.1.2) prepared from rac1fl/fl,cre mice showed no significant changes when 
compared to control samples (Fig. 3.29). That result, however, was in agreement with the lack of 
epidermal defects observed in the mutant mice generated in this study. 
Fig. 3.29 No significant changes of c-Myc protein levels in the Rac1-deficient epidermis. Western 
blot analysis performed on epidermal lysates from 3-day-old, 15-day-old and 8-month-old control and 
mutant mice. Tubulin or GAPDH (star) content was used as a loading control. 
 
3.4.2 No apparent defects in activation of NF-κB, JNK, p38 or Akt 
Several signalling pathways were shown to be Rac1 dependent (Van Aelst and D'Souza-
Schorey, 1997; Bishop and Hall, 2000; Jaffe and Hall, 2005). Therefore, activation of JNK, p38, 
Akt and NF-κB was analysed to investigate possible consequences of the Rac1 deletion in the 
epidermis.  
Western blot analysis of epidermal lysates from control and mutant mice was performed to 
check the amount of phosphorylated forms of JNK, p38 and Akt. Activation of NF-κB was tested 
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indirectly by assessing the amount of IκB-α, which is degraded during the activation of NF-κB.  
No significant changes in the activation of any of the investigated proteins were detected in 
epidermal lysates from 3-day-old and 8-month-old mice (Fig. 3.30), indicating that the presence 
of Rac1 is not essential for normal signalling through those pathways in keratinocytes in vivo. 
Fig. 3.30 No changes in the activation of NF-κB, JNK, Akt and p38 in the Rac1-deficient 
epidermis. Western blot analysis performed on epidermal lysates from 3-day-old and 8-month-old 
control and mutant mice. Levels of IκB-α were checked as an indirect test of NF-κB activation. 
GAPDH content and total levels of JNK, Akt or p38 were used as a loading control 
(p: phosphorylated forms). 
3.4.3 No obvious compensation of Rac1 by related Rho GTPases. 
The lack of an obvious phenotype in the Rac1-deficient epidermis could be a result of 
compensatory mechanisms. An upregulation of the expression or activation of closely related 
Rho GTPase family members might have theoretically counterbalanced the lack of Rac1 in the 
epidermis.  
Western blot analysis of Cdc42, RhoA, Rac2 and Rac3 protein levels (2.8.3) and a 
quantitative RT-PCR analysis of RhoG mRNA levels (2.9) in the epidermis of control and 
mutant mice were performed to investigate that possibility. 
Fig. 3.31 No significant changes in the protein expression and the activation of Cdc42, RhoA and 
Rac2 in the absence of Rac1. Western blot analysis of GTPase-activity assays performed on 
epidermal lysates from 3-day-old and 8-month-old control and mutant mice. No presence of active 
Rac2 was detected in either lysate. Tubulin or GAPDH (star) content was used as a loading control. 
The total protein content of Cdc42 and RhoA in the Rac1-deficient epidermis was 
comparable with control samples at 3 days and 8 months of age (Fig. 3.31). While Rac2 was not 
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detected in any of the epidermal lysates from 3-day-old mice (Fig. 3.32A), there were low 
amounts of the protein present in the epidermis of 8-month-old control and mutant mice, at 
similar levels in both samples (Fig. 3.31). Rac3 protein was not detected in epidermal lysates 
from neither 3-day-old nor 8-month-old control and mutant mice (data not shown and 
Fig. 3.32B, respectively).  
Fig. 3.32 No expression of Rac2 and Rac3 in the Rac1-deficient epidermis at 3 days and 
8 months of age, respectively. Western blot analysis performed on epidermal lysates from control 
and mutant mice. Macrophage (Mac; A) or brain (B) lysate was used as a positive control. GAPDH 
(A) or tubulin (B) content was used as a loading control. 
Activation of Cdc42, RhoA and Rac2 was analysed in GTPase-activity assays performed on 
epidermal lysates from 3-day-old and 8-month-old control and mutant mice (2.8.4).  
In case of Cdc42 and RhoA, no significant changes in the amount of the GTP-bound form 
were observed after the loss of Rac1. No active form of Rac2 was detected in epidermal lysates 
from 8-month-old control or mutant mice (Fig. 3.31). The activity of Rac2 was analysed only in 
the epidermis of adult mice, as no protein was present in 3-day-old samples (Fig. 3.32A). For the 
same reason, lysates were not analysed for the presence of active Rac3. 
Fig. 3.33 No upregulation of the RhoG expression in the absence of Rac1. Real-time PCR analysis 
of RhoG mRNA levels in 6-month-old control and mutant epidermis was performed with two 
different sets of primers. No significant differences between control and Rac1-deficient samples were 
detected. GAPDH expression levels were used for standardization of samples. 
RhoG expression levels were determined in the epidermis of 3-month-old and 6-month-old 
control and mutant mice by a quantitative RT-PCR (2.9.3) using two independent sets of 
primers. Neither of them showed a significant change in the expression of RhoG in the absence 
of Rac1 (Fig. 3.33). 
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Although those data did not exclude compensatory changes in the expression or the 
activation of other proteins in response to the absence of Rac1, they demonstrated that proteins 
most likely capable of the compensation are not involved.  
3.5 Analysis of the wound healing process in the absence of Rac1 
Data obtained in this study demonstrated that Rac1 is not essential for maintenance of the 
epidermis in physiological conditions. Still, a potential role of Rac1 in response to stress stimuli, 
i.e. skin injury, remained to be investigated. In vitro studies suggested the possibility of a Rac1 
importance during the re-epithelialization process because of its involvement in the regulation of 
cell migration (Nobes and Hall, 1999; Fenteany et al., 2000).  
In order to study the consequences of the Rac1 absence for the regeneration of the epidermis, 
wound healing experiments were carried out in control and mutant mice (2.7.5). Two parameters 
were used for the analysis of the wound closure process. The first was a length of the epithelial 
tongue, used as readout of the migratory activity of keratinocytes. The distance was measured 
from the wound edge to the tip of the tongue (Fig. 3.34A; red line). The second analysed 
parameter was the total area covered by the neo-epidermis (yellow area), which was used as 
readout of the hyperplastic growth.  
Fig. 3.34 Impaired wound re-epithelialization in Rac1-deficient epidermis. (A) Schematic 
representation of a wound. Neo-epidermis (yellow area) is expanding out of a wound margin (blue 
line) pointed out with the green arrowhead. The end of the epithelial tongue (red line) is marked with 
the red arrow. (B) HE staining of wound edge sections from control and mutant mice, isolated 5 days 
after the wounding. Arrows indicate the wound margin (green) and the front of the epithelial tongue 
(red), as in the scheme. Bar: 200µm. 
Results 
106 
Histological analysis of tissue samples, isolated from control and mutant mice 5 days after 
the wounding, showed a dramatic delay in the regeneration of the injured epithelium in the 
absence of Rac1 (Fig. 3.34B).  
The differences were quantified by a histomorphometric analysis of wound cross-sections 
from 6 rac1fl/+,cre and 8 rac1fl/fl,cre mice. The results confirmed that Rac1-deficient epithelial 
tongues were significantly shorter than control ones, suggesting a defect in the migration of 
mutant keratinocytes into the wound. (Fig. 3.35A). While the hyperplastic neo-epidermis and 
wound edge epithelium were present in the mutant skin, the amount of new tissue formed in the 
absence of Rac1 was significantly lower in comparison to the control skin (Fig. 3.35B). 
Fig. 3.35 Quantification of the re-epithelialization defect in the absence of Rac1. (A and B) 
Results of histomorphometric analysis of the epithelial tongue length (A) and the neo-epidermis area 
(B), conducted 5 days after the wounding, confirmed dramatic delay in the wound closure process. (C) 
Reduced number of BrdU-positive cells confirmed lower growth rate of mutant keratinocytes in the 
neo-epidermis. Error bars: ± SD; stars: p<0.0001. 
Reduced hyperplasia of the neo-epidermis and the wound edge epidermis in rac1fl/fl,cre mice 
suggested that the proliferation rate of epidermal keratinocytes was decreased in the absence of 
Rac1. To check this assumption, the mitotic activity of keratinocytes in the wound tissue was 
quantified with a BrdU incorporation assay (2.7.5).  
BrdU positive cells in the neo-epidermis and wound edge epidermis were counted in sections 
of 5-day-old wounds isolated from 8 control and 11 mutant mice. The analysis revealed a 
significantly decreased incorporation of BrdU within the wound epithelium of Rac1-deficient 
mice when compared to control animals (Fig. 3.35C). That result confirmed the dramatic 
decrease in the efficiency of the re-epithelialization in the absence of Rac1. 
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3.6 Analysis of the 4-hydroxy-tamoxifen influence on the 
Rac1-deficient epidermis 
Maintenance of the epidermis in rac1fl/fl,cre mice generated for this study, in which the 
deletion of the protein was activated endogenously during the embryogenesis, is not affected by 
the lack of Rac1 (3.3). In contrast, recently reported keratinocyte-specific deletion of the rac1 
gene, induced locally in the skin of adult mice, resulted in a severe defect of the epidermis 
(Benitah et al., 2005). The initial hyperthickening of the epidermis was followed by 
disorganization of the basal layer (a decrease in cellularity combined with an increased cell size) 
and resulted finally in a partial or complete loss of epidermal keratinocytes. The phenotype was 
attributed to an abnormal activation and terminal differentiation of epidermal stem cells, which 
led to the depletion of the stem cell pool. 
One of the explanations for the striking discrepancy between both phenotypes could be the 
use of different methods leading to the removal of Rac1. Repetitive applications of 4-hydroxy-
tamoxifen (4OHT) dissolved in acetone, which were used by Benitah and co-authors to induce 
the deletion, might theoretically lead to more severe effects in the epidermis lacking the Rac1 
than in the normal skin. To test that possibility acetone or 4OHT/acetone solution was applied to 
a clipped area of back skin of rac1fl/+,cre and rac1fl/fl,cre mice, following the protocol described 
by Benitah and co-authors (2.7.4).  
Acetone alone did not cause any obvious changes in either control or mutant epidermis 
(Fig. 3.36A). The application of the 4OHT/acetone solution, however, resulted in a significant 
hyperthickening of the Rac1-deficient epidermis (Fig. 3.36B). Surprisingly, mild alterations were 
detected also in the 4OHT-treated control skin, suggesting, that the compound might be not 
entirely neutral to the epidermis in general. Observed changes were transient though, as 2 weeks 
after stopping the treatment both the control and the Rac1-deficient epidermis looked normal. 
The recovery of the mutant epidermis demonstrated that the 4OHT-treatment did not cause 
irreversible changes in the epithelial stem cell pool (Fig. 3.36C).  
Those data suggest that the treatment related effects might have contributed to the phenotype 
of the mice with a 4OHT-induced deletion of the Rac1 gene (Benitah et al., 2005). However, 
consequences of the treatment alone were not sufficient to explain the dramatic difference 
between both phenotypes, indicating an involvement of other factors such as compensatory 
mechanisms or an influence of the genetic background.  
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Fig. 3.36 Transient hyperthickening of Rac1-deficient epidermis caused by the application of 
4-hydroxy-tamoxifen (4OHT). HE staining of back skin sections from control and mutant mice 
treated with acetone alone (A) or 4OHT/acetone (B and C) every 3 days for 15 days. The mice were 
sacrificed either 1 day (A and B) or 2 weeks (C) after the last application. Bars: 50 µm. 
 
3.7 In vitro analysis of Rac1-deficient primary keratinocytes  
3.7.1 Mutant keratinocytes do not survive in vitro 
Primary keratinocytes were isolated from rac1fl/+,cre and rac1fl/fl,cre adult mice (2.5.4.3) and 
cultured in a standard keratinocyte medium, containing low amount of Ca2+ to prevent the 
induction of terminal differentiation (2.5.4.1). Cells were seeded on the surface coated with 
collagen I and fibronectin (Col/FN) or the LN5-rich matrix (LN) (2.5.4.2). Control cells were 
growing normally and usually reached confluency within a week. However, it was not possible 
to sustain mutant keratinocytes in vitro on either of used substrates (Fig. 3.37).  
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Fig. 3.37 Rac1-deficient primary keratinocytes could not be sustained in vitro. Keratinocytes 
isolated from adult control and mutant mice were seeded in culture dishes coated with collagen I and 
fibronectin (Col/FN) or the LN5-rich matrix (LN). On both substrates, a decreased number of attached 
Rac1-deficient cells was observed 1 day after seeding, when compared to control keratinocytes. 
Adherent mutant cells showed defective spreading and did not expand. Most of them died within a 
week. A few well-spread cells isolated from mutant mice (arrowheads) might have been cells that had 
escaped the deletion of the rac1 gene. Bars: 50 µm. 
Already one day after the seeding, a difference in the amount of attached cells was visible. It 
was becoming more prominent with each day as control keratinocytes were expanding, while the 
number of Rac1-deficient cells was decreasing. Also a dramatic difference in the cell size 
became evident within a couple of days.  
Nearly all Rac1-deficient cells died within a week. That, however, might have been a 
secondary effect, resulting from a too low number of initially (day 1) attached cells, as 
keratinocytes require quite a high cell density to survive and grow in vitro. Seeding mutant cells 
at a higher density did not rescue the culture, though, as the amount of attached cells after 24 h 
did not increase significantly.  
Some cells isolated from the mutant epidermis could adhere and spread like control cells 
(Fig. 3.37, arrowheads). Most likely, these cells had escaped the deletion of the rac1 gene.  
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3.7.2 Slightly impaired adhesion of Rac1-deficient keratinocytes. 
The apparent attachment defect was further analysed with a standard adhesion assay. 
Experiments were performed with freshly isolated keratinocytes on both substrates (Col/FN and 
LN) in normal culture conditions (2.5.4.5). As defects in cell adhesion often result from changes 
in the cell surface expression of integrins, a FACS analysis of the integrin profile was performed 
as well (2.7.2.4) to investigate if that was the reason for the observed reduction in the amount of 
attached mutant keratinocytes.  
Judging from the reduced number of adherent cells, observed 24 h after the seeding, a rather 
severe impairment of adhesion might have been expected. Surprisingly, the results revealed that 
within first 2 h the adhesion of Rac1-deficient keratinocytes to collagen I and fibronectin was 
only slightly reduced, while the attachment to LN5-rich matrix was not significantly impaired 
when compared to control cells (Fig. 3.38).  
The data obtained from FACS analysis confirmed adhesion assay results, as no changes in 
the integrin presence on the cell surface were observed in Rac1-deficient keratinocytes. Integrins 
α1, α6, β2 and β4 were expressed in both types of cells at similar levels, and no abnormal 
upregulation of the expression of integrins α1, α4, α5, αv, β2, β3 and β7 was detected in 
Rac1-deficient primary keratinocytes (Fig. 3.39). 
Fig. 3.38 Slightly impaired attachment to the Col/FN substrate and not significant reduction of 
adhesion to the LN matrix in the absence of Rac1. Adhesion assays were performed with freshly 
isolated keratinocytes from adult control and mutant mice. The amount of adherent cells is presented 
as a percentage of the seeded keratinocytes. Star: p<0.005. 
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Fig. 3.39 Normal cell surface expression of integrins in the absence of Rac1. FACS analysis of 
freshly isolated keratinocytes from control (dark blue) and mutant (red) adult mice showed no 
differences in expression of integrins: α1, α6, β2 and β4. No expression of other integrins (α1, α4, α5, 
αv, β2, β3 and β7) was detected in both control and mutant samples. The relative amount of 
suprabasal cells was slightly higher in mutant samples. 
3.7.3 No increase in the apoptosis or terminal differentiation of 
keratinocytes in the absence of Rac1.  
While the initial adhesion of Rac1-deficient keratinocytes was only slightly impaired, an 
increase in the cell death among attached mutant cells and/or their terminal differentiation might 
have been contributing factors in the observed reduction of the cell number. To investigate those 
possibilities control and mutant cells were IF stained 24 h after seeding for cleaved caspase-3, 
expression of which is characteristic for apoptotic cells, as well as for loricrin, a terminal 
differentiation marker.  
Only 1.3% and 2.2% Rac1-deficient cells seeded on the Col/FN-coated surface and the LN 
matrix, respectively, expressed high amounts of cleaved caspase-3. These values were similar to 
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control: 0.4% (Col/FN) and 2.2% (LN). Furthermore, the amount of loricrin-positive cells was 
about the same in mutant and control keratinocytes: 0.6% on Col/FN coated surface and 0.9% on 
the LN matrix.  
Those results were in agreement with in vivo data that showed no increase in the amount of 
apoptotic (Fig. 3.23) or terminally differentiated cells (Fig. 3.25) in the Rac1-deficient epidermis. 
However, they did not explain the difference between the amounts of attached control and 
mutant cells one day after the seeding. 
3.7.4 Severe spreading defect of Rac1-deficient keratinocytes. 
In order to explain the detachment of initially adherent keratinocytes, a time lapse video 
microscopy technique was employed to investigate the behaviour of control and mutant primary 
keratinocytes for 42 h after the seeding on the Col/FN-coated surface (2.5.4.6). This approach 
enabled to observe the attachment, spreading and movement of cells in a continuous manner, 
making it possible to analyse the phenotype of Rac1-deficient cells in more detail.  
In standard conditions, only a fraction of primary murine keratinocytes is able to 
successfully attach. After initial adhesion, the spreading takes several hours, in contrast to, for 
example, fibroblasts, which spread within minutes.  
Normal attachment and spreading were observed in case of control cells (Movie 1; see the 
appended CD) (7). Attached cells spread steadily and started to move around afterwards. At the 
end of the observation period, the majority of adherent cells were fully expanded.  
In contrast, most of mutant keratinocytes, which attached initially, were not able to spread 
(Movie 2; see the appended CD) (7). Some cells, which started to expand, were not able to 
complete spreading (first three arrows). Others, while extending small protrusions, did not spread 
at all and remained round (fourth arrow). In the end, most of the Rac1-deficient adherent cells 
rounded up and detached, including some cells, which managed to fully spread (last two arrows). 
After 42 h, many fewer mutant keratinocytes were attached and the adherent Rac1-deficient cells 
were not spread to the same extend as control cells.  
To better describe the observed spreading defect in the absence of Rac1, a quantitative 
analysis of the cell area was performed (2.5.4.6). Not surprisingly, dramatic differences in the 
cell size were confirmed (Fig. 3.40). Within the 36-hour-period of time, adherent control 
keratinocytes steadily increased their size. After the initial 12 h, the average size of attached 
Rac1-deficient cells was still comparable to the control value. However, mutant keratinocytes 
did not expand any further during the following 24 h.  
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Fig. 3.40 Severe spreading defect of Rac1-deficeint keratinocytes in vitro. Quantitative analysis of 
cell spreading performed on primary keratinocytes after seeding on Col/FN-coated plastic. Cell size 
was analysed at indicated time points by measuring the pixel area of 30-40 randomly chosen control 
and mutant cells. Initially, no significant differences were observed. After 12 hours Rac1-deficient 
cells stopped spreading while control cells continued to increase their size. Stars: p<0.0001. 
The severe spreading defect observed in vitro in mutant keratinocytes suggested strongly 
that an impairment of the F-actin assembly occurs in the absence of Rac1. To investigate that 
possibility, primary keratinocytes were isolated from adult mice and cultured for 1 and 3 days on 
the Col/FN-coated surface. Subsequently, the actin cytoskeleton and focal adhesions were 
immunofluorescently stained (2.5.4.4). 
Results of the microscopic analysis showed that already 1 day after the seeding most control 
keratinocytes were spread and had fully developed focal adhesions (visualized with an antibody 
against paxillin) and a well organized actin cytoskeleton (visualized with a fluorescently labeled 
phalloidin) (Fig. 3.41). In contrast, the majority of Rac1-deficient cells remained much smaller 
than control keratinocytes, even 3 days after seeding. They formed paxillin containing focal 
adhesions, which was in agreement with the normal expression of the integrins. However they 
were not as developed as in control cells and the actin cytoskeleton was clearly disorganized.  
 
Taken together, these results suggest that the impaired ability of Rac1-deficient keratinocytes 
to spread in vitro, which was most likely a consequence of a defect in the actin cytoskeleton 
organization, was the cause of the observed detachment of mutant cells. 
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Fig. 3.41 Impaired organization of the actin cytoskeleton in Rac1-deficient keratinocytes in vitro. 
Mutant cells were much smaller and showed clear defect of the actin assembly, but were able to form 
focal adhesions. Control and mutant primary keratinocytes were seeded on a Col/FN-coated glass. IF 
staining for F-actin (with Alexa488-labeled phalloidin), paxillin and nuclear DNA (DAPI) was 
performed 1 and 3 days after the isolation. 
 
 
3.8 In vitro analysis of ES cell differentiation in the absence of Rac1 
The conditional deletion of the rac1 gene, generated for this study, can not be used to study 
the role of Rac1 in the early stages of the epidermal development as the deletion is activated after 
the epithelial lineage commitment and first stages of epidermis differentiation.  
The constitutive deletion of the rac1 gene leads to a failure in the formation of three germ 
layers during gastrulation (Sugihara et al., 1998). It would be difficult to explain the molecular 
mechanisms that underline the defect using the in vivo system, because of the low number of 
cells and inaccessibility of the embryos at the early stages of development.  
In vitro differentiation of ES cells offers a unique approach to study events that occur during 
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early embryogenesis. Upon withdrawal of LIF and stromal contact, ES cells undergo 
spontaneous differentiation into three-dimensional structures called embryoid bodies (EBs), 
which consist of an outer layer of endodermal secretory cells, the BM, the polarized epiblast 
(primitive ectoderm layer, which later gives rise to all tree germ layers) and the central cavity. 
This process recapitulates stages of the peri-implantation embryonic development and can be 
used as an in vitro tool to study cell differentiation, BM assembly, establishment of cell polarity 
and cell-cell contacts or mechanisms of apoptosis and cavitation (Li and Yurchenco, 2006). 
Obtained data would complement the analysis of in vivo gene deletion and enable a better 
understanding of the role of Rac1. 
3.8.1 Generation of Rac1 (−/−) ES cells 
Rac1-deficient ES cells were generated from one of rac1−/+ clones, which were obtained 
simultaneously with rac1fl/+ clones during generation of the conditional knock-out mice (3.1.2). 
The clone was re-electroporated with the targeting construct (2.6.3) in order to homologously 
recombine the remaining wild type allele. After the selection with G418, ES cells clones were 
picked and screened by a Southern blot analysis with the external probe for rac1−/3loxP genotype 
(Fig. 3.42A). The subsequent cre transfection and FIAU selection (2.6.4) resulted in generation 
of clones carrying either the conditional allele (rac1−/fl) or the additional null allele (rac1−/−). 
Both types of clones were identified by a Southern blot analysis with the internal probe 
(Fig. 3.42B). 
Fig. 3.42 Screening of ES cell clones. (A) Results of Southern blot analysis of HindIII-digested 
DNA, hybridized with the external probe to check for the homologous recombination of the targeting 
construct. Bands: wt (+) – 14.4 kbp, null (–) and 3loxP – 9.1 kbp. (B) Results of Southern blot 
analysis after the cre transfection. Genomic DNA from ES cell clones was cut with BamHI and 
hybridized with the internal probe to check for the presence of the conditional or the second null 
allele, generated through a Cre-mediated recombination. Bands: null (–) - 8.3 kbp, fl - 6.1 kbp. 
The absence of Rac1 in ES cell clones carrying two null alleles of the rac1 gene – 
Rac1 (−/−) – was confirmed with Western blot analysis. Rac1 (fl/−) clones were used as control 
cell lines during the analysis of Rac1-deficient ES cells.  
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Fig. 3.43 Rac1 (−/−) ES cells showed a complete loss of Rac1 protein. Western blot analysis of 
protein lysates from control and mutant ES cells. GAPDH content was used as a loading control. 
Normal ES cells form compact three-dimensional colonies when they are grown in standard 
culture conditions (2.5.1.1). In the undifferentiated state, the colonies have a smooth surface and 
borders between cells are not easily visible. As expected, no defects in the morphology of the 
Rac1 (fl/−) ES cell colonies were observed (Fig. 3.44).  
Rac1 (−/−) ES cell formed colonies; however, they were not as dense and smooth as the 
control ones. Mutant colonies resembled a raspberry and aggregates of cells were loosely 
attached to their surface (Fig. 3.44). Many cell clumps were detaching and floating in the 
medium.  
The abnormal appearance of mutant ES cells suggested an adhesion defect in the absence of 
Rac1. However, it was not severe enough to prevent the expansion of Rac1-deficient ES cells in 
culture, as in case of mutant keratinocytes. 
Fig. 3.44 Aberrant morphology of ES cell colonies in the absence of Rac1. Phase contrast pictures 
of control and mutant ES cells growing on a feeder cell layer. Rac1 (−/−) colonies were less compact 
and, in contrast to a smooth-surfaced control colonies, showed a raspberry-like morphology.  
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3.8.2 Differentiation of Rac1-deficient ES cells into EBs 
During normal development of EBs in suspension, small aggregates of ES cells become 
compacted balls of proliferating cells. Within 3 days, the outer layer of cells differentiates into 
the primitive endoderm. The subsequent transition into the secretory endoderm (mostly visceral) 
is followed by the deposition of ECM components on the inner (basal) side of the endoderm. 
Assembly of the BM induces transformation of underlying ES cells into the epiblast. The cells 
that are not in contact with the BM undergo apoptosis and the cavity is formed. The conversion 
of small clusters of ES cells into cystic EBs lasts normally 5-6 days in suspension culture (Li and 
Yurchenco, 2006).  
Rac1 (−/−) and Rac1 (fl/−) ES cells were cultured in suspension for 7 days to promote 
differentiation into EBs (2.5.3.1). Control ES cells formed normal EBs with the well-developed 
endoderm, epiblast and cavity (Fig. 3.45).  
Despite the observed adhesion defect, Rac1-deficient cells were able to aggregate and 
differentiate into EBs with all the normal components: the endoderm, the BM, the epiblast and 
the cavity. However, the epiblast was often abnormally thickened and some cells attached to the 
BM underwent cell death (Fig. 3.45, stars). That observation was analogous to the reported 
phenotype of Rac1-null murine embryos (Sugihara et al., 1998), which showed the presence of 
apoptotic cells between the ectodermal and the endodermal layer. In addition, the initially normal 
endoderm often looked disorganized at the later stages of the mutant EBs’ differentiation. 
Fig. 3.45 Rac1-deficient EBs developed the endoderm (en) and the epiblast (ep), and formed the 
cavity (cv). Phase contrast pictures of control and mutant EBs taken after 7 days of differentiation in 
suspension. In the absence of Rac1, the epiblast (ep) was often thickened and the presence of dead 
cells, in proximity of the BM was observed (stars). Also the endoderm seemed to be affected by the 
lack of Rac1. Bar: 20 µm. 
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3.8.3 Analysis of the epiblast polarization in the absence of Rac1 
The BM is formed after 3-4 days of the EB’s differentiation. Its presence induces profound 
changes in undifferentiated cells inside the EB. ES cells adjacent the BM differentiate into the 
primitive ectoderm. During this transition cells become polarized and change their polygonal 
shape into organized morphology of a pseudostratified columnar epithelium. The polarization is 
characterized by uniform translocation of specific proteins and organelles to the basal (e.g. 
integrins) or the apical side (e.g. Golgi complex) of the cell. 
To analyse if Rac1-deficient ES cells can form the polarized epiblast, IF staining for actin 
(phalloidin), microtubule organizing centre (MTOC; pericentrin) and Golgi complex (GM130) 
was performed (2.5.3.2). 
Fig. 3.46 Polarized distribution of F-actin, MTOC and Golgi apparatus in Rac1-deficient EBs. 
IF staining of control and mutant EBs was performed after 7 days of the differentiation. Antibodies 
against pericentrin and GM130 were used to visualize MTOC and Golgi complexes, respectively. 
F-actin was labeled with phalloidin (Alexa568).The BM was visualized with LNα1 or LNγ1, and 
nuclei with DAPI staining. Stars indicate dead epiblast cells observed at the BM in Rac1 (–/–) EBs. 
Bar: 20 µm. 
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The distribution of tested marker proteins was comparable in control and mutant EBs 
(Fig. 3.47, arrowheads). That result was in agreement with in vivo data, which showed that 
Rac1-null embryos can develop an epiblast (Sugihara et al., 1998). However, while the 
polarization of the primitive ectoderm seemed to be independent of the Rac1 presence, dying 
cells observed in the proximity of the BM (Fig. 3.47, stars) demonstrated a defect in the 
maintenance of Rac1-deficient epiblast cells. The defect might result from the inability of mutant 
cells to sustain the cell-ECM adhesion, but to explain the underlying mechanism further analysis 
is necessary.  
After the epiblast is formed, remaining cells within the EB undergo a controlled apoptosis, 
which leads to the formation of the cystic EB with a large central lumen. Rac1-deficient EBs 
were able to from the cavity, however the process seemed to be not as efficient as in control EBs. 
After 7 days in suspension, when all inner cells of Rac1 (fl/−) EBs were clearly apoptotic and the 
formation of cavity was nearly completed (Fig. 3.47, DAPI), nucleated cells expressing analysed 
markers, were often detected inside the Rac1 (−/−) EBs. That observation suggested a defect in 
the regulation of apoptosis in the absence of Rac1, but more extensive studies are required to 
determine the exact role of Rac1 in the cavitation process. 
3.8.4 Analysis of the cell-cell contacts formation in Rac1-deficient EBs 
As shown earlier (3.3), cell-cell adhesion in the fully differentiated epidermis is not affected 
by the absence of Rac1. However, the in vivo system created in this study was not suitable for 
the analysis of the Rac1 role in the establishment of cell-cell contacts during the formation of the 
polarized epithelium. Therefore, the ability of Rac1-deficient cells to form adherens junctions 
during the differentiation of the epiblast was analysed in Rac1 (–/–) EBs. In addition, the 
establishment of tight junctions in the endoderm layer was investigated.  
IF staining of control and mutant EBs (2.5.3.2) showed that E-cadherin was localized to the 
membrane and its concentration increased toward the apical side of the epiblast cells. The normal 
polarized distribution of the adherens junction-specific protein indicated that the formation of 
cell-cell contacts or their correct localization is not dependent on the presence of Rac1 (Fig. 3.47, 
E-cadherin).  
In the developing endoderm of normal EBs, tight junctions between cells are formed close to 
the apical side. After 3 days of suspension culture, IF staining for ZO-1 (2.5.3.2), a component of 
tight junctions (Stevenson et al., 1986), showed no differences in the presence or the localization 
of those cell-cell contacts between EBs differentiated from Rac1 (fl/−) and Rac1 (−/−) ES cells 
(Fig. 3.47, ZO-1).  
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Fig. 3.47 Normal formation of polarized cell-cell junctions in Rac1-deficient EBs. IF staining of 
control and mutant EBs for E-cadherin and ZO-1 was performed after 7 and 3 days of differentiation, 
respectively. Normal cell membrane localization of E-cadherin was visualized in the absence of Rac1 
in both the endoderm and the epiblast, similar to control EBs. ZO-1 was present at the apical side of 
the endoderm in both control and mutant EBs. BM was visualized with LNα1 and nuclei with DAPI 
staining. Stars indicate dead epiblast cells observed at the BM in Rac1 (–/–) EBs. Bar: 20 µm. 
In addition, the EM analysis of control and mutant EBs (2.5.3.2) showed a normal structure 
of tight junctions and their belt-like presence around the cell in the Rac1-deficient endoderm 
(Fig. 3.48), confirming that Rac1 is not essential for the formation those cell-cell contacts. 
Fig. 3.48 Normal formation of tight junctions in the endoderm (en) of Rac1-deficient EBs. 
Ultrastructural analysis of control and mutant endoderm was performed after 3 days of EBs 
differentiation. The continuous (belt-like) presence of tight junctions was observed between endoderm 
cells in both Rac1 (fl/−) and Rac1 (−/−) EBs (arrows). Bar: 2µm. 
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However, while the endoderm developed from Rac1 (−/−) ES cells without obvious 
problems, the disorganized morphology of the outer cell layer, observed at later time points 
suggests, that the presence of Rac1 is not completely dispensable for its proper maintenance. 
3.8.5 Analysis of the Rac1-deficient ES cells differentiation potential 
Epiblast cells within long-term cultured EBs can differentiate into a variety of cell types 
representing derivatives of all three embryonic layers. The ability of Rac1 (−/−) ES cells to give 
rise to different cell lineages was analysed by allowing the progenitor cells developed within 
EBs to differentiate further.  
After 6 days in suspension culture, EBs were transferred into standard cell-culture plates and 
cultured for 1-2 weeks more. After attaching, EBs continued to spontaneously differentiate and 
gave rise to various tissue-like structures. The presence of different cell types was confirmed 
with IF staining for selected tissue-specific markers (2.5.3.3).  
After one week, some Rac1 (fl/−) cells formed complex endothelial networks, visualized 
with PECAM staining. While Rac1 (−/−) ES cells were able to give rise to endothelial lineage, 
the formation of a vascular network seemed to be impaired (Fig. 3.49, PECAM).  
Staining for E-cadherin showed well developed sheets of epithelial cells, which had 
differentiated from both control and Rac1-deficient ES cells. Again, cadherin dependent cell-cell 
contacts were seemingly not disturbed in the absence of Rac1. Interestingly, mutant cells were in 
general smaller than control ones (Fig. 3.49, E-cadherin).  
Visualization of the actin cytoskeleton in single cells migrating out of the differentiating 
tissue-like structures, confirmed the difference in size between control and mutant cells. In 
addition, some of Rac1-deficient cells seemed to have an impaired actin cytoskeleton (Fig. 3.49, 
arrowheads). However, more experiments would be necessary to determine if that defect was 
random or cell type-specific. 
Neurofilament-M-expressing cells developed from Rac1 (fl/−) as well as from Rac1 (−/−) 
ES cells, showing that commitment to the neural cell type is not dependent on the presence of 
Rac1. However, the length of axon-like protrusions grown by Rac1-deficient cells seemed to be 
reduced (Fig. 3.49, Neurofilament-M). 
In both cultures, rhythmically contracting cell formations were observed demonstrating an 
ability of Rac1-deficient ES cells to develop into functional cardiomyocytes (not shown). 
These results are preliminary; however, they provide some insight into the differentiation 
capabilities of Rac1-deficient ES cells, pointing out directions for further studies, both in vivo 
and in vitro. 
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Fig. 3.49 Impaired formation of endothelial network and seemingly normal differentiation into 
epithelium and neural lineage in the absence of Rac1. After 6 days in suspension culture, 
Rac1 (fl/−) and Rac1 (−/−) EBs were plated on plastic and allowed to spontaneously differentiate for a 
week. To asses the differentiation potential of Rac1-deficient progenitor cells, IF staining was 
performed for proteins specific for endothelial, epithelial and neural cells: PECAM, E-cadherin and 
Neurofilament-M, respectively. Although PECAM-positive mutant cells were observed, formation of 
endothelial network seemed to be less efficient when compared to control cells. Rac1-deficient 
epithelial cells were forming normal E-cadherin-containing cell-cell contacts. Also, neural cells were 
developing in the absence of Rac1. However, the length of axon-like extensions seemed to be reduced. 
Mutant epithelial cells seemed smaller in comparison to control cells. Actin cytoskeleton staining, 
performed with fluorescently-labeled phalloidin, 2 weeks after the plating of EBs, showed a general 
reduction in cell size in the absence of Rac1 and an impaired actin cytoskeleton organization in some 
mutant cells (arrows). Bars: 50 µm. 
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4 DISCUSSION 
Rac1, a member of the Rho GTPase family, was first identified as one of the major 
regulators of the actin cytoskeleton (Ridley et al., 1992). Over the last 15 years a multitude of 
studies described the involvement of Rac1 in a variety of cellular processes, including cell 
spreading, cell migration, cell-cell and cell-ECM adhesion, cell-cycle progression and gene 
expression (Jaffe and Hall, 2005). However, when this project was initiated, the knowledge of 
Rac1 function was based almost exclusively on in vitro studies using dominant-negative or 
constitutively active forms of the protein. Although mutant forms are very useful tools, they 
might influence the function of other members of the Rho family or cause unspecific effects due 
to overexpression and mislocalized activity within the cell. Also, cell culture conditions do not 
reflect the complexity of the in vivo situation.  
At that time, only one study explored the function of Rac1 in vivo by generation and analysis 
of mice with a constitutive ablation of the rac1 gene (Sugihara et al., 1998), which resulted in 
the embryonic lethality at the onset of gastrulation (around day 8.5), thus demonstrating the 
essential role of Rac1 in the early murine development.  
In order to circumvent the embryonic lethality effect, genetically modified mice allowing for 
the deletion of the rac1 gene in a tissue- and time-specific manner, were generated in this study. 
Since in vitro studies suggested a crucial role of Rac1 in the formation and maintenance of 
cell-cell contacts between epithelial cells, mice with a keratinocyte-specific deletion of the rac1 
gene were generated and analysed. 
4.1 The absence of Rac1 leads to the HF degeneration 
The most obvious consequence of the rac1 gene deletion in the murine epidermis was an 
almost complete loss of fur (3.1.3) caused by an impaired growth and progressive deterioration 
of the HFs. While the morphology of HFs shortly after birth was not obviously affected by the 
absence of Rac1, within 2 weeks the lower parts of HFs became increasingly distorted and lost 
their integrity (3.2.1), which was accompanied by the loss of expression of epithelial and 
HF-specific markers in those regions (3.2.2). Changes in the differentiation state of cells in the 
lower parts of HFs were followed by the infiltration of macrophages, which removed the 
non-permanent parts of HFs (3.2.3). No reconstitution of anagen HFs was observed afterwards. 
However, infundibula, SGs and most likely bulge regions were preserved throughout the whole 
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life span of mutant mice. 
It is interesting to note, that, although Rac1 protein was clearly lost in the epidermis of 
rac1fl/fl,cre mice at least at day 3 after birth, no obvious changes in the HF morphology were 
visible until later stages of the morphogenesis, indicating that Rac1 is not crucial for the 
downward growth of the developing HF as well as for the initial differentiation of ORS, IRS and 
HS. However, the subsequent loss of HF layer-specific markers in the non-permanent part of the 
HF shows that Rac1 is required for the maintenance of HF keratinocytes in the differentiated 
state. The loss of HF-identity most likely reflects changes in gene expression, which could be 
either a direct result of the absence of Rac1 signalling or an indirect consequence of the loss of 
cell-cell and cell-ECM adhesion between the Rac1-deficient cells. 
The direct involvement of Rac1 in the regulation of gene expression was demonstrated 
before in cell culture experiments. Rac1 was shown to act as a potent stimulator of MAPK 
signalling cascades by activating JNK and p38 (Coso et al., 1995; Minden et al., 1995). 
Activated JNK translocates to the nucleus, where it phosphorylates transcription factors such as 
c-Jun, while p38 is known to activate both transcription factors (e.g. ATF-2) and other kinases 
implicated in the regulation of gene expression (e.g. MAPKAP kinase 2) (Gupta et al., 1995). 
Rac1 was also implicated in the integrin-dependent activation of NF-κB signalling pathway 
(Reyes-Reyes et al., 2001), which was previously shown to play an important role in the HF 
morphogenesis (Schmidt-Ullrich et al., 2001). In unstimulated cells, NF-κB is sequestered in the 
cytoplasm by binding to members of the IκB family. Upon activation, IκB becomes degraded 
and NF-κB translocates to the nucleus, where it can induce the transcription of many target 
genes. 
Although no significant differences in the phosphorylation levels of JNK and p38 as well as 
no changes in the amount of IκB-α were detected in epidermal lysates from rac1fl/fl,cre mice 
(3.4.2), it is possible that Rac1 plays a role in the activation of these signalling pathways 
specifically in HF keratinocytes. Such differences would most likely escape detection in whole 
epidermal lysates, where contribution of HF cells is rather low. The activation of p38 or JNK 
signalling pathways in mutant HFs could be analysed in more detail by IF staining of skin 
sections with antibodies specifically recognizing phosphorylated forms of these proteins. The 
activation of NF-κB signalling in the absence of Rac1 could be further studied by crossing 
rac1fl/fl,cre mice with NF-κB reporter mice (Schmidt-Ullrich et al., 1996). 
The lack of Rac1 could also indirectly influence the HF-specific gene expression by 
affecting the cell-cell and cell-ECM adhesion. This notion is supported by the observation that 
the loss of epithelial-specific markers in the absence of Rac1 seemed to be preceded by 
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morphological defects (Fig. 3.10, Fig. 3.19) and the loss of cell polarity (Fig. 3.18).  
Although no obvious defects in the formation of cell-cell or cell-ECM contacts were 
observed in the epidermis of rac1fl/fl,cre mice (3.3), it is possible that Rac1 is more critical for 
their maintenance in the HF. A more detailed ultrastructural analysis of cell-cell contacts in the 
lower parts of HFs would be certainly helpful to further address this point. 
 
During formation of the IRS, “Flügelzellen” from the Huxley layer of the IRS penetrate 
through the lower, less differentiated part of the Henle layer and come in contact with CL 
keratinocytes in a process apparently dependent on the formation of lamellipodia (Langbein et 
al., 2003). Loss of Rac1 might impair this migration, thus contributing to the malformation of 
HFs during morphogenesis. 
 
The exact molecular mechanism causing the infiltration of macrophages is not clear. Since 
no increase in apoptosis was observed in the lower parts of mutant HFs (Fig. 3.23), it is possible 
that the alterations of gene expression in Rac1-deficient HF keratinocytes lead to the secretion of 
macrophage attracting substances. This possibility could be investigated using an anti-
inflammatory/immunosuppressive drug, such as dexamethasone, which would allow to 
determine if production of inflammatory cytokines and chemokines is involved in the skin 
inflammation of rac1fl/fl,cre mice. If successful, blocking of macrophage infiltration would also 
allow for a more detailed analysis of changes in the HF morphology. 
Macrophage mediated removal of HFs is sometimes observed under normal conditions 
(Eichmuller et al., 1998). It is possible that Rac1 is involved in the regulation of this process and 
its absence leads to an abnormal induction of such a programmed organ deletion.  
 
The lack of the HF re-growth observed after the removal of the non-permanent parts of HFs 
can have different reasons. It is possible that the Rac1-mediated signalling plays an important 
role in the activation of bulge stem cells, which is necessary for the initiation of anagen (Stenn 
and Paus, 2001; Blanpain and Fuchs, 2006). Alternatively, the severe deterioration of the HFs 
and the lack of a proper involution phase (catagen), which normally leads to the retraction of the 
DP within the close proximity of the bulge, might have resulted in a separation of the DP 
fibroblasts from the HFs. Since anagen is induced by the crosstalk between DP cells and HF 
stem cells that would result in the inability of Rac1-deficient HFs to cycle. 
 
Discussion 
126 
4.2 Epidermis maintenance does not depend on the presence of Rac1 
In contrast to the severe defect observed in the HFs, rac1fl/fl,cre mice showed no obvious 
aberrations of the epidermal morphology (3.3). Polarization, proliferation and terminal 
differentiation of epidermal keratinocytes were normal, as well as the formation of adherens 
junctions, desmosomes and hemidesmosomes. Also, the deposition of the BM was not affected 
in the absence of Rac1. A slight increase in the intercellular distance, detected by ultrastructural 
analysis between some basal keratinocytes, had no noticeable consequences for the integrity of 
the Rac1-deficient epidermis, which was maintained throughout the whole life span of 
rac1fl/fl,cre mice. 
Those observations are surprising, as they stand in contrast to previous reports, which 
showed an essential role of Rac1 in the formation and maintenance of cadherin-dependent 
cell-cell contacts between epithelial cells in vitro (Braga et al., 1997; Braga et al., 1999) (1.3.1). 
Interestingly, it was also reported that the presence of DN-Rac1 disrupted cell-cell adhesion only 
in keratinocytes but not in endothelial cells or fibroblasts further indicating that Rac1 activity is 
especially important in epithelial cells (Braga et al., 2000).  
One possible explanation for the lack of defects after inactivation of the rac1 gene could be 
that the absence of Rac1 was compensated by other members of the Rac family. However, Rac2 
as well as Rac3 were hardly or not at all detectable in epidermal lysates from both control and 
rac1fl/fl,cre mice (Fig. 3.32). In addition, the expression levels of RhoG mRNA were not 
increased in the mutant epidermis (Fig. 3.33). Although, due to the unavailability of a RhoG 
antibody, it could not be excluded, that the activation of RhoG was increased, it seems unlikely 
that this rather distinct family member could fully compensate for the loss of Rac1.  
The possibility of compensation by other closely related members of the Rho GTPase family 
was also analysed, as at least some of them have been shown to be involved in the maintenance 
of the epidermis (Wu et al., 2006). However, both expression and activation levels of Cdc42 and 
RhoA were not significantly altered in epidermal lysates of rac1fl/fl,cre mice (Fig. 3.31).  
While the compensation by other proteins can not by excluded at this point, these results 
show that most likely candidates are not involved. 
 
Although these data do not rule out the involvement of Rac1 in the regulation of cell-cell 
contact formation and maintenance between keratinocytes in vitro, they clearly show that Rac1 is 
not essential for these processes in vivo and is dispensable for maintenance of epidermal 
homeostasis in physiological conditions. Thus, these results underline the importance of using in 
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vivo models for identifying biologically relevant functions of proteins.  
4.3 Wound healing is impaired in the absence of Rac1 
Although the loss of Rac1 in keratinocytes had surprisingly little effect on epidermal 
homeostasis under physiological conditions, it resulted in a severe impairment of the epidermal 
response to the pathological situation caused by a skin injury (3.5). Wound closure was 
significantly less efficient in the absence of Rac1. Mutant keratinocytes showed an impaired 
migration into the wounded area as well as a reduced proliferation resulting in a slower growth 
of the neo-epidermis. Those defects were analogous to the in vitro phenotype of Rac1-deficent 
fibroblasts, which show decreased proliferation, impaired directed migration and wound closure 
(Vidali et al., 2006).  
While the reduced proliferation seemed to be caused by an impaired activation of the 
MAPK/ERK signalling cascade (Tscharntke et al., 2007), which is known to induce G1/S cell 
cycle progression (Roux and Blenis, 2004), the loss of Rac1 could affect cell migration in several 
ways. Because Rac1 was shown to regulate the formation of focal complexes (Rottner et al., 
1999), it is possible that the absence of Rac1 in migrating keratinocytes impairs the 
establishment of new cell-ECM contacts in the leading edge. The loss of Rac1 could also inhibit 
the formation of membrane protrusions as it was demonstrated in Rac1-deficient fibroblasts in 
vitro (Vidali et al., 2006). In addition, the RhoA-dependent actin/myosin contractility, which is 
important for cell migration, could be reduced in the absence of Rac1. 
Furthermore, Rac1 could be important for the recruitment of bulge stem cells during 
re-epithelialization. It was shown that, while bulge stem cells are not involved in epidermal 
homeostasis, they are mobilized during epidermal wound healing (Ito et al., 2005). In addition to 
influencing the migration of progenitor cells from the bulge into the wounded area, Rac1 might 
play a role in the activation of bulge stem cells. In order to investigate the ability of 
Rac1-deficient bulge stem cells to contribute to the wound closure, rac1fl/fl,cre mice could be 
intercrossed with reporter mice allowing for the visualization of bulge stem cell-derived 
keratinocytes, which were described previously (Morris et al., 2004). 
 
Taken together, the data presented in this thesis show that Rac1 plays an important role 
during the epithelial wound closure in vivo by regulating proliferation and migration of 
epidermal keratinocytes.  
Discussion 
128 
4.4 Severe spreading defect leads to death of Rac1-deficient primary 
keratinocytes in vitro 
An interesting finding of this study is that, in contrast to the rather mild phenotype observed 
in vivo, deletion of the rac1 gene in keratinocytes has severe consequences in vitro. Although 
Rac1-deficient primary keratinocytes displayed only a mild adhesion defect, they were not able 
to spread and failed to form lamellipodia. Finally, almost all Rac1-deficient cells rounded up and 
detached. Mutant cells, which remained attached, could form focal contacts but failed to develop 
larger focal adhesions, most likely because of the strongly impaired actin cytoskeleton. The fact 
that neither apoptosis was increased nor the differentiation state of isolated keratinocytes was 
altered indicates that the cell detachment was caused primarily by the inability of Rac1-deficient 
cells to spread. 
While not reflecting the in vivo situation, those defects resembled in vitro phenotypes 
observed in other cell types after inactivation of the rac1 gene. The absence of Rac1 in murine 
embryonic fibroblasts causes impaired spreading as well as defective focal adhesion and stress 
fibre formation (Guo et al., 2006; Vidali et al., 2006). Rac1-deficient macrophages display 
dramatic cell shape changes and impaired podosome assembly (Wells et al., 2004; Wheeler et 
al., 2006). Also, epiblast cells isolated from Rac1-deficient embryos show spreading and 
adhesion defect (Sugihara et al., 1998). Therefore, there seems to be no doubt that Rac1 is 
indeed crucial for the regulation of the actin cytoskeleton, cell spreading and the formation of 
integrin-based cell-EMC adhesions in different cell types in vitro.  
However, the dramatic difference between the consequences of the rac1 gene deletion in 
keratinocytes in vivo and in vitro demonstrates that the results obtained from studies of in vitro 
model systems have to be considered carefully and can not be simply used to predict the function 
of a given protein in vivo.  
4.5 Discrepancies between epidermal phenotypes resulting from the 
lack of Rac1  
While the study described in this thesis was ongoing, another group reported the analysis of 
mice with a keratinocyte-restricted deletion of the rac1 gene (Benitah et al., 2005). The loss of 
Rac1 was induced locally in the skin of adult mice and resulted in severe epidermal defects. 
Those mice displayed transient hyperproliferation of epidermal cells, which was followed by a 
progressive disorganization of the basal layer and, finally, a complete loss of epidermal 
keratinocytes. All mutant mice died shortly afterwards. The severe defects were attributed to the 
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increased expression of c-Myc, which caused an enhanced terminal differentiation of basal 
keratinocytes leading to the depletion of the epidermal stem cell compartment (Benitah et al., 
2005). That phenotype is dramatically different from the data obtained in this study, which show 
that the Rac1-deficient epidermis was maintained even in 2-year-old mice and that the 
expression of c-Myc was not altered in the absence of Rac1. The lack of epidermal keratinocytes 
deterioration in rac1fl/fl,cre mice, shows that the stem cell renewal was not compromised. 
The simplest explanation for the contradictory results would be that Benitha and co-authors 
created a complete knockout, while some functional Rac1 protein was left in the mutant mice 
described here. The other group used mice, where the rac1 gene was inactivated by deletion of 
exon 1 (Glogauer et al., 2003), while in this study exon 3 was targeted. The latter strategy might 
theoretically result in a synthesis of a partial Rac1 protein, consisting of amino acids encoded by 
exon 1 and exon 2 (3.1). However, no evidence for the presence of such a polypeptide was 
provided by Western blot analysis performed with two different monoclonal antibodies 
(Fig. 3.5). In addition, it is extremely unlikely that such a short protein, which can not bind 
nucleotides or interact with effector proteins, could functionally replace full-length Rac1. It 
should be also noted, that the phenotype of Rac1-deficient EBs generated in this study closely 
reflects the defects of Rac1-null embryos, demonstrating that deletion of exon 3 leads to a 
complete absence of functional Rac1 protein. 
Another explanation for the contrasting results could be the different time point of Rac1 
deletion. While in the rac1fl/fl,cre mice the deletion of the rac1 gene was endogenously activated 
during embryogenesis by Cre recombinase expressed under the control of K5 promoter, Benitah 
and co-authors induced the gene deletion in adult mice by application of 4-hydroxy-tamoxifen 
(4OHT), which activated the Cre-estrogen receptor fusion protein expressed under the control of 
K14 promoter (Vasioukhin et al., 1999). It is possible, that the deletion of Rac1 during 
embryogenesis allows for a compensatory response, such as upregulation of other Rho GTPases, 
which can not be initiated in the adult tissue. While, the most likely candidates such as Rac2 and 
Rac3 or Cdc42 and RhoA seem to be not involved, as discussed above (4.2), compensatory 
upregulation of other signalling molecules can not be excluded. 
Different genetic backgrounds of the mouse strains used for the analysis in these studies 
could also contribute to the observed differences. In epidermal growth factor receptor-deficient 
mice, for example, the phenotype varies from placental defects to postnatal defects in different 
tissues depending on the strain of analysed mice (Sibilia et al., 1998). 
Finally, it is possible that differences between epidermal phenotypes resulted from 
unspecific effects related to the 4OHT-treatment, which were more severe in the Rac1-deficient 
Discussion 
130 
epidermis. This notion is supported by the observation that the application of 4OHT/acetone to 
the skin of rac1fl/fl,cre mice caused a transient hyperthickening of the Rac1-deficient epidermis 
(Fig. 3.36), which was similar to the initial phenotype reported by Benitah and co-authors 
(Benitah et al., 2005), while having only minor effect on the control epidermis. While the later 
defects described in that study were not observed, indicating that other factors also play a role, 
these data show that the 4OHT-treatment is not neutral and could have contributed to observed 
differences.  
Altogether, the data of this study clearly demonstrate that the presence of Rac1 is not 
essential for stem cell maintenance in the epidermis. This conclusion is supported by a recent 
publication, which showed that transgenic mice expressing DN-Rac1 in basal keratinocytes do 
not display any epidermal defects under the physiological conditions as well (Tscharntke et al., 
2007). 
4.6 The role of Rac1 in embryonic development 
Constitutive deletion of the rac1 gene leads to early embryonic lethality at the onset of 
gastrulation. It was concluded that mutant embryos failed to develop the mesoderm due to 
migration and ECM-adhesion defects of epiblast cells (Sugihara et al., 1998). In order to 
investigate the role of Rac1 during embryogenesis in more detail and to analyse its importance 
for the formation of cell-cell contacts during epithelial differentiation and polarization, EBs were 
generated from Rac1-deficient ES cells. 
Similar to the in vivo situation, Rac1-deficient EBs were able to form the endoderm as well 
as the embryonic ectoderm (epiblast) (3.8.2). The differentiation and polarization of these cell 
layers as well as the deposition of the BM were rather normal in the absence of Rac1 (3.8.3). 
However, as in vivo, some mutant epiblast cells were apparently dying, despite their proximity to 
the BM, showing that the presence of Rac1 is important for sustained cell-ECM adhesion or 
adhesion-dependent cell survival. The role of Rac1 in the regulation of apoptosis and thus 
cavitation was also suggested by the observation that this process seemed to be less efficient in 
the absence of Rac1. As this in vitro model seems to closely replicate the in vivo phenotype 
resulting from the constitutive lack of Rac1, further studies of these defects should result in 
clarifying the exact functions of Rac1 in the early embryonic development. 
It is also interesting to note that the absence of Rac1 had no apparent effect on the 
establishment of tight junctions as well as cadherin-based cell-cell contacts between 
differentiating cells (3.8.4), further indicating that the function of Rac1 in establishment of 
cell-cell adhesion is not as essential as suggested by previous in vitro studies.  
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Since the in vivo model generated in this study did not allow for the analysis of the role of 
Rac1 during the development of the epithelial cell lineage, Rac1-deficient EBs were further 
differentiated to investigate that process (3.8.5). The obtained results showed that epithelial 
sheets could form normally in the absence of Rac1. They demonstrated also that Rac1 is not 
required for the differentiation of ES cells into endothelial and neuronal cells as well as 
cardiomyocytes. As the formation of a vascular network seemed to be impaired, it could be 
interesting to analyse in the future the role of Rac1 during vasculogenesis in vivo. 
4.7 Future prospects 
The results of this study indicate that, while Rac1 is not essential for the epidermal 
homeostasis in physiological conditions, it seems to play an important role in pathological 
situations such as wound healing.  
It is interesting to note, that Rac1 is frequently overexpressed in human breast cancers and 
oral squamous cell carcinomas (Fritz et al., 1999; Liu et al., 2004). In addition, it was shown that 
DN-Rac1 prevents Ras-induced transformation of fibroblasts (Qiu et al., 1995) and decreases 
tumour formation and malignancy of a squamous cell carcinoma line (Kwei et al., 2006). 
Moreover, mice lacking the Rac1-specific GEF Tiam1 are rather resistant to Ras-induced skin 
tumours (Malliri et al., 2002). All these data suggest an involvement of Rac1 in tumourigenesis 
and tumour progression.  
The mice lacking Rac1 in the epidermis, generated in this study, provide an excellent tool to 
study the role of Rac1 during chemically induced tumour formation and malignant conversion. 
 
In addition, rac1fl/fl mice, which were generated in this study, can be used to inactivate the 
rac1 gene in other tissues by intercrossing them with different transgenic mice expressing the 
Cre recombinase in the cell type of interest. 
They were already used to analyse the role of Rac1 in oligodendrocytes in vivo. Those 
experiments revealed that Rac1 regulates axon myelination in the central nervous system 
(Thurnherr et al., 2006). In another study, the deletion of Rac1 in the peripheral nervous system 
demonstrated its role in radial sorting of axons in sciatic nerves (Benninger et al., submitted 
manuscript).  
Ongoing studies are investigating the role of Rac1 in other cell types, e.g. platelets or 
chondrocytes. They will no doubt contribute to the better understanding of the in vivo function of 
Rac1. 
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5 SUMMARY 
Rac1 is a ubiquitously expressed member of the Rho family of small GTPases, which acts as 
a molecular switch by shuttling in a highly regulated manner between an active (GTP-bound) 
and an inactive (GDP-bound) state. Different signalling pathways, which involve integrins, 
growth factor receptors, cadherins as well as other Rho GTPases, can induce Rac1 activation. 
Only in the GTP-bound form, Rac1 can associate with different effector molecules to initiate 
cellular responses.  
Initially described as an important regulator of the actin cytoskeleton, Rac1 was later found 
to be also involved in the modulation of other processes such as cell adhesion, proliferation, 
survival, differentiation and migration. In epithelial cells, Rac1 was shown to regulate the 
formation and maintenance of cadherin-dependent cell-cell contacts, which are essential for the 
establishment of the polarized cell morphology. 
Before this project was initiated, almost all knowledge about the function of Rac1 was based 
on in vitro studies. As constitutive deletion of the murine rac1 gene leads to early embryonic 
lethality, mice allowing for a conditional inactivation of the rac1 gene were generated in this 
study to enable the analysis of the function of Rac1 in selected tissues. To investigate the role of 
Rac1 in the epidermis and hair follicles and to determine its function in the establishment and 
maintenance of cell-cell contacts between epithelial cells in vivo, mice with a keratinocyte-
restricted ablation of the rac1 gene were generated and analyzed. 
The results obtained in this study showed that the absence of Rac1 in the murine epidermis 
leads to a progressive hair loss but surprisingly has no effect on the maintenance of the 
epidermis. The hair loss is caused by the inability of hair follicle keratinocytes to maintain their 
differentiation state, which leads to the phagocytic removal of the non-permanent parts of the 
hair follicles by infiltrating macrophages. In contrast, differentiation and proliferation of 
epidermal keratinocytes as well as the formation and maintenance of cell-cell and cell-matrix 
contacts, and the deposition of the basement membrane in the epidermis are not affected by the 
loss of Rac1. Biochemical analysis of epidermal lysates demonstrated that the absence of 
epidermal defects in vivo is not a result of compensatory upregulation of closely related members 
of the Rho family of GTPases, further indicating that the function of Rac1 in epithelial cells in 
vivo is limited. Also, the analysis of the formation of the embryoid bodies from Rac1-deficient 
embryonic stem cells showed that the presence of Rac1 is not required for the establishment of 
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cell-cell contacts during differentiation of the polarized primitive ectoderm and for the formation 
of epithelial sheets, supporting the conclusion that the function of Rac1 in the regulation of 
cell-cell adhesion between epithelial cells is dispensable.  
However, the re-epithelialization after wounding was impaired in the mutant epidermis, 
demonstrating that Rac1 plays an important role in pathological conditions. The delayed wound 
closure in the absence of Rac1 is caused by impaired cell migration and proliferation of 
neo-epidermal keratinocytes. 
Another interesting finding of this study was the observation that, in contrast to the steady 
state in vivo situation, isolated Rac1-deficent primary keratinocytes display severe defects in cell 
culture, which lead to their detachment from the matrix. While the initial adhesion is only mildly 
affected by the lack of Rac1, mutant keratinocytes are unable to spread, show an impaired 
organization of the actin cytoskeleton and fail to form mature focal adhesions.  
The differences between in vivo and in vitro effects resulting from the inactivation of the 
rac1 gene indicate that the function of Rac1 in epithelial cells depends on the complexity of the 
cellular system and emphasize the importance of performing in vivo studies to fully understand 
its role. 
 
Taken together, the data presented in this study show that Rac1 plays an important role in the 
maintenance of hair follicles and during epidermal wound healing, but that it is not essential for 
the homeostasis of the epidermis in physiological conditions and for the formation and 
maintenance of cell-cell contacts between epithelial cells in vivo. 
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7 APPENDIX CD 
Supplementary CD contains two time-lapse video microscopy movies (2.5.4.6) which are 
referred to in chapter: Severe spreading defect of Rac1 deficient keratinocytes (3.7.4). It can be 
found in the envelope glued to the inside back cover. 
Movies are provided in two different formats and can be viewed using standard media 
players, e.g. Windows Media Player (*.avi) or QuickTime (*.mov). 
 
Movie 1. Time lapse microscopy of primary control keratinocytes.  
Cells isolated from an adult control mouse were seeded on collagen I/fibronectin (Col/FN) 
coated plastic and recorded for 42 h. Adherent keratinocytes spread and remained attached. 
Pictures were taken every 20 min. Display rate: 5 frames/s. Time format: day/hour/minute. 
Bar: 100 µm. 
 
Movie 2. Time lapse microscopy of primary Rac1-deficient keratinocytes.  
Cells isolated from an adult mutant mouse were seeded on collagen I/fibronectin (Col/FN) 
coated plastic and recorded for 42 h. The majority of adherent Rac-1 null keratinocytes were not 
able to spread to the full extent (first three arrows) or not at all (fourth arrow). Finally, most of 
the mutant adherent cells rounded up and detached, including some cells that were almost fully 
spread (last two arrows). Many fewer cells were attached and spread after 42 h, compared to 
control keratinocytes (see Movie 1).  
Pictures were taken every 20 min. Display rate: 5 frames/s. Time format: day/hour/minute. 
Bar: 100 µm. 
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